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Neural stem cells (NSCs) give rise to the nervous system during development, and 
persist in the adult to replace neurons in certain regions of the brain. NSCs can be 
isolated and maintained as neurospheres in vitro, and give rise to neurons, 
oligodendrocytes and astrocytes upon differentiation. Chondroitin sulfate 
proteoglycans (CSPGs) are components of the extracellular matrix and are involved in 
neural development. Here I show that CSPG is a component of the NSC-conditioned 
medium (NSC-CM), and is partly responsible for the ability of NSC-CM to stimulate 
neurosphere formation. Neurospheres can arise from NSCs or lineage restricted 
progenitors. To determine whether CSPG stimulates NSCs or progenitors, two 
cardinal features of stem cells were evaluated, self-renewal and multipotency. CSPG 
generated neurospheres can be expanded for at least seven times, and demonstrate 
increased proliferation in the neural colony forming cell assay (NCFCA). Clonally-
derived neurospheres from CSPG treated cultures show increased multipotency. 
CSPG generated neurospheres display similar genetic profile as controls. The NSC 
frequency was estimated based on the percentage of clonally-derived neurospheres 
that displayed multipotency. CSPG increases the NSC frequency by more than three-
fold. Thus CSPG stimulates NSC survival. CSPG also increases neurosphere size and 
reduces the population doubling time of neurospheres in culture, indicating that CSPG 
stimulates proliferation. In addition, CSPG is involved in maintaining the 3-
dimensional structure of neurospheres. Using chondroitinase-ABC, sodium chlorate, 
β-D-xyloside and differentially sulfated chondroitin sulfate glycosaminoglycans (CS-
GAGs), I dissected the structure of CSPG and attribute the regulation of NSC survival 
and proliferation to the full proteoglycan structure including specific sulfation motifs, 
viii 
whereas maintenance of the neurosphere structure requires only the CS-GAG. Lastly, 
I demonstrate that CSPG functions in NSC survival and proliferation via EGFR, 
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1.1. Mammalian development 
During mammalian development, the zygote (fertilized egg) goes through a series of 
cleavages whereby the large egg is divided into numerous smaller, nucleated cells 
called blastomeres. At the eight-cell stage compaction occurs to form a compacted 
eight-cell embryo. A subsequent round of cell division produces the 16-cell morula 
consisting of a small group of internal cells surrounded by a larger group of external 
cells. Most of the external cells1 go on to form the trophectoderm and give rise to 
chorion (the embryonic portion of the placenta), while the inner cells generate the 
inner cell mass (ICM) and form the embryo proper including the yolk sac and amnion. 
The trophectoderm and the ICM become separate cell layers by the 64-cell stage and 
no longer contribute cells to each other. This marks the first differentiation event in 
mammalian development, and it is required for the early embryo to attach to the 
uterus. Subsequently, cavitation occurs whereby the trophoblast cells secrete fluid to 
fill the morula and the ICM shifts to one side to form a structure known as the 
blastocyst. The blastocyst then leaves the zona pellucida (the extracellular matrix 
(ECM) of the egg) and implants into the uterine wall. The ICM further delaminates to 
form the epiblast which generates the actual embryo and hypoblast that forms the 
extraembryonic endoderm. The next step is gastrulation, a process whereby the 
epiblast cells undergo extensive migration to form the body plan (Figure 1.1). 
Gastrulation begins at the posterior end of the embryo where the epiblast cells ingress 
to form the primitive streak. The streak elongates towards the future head region and  
                                                 
1 Some trophoblast cells contribute to the embryo proper during the transition to the 32-cell stage.  
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defines the axes of the embryo. A depression in the streak called the primitive groove 
allows epiblast cells to migrate into the blastocole (region between the epiblast and 
hypoblast) to form the endoderm and mesoderm. The ectoderm is formed from the 
remaining epiblasts that did not migrate into the blastocole. These three germ layers 
go on to produce the various tissues in the body (Figure 1.2). The endoderm is the 
innermost layer and gives rise to the digestive tube and its associated organs including 
the lungs. The ectodermal layer on the outside forms the skin, nerves and pigment 
cells. The mesoderm is in between and forms the blood, heart, kidneys, bones and 
connective tissues (Gilbert, 2000).  
1.2. The stem cell concept 
Once development has been completed, many adult tissues are not replaced. For 
example, most neurons and bones cannot be replaced after injury. However, some 
tissues such as the skin and blood are constantly being replaced, and this requires a 
specialized population of cells, the stem cells. Stem cells are uncommitted cells that 
have the potential to give rise to differentiated cell types in the body. During 
development, the zygote proliferates and differentiates to give rise to all cell lineages 
of an organism including extraembryonic tissues such as the placenta (Figure 1.2). 
This characteristic of the zygote is termed totipotency, and is extended to about the 
four-cell blastomere stage (Van de Velde et al., 2008). Cells become progressively 
more restricted with development until the final mature cell types are formed. In the 
adult, stem cell reservoirs persist in most tissues such as the blood and skin to 
maintain homeostasis of the tissue throughout life. Even the central nervous system 
(CNS) which was originally thought to lack regenerative capacities is now known to 
contain stem cells (see section 1.6.2). However, tissue regeneration in mammals is  
  









Figure 1.1. Amnion structure and cell movements during human gastrulation.  
(A) Human embryo and uterine connections at day 15 of gestation. On the left, the embryo is cut sagittally through the midline; the right view 
looks down upon the dorsal surface of the embryo. (B) The movements of the epiblast cells through the primitive streak and Hensen's node. At 
days 14 and 15, the ingressing epiblast cells are thought to replace the hypoblast cells (which contribute to the yolk sac lining), while at day 16, 







Figure 1.2. Differentiation of human tissues. 
The totipotent zygote gives rise to the blastocyst. This in turn gives rise to the three 
germ layers of the developing embryo. Ectoderm is the outermost layer and forms the 
skin, nerves and pigment cells. Endoderm is the innermost layer and forms the 
digestive tract, the lungs and associated organs. Sandwiched in between the two is the 
mesoderm that forms muscles (cardiac and smooth muscles of the gut), kidney tubule 







poor and injuries are normally repaired by formation of fibrous scar tissues 
(Klussmann and Martin-Villalba, 2005; Sun and Weber, 2000) which is different from 
the ability of some metazoans, such as planarians, uredale amphibians and zebrafish, 
to regenerate body organs and appendages (Brockes and Kumar, 2005). 
 
Stem cells can be isolated from the ICM (embryonic stem cells, ESCs) or from 
particular tissues (somatic stem cells, SSCs). SSCs can be further categorised into 
embryonic or adult depending on the source from which they were isolated. Cells in 
the ICM are pluripotent as they give rise to the organism but not the extraembryonic 
tissues, while SSCs are multipotent as they can only differentiate into the cell types of 
the tissue from which they were isolated. In addition to their differentiation potentials, 
defining characteristics of stem cells also include the capacity to create more stem 
cells (self-renewal), to proliferate extensively, maintain multipotency over an 
extended period of time, and to reconstitute the tissue from which the stem cell is 
derived (Potten and Loeffler, 1990). Thus in general the definition of a stem cell is 
based on its functional properties and this is due to limited definitive markers 
available for these cells.  
 
There is a great deal of interest in stem cells because of their therapeutic potential. 
They can potentially be used for cell replacement therapies to treat diseases such as 
Parkinson’s disease (PD) and muscular dystrophy (Master et al., 2007; Price et al., 
2007). Transplanted stem cells can also be used to deliver natural or genetically 
engineered trophic factors and therapeutic molecules. For ex vivo applications, stem 
cells can be induced to differentiate into homogeneous cell types for tissue specific 
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drug testing and disease modelling. They can also be used as a model to understand 
development (Singec et al., 2007).  
 
1.3. Symmetrical and asymmetrical division 
Self-renewal is an important criterion for stem cells. In the strictest sense, self-
renewal means that the cell makes an exact copy of itself i.e. symmetrical division. 
However, this is difficult to demonstrate unless markers such as changes in protein 
expression are available to distinguish a stem cell and a more restricted progenitor 
cell. When such markers are not available, the potential of the daughter cells is used 
to determine whether self-renewal has occurred. Thus if the daughter cell retains the 
developmental potential of the mother stem cell i.e. able to copy itself and 
differentiate into the same types of cells as the mother cell, then the mother cell is said 
to have renewed itself.  
 
Stem cells can divide symmetrically or asymmetrically. The former process leads to 
the expansion of the stem cell pool while the latter generates differentiated progeny as 
well as maintains the stem cell population. Much of the knowledge regarding stem 
cell division has been gained from studies in model organisms such as Caenorhabditis 
elegans and Drosophila. Two main mechanisms are involved in asymmetrical 
division, asymmetric partitioning of cell components that determine cell fate, and 
asymmetric positioning of the daughter cell relative to external cues (Morrison and 
Kimble, 2006). For example, in C. elegans PAR proteins are asymmetrically localised 
to regulate cell division (Gonczy and Rose, 2005). In Drosophila the cell fate 
determinant prospero is segregated to the ganglion mother cell and excluded from 
undifferentiated neuroblasts, while numb is involved in specifying the type of neuron 
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that will be generated (Spana and Doe, 1995; Spana et al., 1995). The numb protein is 
also involved in asymmetrical division in mammalian neural stem cells (NSCs) where 
it is segregated into daughter cells destined for neuronal differentiation (Shen et al., 
2002; Zhong et al., 1996). Positional regulation of asymmetrical division can be 
demonstrated in tissues such as the epidermis. The stem cell in the basal layer divides 
to form one daughter cell that remain in the basal layer and retains stem cell 
properties, while the other daughter cell migrates into the suprabasal layer where it 
divides symmetrically several times before terminal differentiation (Lechler and 
Fuchs, 2005). Asymmetrical division occurs during embryogenesis and continues into 
adulthood to maintain homeostasis in certain tissues such as the nervous system. 
Symmetrical division is largely an embryonic activity. However, during injury, stem 
cells can adopt this form of cell division to expand and replenish the depleted stem 
cell pool (Morrison and Kimble, 2006).  
 
1.4. Types of stem cells 
1.4.1. Embryonic stem cells 
During embryogenesis, the ICM differentiates to form the three germ layers from 
which all the tissues of the organism are derived (Figure 1.2). ESCs are isolated from 
the ICM and retain the pluripotent nature of the ICM. This is demonstrated by their 
ability to form teratocarcinomas containing differentiated cells from the three germ 
layers as wells as undifferentiated cells when injected ectopically into mice. In 
addition, ESCs have been used extensively to generate transgenic animals as they 
have the unique ability to re-enter embryogenesis even after long term culture. When 
injected into the pre-implantation embryo, ESCs integrate uniformly into the embryo, 
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forming functional differentiated progeny in all tissues and organs (Smith, 2001). In 
culture, the pluripotency of ESCs is maintained by culturing with embryonic 
fibroblast feeder cells and leukaemia inducing factor (LIF) and can be induced to 
differentiate into a variety of committed cell types (Singec et al., 2007). The 
identification of human ESCs (hESCs) holds great potential for therapeutic purposes 
since hESCs are similar to their mouse counterparts in terms of self-renewal and 
differentiation capacity. The potential to differentiate into any cell type allows the 
possibility of developing a source of ready-to-use cells. ESCs may also be used to 
correct genetic defects in the treatment of diseases such as type I diabetes 
(Choumerianou et al., 2008). Furthermore, hESCs mimic aspects of early 
development in their ability to form complex teratomas consisting of a range of 
differentiated somatic tissues. Some of these tissues appear highly organised and 
resemble normal embryonic and adult structures (Przyborski, 2005). Thus hESCs can 
be used as a model system for the study of human embryogenesis.  
 
Some limitations involved in using ESCs include the possibility of teratoma formation 
when grafts are contaminated with undifferentiated cells, and the risk of cross species 
contamination as hESCs are normally cultured with feeder cells and animal serum. 
Efforts to overcome these limitations include improving differentiation and 
purification protocols to increase the yield of differentiated cells, and culturing hESCs 
in feeder-free defined medium (Choumerianou et al., 2008). Perhaps more 
challenging than these practical issues are the ethical constraints when working with 
hESCs. The need to obtain these cells from embryos (left over from in vitro 
fertilisation) has raised strong opposition from some religious groups and 
policymakers based on the argument that blastocyst stage embryos are sentient human 
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beings. The ability to derive hESCs from single blastomeres without destroying the 
embryo may help to alleviate some ethical concerns (Klimanskaya et al., 2006). 
However, other issues have been raised regarding this procedure, including the 
possibility that removing a cell from the embryo might affect its survival and 
development (Pearson, 2006). More recently a new type of pluripotent stem cell 
known as inducible pluripotent stem (IPS) cells was introduced, whereby adult 
fibroblasts are reprogrammed using four transcription factors, Oct3/4, Sox2, Klf4, and 
c-Myc (Takahashi et al., 2007; Wernig et al., 2007). If this method can be 
demonstrated to be as robust as the current derivation of ESCs it may eliminate the 
need for ESCs altogether. 
 
1.4.2. Somatic stem cells 
SSCs are tissue specific stem cells. They are more restricted in their potential 
compared to ESCs and are known as multipotent stem cells. The major advantages of 
using SSCs over ESCs include no risk of teratoma formation and relative ease of 
differentiation into the desired cell types compared to ESCs since they are already 
restricted to the lineage of choice. Furthermore, extraction of SSCs from adult tissues 
can reduce ethical concerns as consent from patients can be obtained. In addition, 
isolating stem cells from the patient will eliminate the problem of immune rejection 
with non-autologous transplants. However, with perhaps the exception of skin and 
bone marrow, adult stem cells are generally very difficult to obtain. For example, in 
the nervous system NSCs reside deep in the adult brain and thus can only be extracted 
from deceased individuals or derived from embryos. So autologous transplantation of 
NSCs will not be possible. Further discussions on NSCs, the focus of this thesis, will 
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be provided in section 1.6. Here I will give a brief overview of a few other types of 
SSCs. 
 
The blood has a rapid turnover rate as erythrocytes only have an average lifespan of 
120 days in humans. Worn out erythrocytes are removed by macrophages in the liver 
and spleen, which remove more than 1011 senescent erythrocytes on a daily basis 
(Alberts, 2002). Thus maintenance of blood homeostasis is the job of haematopoietic 
stem cells (HSCs) found in the bone marrow. HSCs are the most well studied type of 
SSC with a history of more than 50 years. HSCs isolated from the bone marrow, can 
differentiate into all of the cell types of the haematopoietic system (Figure 1.3) and 
reconstitute the blood system of a lethally irradiated host. HSC is the first type of SSC 
to be highly enriched by cell surface marker sorting (Spangrude et al., 1988). 
Although these cells can be isolated based the presence of a number of surface 
antigens, transplantation and reconstitution of the haematopoietic tissue remain key 
requirements for confirmation of the identity of these cells. Haematopoietic cell 
transplant is the first type of stem cell therapy applied to the clinics and has become 
standard practice to treat blood and autoimmune disorders (Weissman, 2000). 
Although prospective purification of HSCs is possible, current transplantation 
procedures still use a heterogeneous population of cells. This is because the presence 
of mature cell types in the bone marrow inoculum also plays a role in the proper 
reconstitution of the blood. Thus, transplantation of purified HSCs will need to be 
optimized with appropriate introduction of more mature cell types including 
neutrophils to confer immunity, and red blood cells and platelets to reduce transfusion 
dependency (Weissman and Shizuru, 2008). 
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The bone marrow also contains another type of stem cell, the mesenchymal stem cells 
(MSCs), which give rise to bone, cartilage, adipocytes and muscle cells. MSCs have 
mainly been studied for their in vitro differentiation capacities, whereas their role in 
normal tissue homeostasis is less well understood (Riazi et al., 2009). Two reports 
suggest that MSCs may be involved in maintenance of bone mineral density during 
aging as decreased MSC self renewal in Sca-1 mice resulted in premature type II 
osteoporosis (Bonyadi et al., 2003; Holmes et al., 2007). MSCs can also be derived 
from other tissue sources including adipose tissue, the umbilical cord and hair 
follicles. In the clinic MSCs have been used to treat bone diseases such as 




Figure 1.3. Haematopoietic and stromal cell differentiation  
© 2001 Terese Winslow 
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The skin epidermis is the largest organ of the body and provides a protective barrier 
against harmful microbes as well as retaining essential body fluids. Being on the 
outside, it receives constant assaults, including ultraviolet radiation from the sun, 
scratches and wounds. Thus continuous self-renewal occurs in the skin to repair 
damage and replace old cells. Epidermal stem cells (EpSCs) reside in adult hair 
follicles, the epidermis and sebaceous glands (Fuchs, 2007). In the hair follicle EpSCs 
reside in a specialized compartment called the bulge, where they are involved in the 
cyclic regeneration of hair cells (Figure 1.4). Bulge cells are normally quiescent and 
only become activated at the start of each hair cycle. In addition, they are activated 
during tissue damage and participate in wound healing (Blanpain and Fuchs, 2006). In 
the skin epidermis between hair follicles the basal cells also display stem cell 
characteristics. They are involved in the regeneration of the epidermis, which occurs 
every four weeks in humans, and wound repair (Fuchs, 2007). The sebaceous gland 
contains progenitors that give rise to sebocytes, cells that release oils to lubricate and 
protect the skin when they disintegrate at the end of their cell cycle. In terms of 
clinical applications EpSCs have been propagated from severely burned patients and 
autologous grafting of these cells leads to functional re-epithelialisation of the 
damaged skin (Pellegrini et al., 1999; Ronfard et al., 2000). In addition to their ability 
to regenerate the epidermis, EpSCs have been shown to generate neurons, glial cells 
smooth muscle and melanocytes (Amoh et al., 2005a; Amoh et al., 2005b). EpSCs are 
more accessible than other SSCs which will be their major advantage.  
 
  












Figure 1.4. Epidermal stem cell niche. 
A) Structure of the hair follicle and its surrounding tissue. In the epidermis, EpSCs reside in the basal layer and self-renews while producing 
differentiated keratinocytes that migrate out to form the external layers of the skin. The sebaceous gland also contains progenitors that replenish 
the sebocytes. Inner root sheath (IRS), dermal pillar (DP), matrix (Mx), outer root sheath (ORS). Modified from (Blanpain and Fuchs, 2006). B) 
The bulge contains infrequently cycling, label-retaining cells, which include multipotent stem cells (green) that can generate the new hair follicle 
during cycling and repair the epidermis on injury. The bulge is in a specialized niche, surrounded by other cell types, which together provide 
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1.4.3. Stem cells and cancer 
Stem cells and cancer cells share many common properties including the ability to 
self-renew, proliferate and migrate extensively. However, while in stem cells these 
functions are tightly regulated including appropriate apoptosis, in cancer cells these 
abilities are thought to arise as a result of deregulation. Studies in stem cell biology 
have provided new insights into cancer biology and vice versa. Classical pathways 
associated with cancer have been found to operate in stem cells (Figure 1.5). Cancer is 
thought to arise from the transformation of normal stem cells. Because of their 
extended lifespan and self-renewal properties stem cells are easier to transform 
compared to differentiated cells through the accumulation of mutations (Reya et al., 
2001). Cells capable of initiating human acute myeloid leukaemia (AML) in mice are 
phenotypically similar to normal HSCs in terms of marker expression and self-
renewal ability (Bonnet and Dick, 1997). Mutations associated with various form of 
leukaemia can also be found in HSCs (George et al., 2001; Miyamoto et al., 2000). 
Cancer cells are heterogeneous and only a small number of cells are clonogenic in 
culture and in vivo (Reya et al., 2001). This gave rise to the idea of cancer stem cells 
i.e. these are the only cells that can self-renew and lead to propagation of the cancer. 
The implication of this is that better identification and characterisation of these cancer 

















Figure 1.5. Self-renewal signalling pathways in stem and cancer cells 
Wnt, Shh and Notch pathways have been shown to contribute to the self-renewal of stem cells and/or progenitors in a variety of organs, 
including the haematopoietic and nervous systems. When deregulated, these pathways can contribute to oncogenesis. Mutations of these 
pathways have been associated with a number of human tumours, including colon carcinoma and epidermal tumours (Wnt), medulloblastoma 
and basal cell carcinoma (Shh), and T-cell leukaemia (Notch). (Reya et al., 2001) 
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1.5. Neural development 
Before embarking on the discussion of NSCs, a brief introduction of neural 
development is appropriate. Once the formation of the three germ layers is completed 
during the gastrulation stage, the process of neurulation begins. During late 
gastrulation, invaginations of the mesoderm along the primitive streak results in the 
formation of the notochord, a column of cells that extend along the anterior-posterior 
axis of the embryo and defines the midline of the embryo. Signals from the notochord 
induce the ectodermal layer immediately above it to thicken into the neural plate 
(Figure 1.6A). The lateral margins of the neural plate then fold together to form the 
neural tube which will develop into the brain and spinal cord (Figure 1.6B & C). The 
neural plate directly above the notochord becomes the floorplate which eventually 
gives rise to spinal and hindbrain motor neurons, while cells further away from the 
notochord develop into sensory neurons within the spinal cord and hindbrain. Where 
the edges of the neural plate meet to complete the neural tube, a group of cells known 
as the neural crest emerges (Figure 1.6C). These cells develop into the sensory and 
autonomic ganglia which are the major components of the peripheral nervous system. 
In addition they also migrate away from the neural tube to give rise to a variety of 
progeny, including the neurosecretory cells of the adrenal gland, the neurons of the 
enteric nervous system and non-neural structures such as pigment cells, cartilage, and 
bone. Adjacent to the region of the neural tube destine to form the spinal cord, the 
mesoderm thickens to form the somites that will develop into the axial musculature 
and skeleton (Figure 1.6C & D). Finally, the anterior neural fold closes and expands 
to form the brain. The major brain regions are formed through a series of 
morphogenetic movements that bend, fold, and constrict the neural tube (Figure 1.7).  
 
  











Figure 1.6. Neurulation in the mammalian embryo. 
On the left are dorsal views of the embryo at several different stages of early development; each boxed view on the right is a midline cross 
section through the embryo at the same stage. (A) During late gastrulation and early neurulation, the notochord forms by invagination of the 
mesoderm in the region of the primitive streak. (B) As neurulation proceeds, the neural plate begins to fold on itself, forming the neural groove 
and ultimately the neural tube. The neural plate immediately above the notochord differentiates into the floorplate, whereas the neural crest 
emerges at the lateral margins of the neural plate (farthest from the notochord). (C) Once the edges of the neural plate meet in the midline, the 
neural tube is complete. The mesoderm adjacent to the tube then thickens and subdivides into structures called somites—the precursors of the 
axial musculature and skeleton. (D) As development continues, the neural tube adjacent to the somites becomes the rudimentary spinal cord, and 
the neural crest gives rise to sensory and autonomic ganglia (the major elements of the peripheral nervous system). Finally, the anterior ends of 
the neural plate (anterior neural folds) grow together at the midline and continue to expand, eventually giving rise to the brain (Purves, 2001).
  











Figure 1.7. Regional specification of the developing brain. 
 (A) Early in gestation the neural tube becomes subdivided into the prosencephalon (at the anterior end of the embryo), mesencephalon, and 
rhombencephalon. The spinal cord differentiates from the more posterior region of the neural tube. The initial bending of the neural tube at its 
anterior end leads to a cane shape. Below is a longitudinal section of the neural tube at this stage, showing the position of the major brain 
regions. (B) Further development distinguishes the telencephalon and diencephalon from the prosencephalon; two other subdivisions—the 
metencephalon and myelencephalon—derive from the rhombencephalon. These subregions give rise to the rudiments of the major functional 
subdivisions of the brain, while the spaces they enclose eventually form the ventricles of the mature brain. Below is a longitudinal section of the 
embryo at the developmental stage shown in (B). (C) The foetal brain and spinal cord are clearly differentiated by the end of the second 
trimester.Several major subdivisions, including the cerebral cortex and cerebellum, are clearly seen from the lateral surfaces (Purves, 2001).
 Introduction:  19 
With the rudimentary regions of the brain in place neural precursors begin to 
differentiate into the permanent cellular elements of the brain – neurons and glia 
(Purves, 2001). 
 
1.6. Neural stem cells 
By definition, an NSC is a cell that is capable of giving rise to all of the cell types of 
the CNS. This includes the different types of neurons and glial cells in the different 
regions of the brain. In the embryonic CNS, neuroepithelial cells lining the ventricular 
zone (VZ) are thought to be stem cells (Figure 1.8). However, early transplantation 
work showed that retinal precursors are restricted to the retinal fate before neurons are 
present. This suggests that CNS precursor cells become committed to particular fates 
very early, some time between gastrulation and the differentiation of neurons 
(McKay, 1989). It is likely that as cells migrate during gastrulation and neurulation 
their fate become restricted to the final position they take. Thus, the true NSC is likely 
to exist prior to the proper formation of the neuroepithelium. However, it is possible 
to demonstrate the presence of multipotent precursors in the developing CNS. For 
example, vertebrate retina cell fate experiments have shown that a single precursor 
cell can give rise to 12 rods, one bipolar and one Müller glial cell (Turner and Cepko, 
1987). To date, there has been no demonstration of a single neural cell giving rise to 
all of the cell types of the CNS. Thus the term NSC really refers to neural precursor 
cells that can differentiate into the three main cell types of the nervous system, 
namely neurons, oligodendrocytes and astrocytes. In literature, a variety of names 
have been used for these cells, including neural precursors, neural progenitors and 
neural stem/progenitor cells, as researchers try to find the most fitting description for 
them. In this thesis, I will use the term NSC to refer to cells identified/isolated from 
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the nervous system (both embryonic and adult) that have the capacity to proliferate, 
self-renew and differentiate into neurons, astrocytes and oligodendrocytes. Neural 
progenitors will refer to cells that are derived from NSCs with limited capacity to self-
renew and differentiate. Neural precursors will refer to all cells that precede 
terminally differentiated cells, and thus will encompass both NSCs and progenitors.  
 
1.6.1. Embryonic neural stem cells 
During development neuroepithelial cells mature into radial glial cells (RGCs) which 
migrate into the subventricular zone (SVZ) to generate the basal progenitors (Figure 
1.8). The basal progenitors then differentiate into neurons that migrate into the 
marginal zone to form the different layers of the cortex (Merkle and Alvarez-Buylla, 
2006; Temple, 2001). Initially, neuroepithelial cells divide symmetrically to expand 
the stem cell pool (Figure 1.9). Subsequently asymmetrical division takes place to 
generate a daughter stem cell and a more differentiated cell such as a restricted 
progenitor (basal progenitor) or a terminally differentiated cell (neuron). The 
characteristic of neuroepithelial cells include interkinetic nuclear migration (the nuclei 
migrate up and down the apical-basal axis during the cell cycle; Figure 1.10) 
expression of prominin-1 at the apical membrane, and presence of tight junctions and 
adherent junctions at the apical end of the lateral plasma membrane (Götz and 
Huttner, 2005). RGCs are derived from the neuroepithelial cells and are distinct from 
the latter in several aspects. RGCs exhibit astroglia properties, such as expression of 
the glutamate-aspartate transporter (GLAST) protein and brain lipid binding protein 
(BLBP), in addition to residual neuroepithelial characteristics such as nestin 
expression and interkinetic nuclear migration (Campbell and Gotz, 2002; Kriegstein 
and Gotz, 2003). 
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Figure 1.8. NSCs and their progeny in the developing forebrain.  
The NSCs (shown in blue) of the lateral ventricular wall change their shape and 
produce different progeny as the brain develops. They begin as neuroepithelial cells 
and transform into radial glial cells, which mature into astrocyte-like cells. NSCs 
maintain contact with the ventricle, into which they project a primary cilium. The 
potential of an individual stem cell in vivo is not known and the progeny shown in this 
schematic are produced by the NSC population. Stem cells produce progeny either 
directly or via an intermediate progenitor (shown in green), which has been either 
included or omitted for clarity. Different types of progeny may be produced by 
different intermediate progenitors, although just one is shown here. (a) At early 
developmental stages the CNS is a tubular structure. It is made up of neuroepithelial 
cells, which divide symmetrically at the ventricular surface to expand the stem cell 
pool. At this time, some early-born neurons such as Cajal-Retzius cells are produced. 
(b) Neuroepithelial cells probably differentiate into embryonic radial glial cells, 
which divide to generate striatal neurons and oligodendrocytes either directly or via 
an intermediate progenitor in the subventricular zone (SVZ). The radial processes of 
radial glial cells support the migration of neuroblasts (shown in red). (c) Radial glial 
cells persist in the neonatal brain, where they generate oligodendrocytes, olfactory 
bulb interneurons, and ependymal cells. They also generate astrocytes, some of which 
remain stem cells in the adult. (d) In the adult brain, neurogenic astrocytes often retain 
a radial process and contact both the ventricle and the basal lamina of blood vessels. 
They generate oligodendrocytes and olfactory bulb interneurons. Stri, striatum; VZ, 
ventricular zone (Merkle and Alvarez-Buylla, 2006) 
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Figure 1.9. Lineage trees of neurogenesis.  
The lineage trees shown provide a simplified view of the 
relationship between neuroepithelial cells (NE), radial glial 
cells (RG) and neurons (N), without (a) and with (b) basal 
progenitors (BP) as cellular intermediates in the generation 
of neurons. They also show the types of cell division 






Figure 1.10. Polarized features of neuroepithelial cells, radial glial cells 
and basal progenitors.  
(a) In neuroepithelial cells, interkinetic nuclear migration spans the entire 
apical–basal axis of the cell, with the nucleus migrating to the basal side during 
G1 phase, being at the basal side during S phase, migrating back to the apical 
side during G2 phase, and mitosis occurring at the apical surface. (b) In radial 
glial cells, the basally directed interkinetic nuclear migration does not extend all 
the way to the basal side (that is, through the neuronal layer to their pial end-
feet), but is confined to the portion of the cell between the apical surface and 
the basal boundary of the ventricular zone or the subventricular zone (not 
shown). (c) In basal progenitors, the nucleus migrates from the apical surface to 
the basal boundary of the ventricular zone (dashed line) or subventricular zone 
(not shown) for S phase and mitosis, and this is concomitant with the retraction 
of the cell from the apical surface (Götz and Huttner, 2005). 
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RGCs as a population can give rise to neurons, astrocytes and oligodendrocytes, but 
rarely will any individual RGC give rise to all three (Anthony et al., 2004; Grove et 
al., 1993; Malatesta et al., 2000; McCarthy et al., 2001). Thus they are more restricted 
in their potential than neuroepithelial cells. The basal progenitors derived from RGCs 
are also neuron progenitors. However, the main difference between them is that while 
RGCs can self-renew and give rise to more differentiated progeny, basal progenitors 
divide symmetrically to generate two neuronal daughter cells without self-renewal 
(Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004). In addition the 
neuroepithelial cells and RGCs span the VZ, while the basal progenitors migrate and 
form the SVZ. Genetic markers that distinguish basal progenitors from their 
predecessors include the non-coding RNA SVET1, and genes that encode the 
transcription factors TBR2, CUX1 and CUX2 (Götz and Huttner, 2005). Thus, these 
progenitors serve to expand the neuronal population.  
 
During development, neurogenesis (making new neurons) occurs largely during the 
embryonic period prior to the generation of glial cells (gliogenesis), which normally 
occurs after birth. In rodents neurogenesis starts around E12, peaks around E15 and 
ends around birth (Jacobson and M, 1991). Although RGCs are present at early 
stages, astrocytes are only detected around E16, while oligodendrocytes appear 
around birth (Levison et al., 1993; Parnavelas, 1999). This sequence of development 
can also be demonstrated in vitro. Using cortical NSCs Qian et al. (2000) showed that 
neurons are generated first, followed by differentiation of astrocytes.  
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1.6.2. Adult neural stem cells 
Prior to the 1990s, it was generally accepted that neurogenesis is purely an 
embryonic/early postnatal process, and the adult brain is incapable of regenerating 
itself. Early experiments in the 1960s hinted at the presence of proliferative cells in 
the adult brain, but the identity of these cells were not clear (Altman, 1969; Altman 
and Das, 1965). In the 1970s, Michael Kaplan reproduced Altman’s experiments 
combined with electron microscopy, and demonstrated that thymidine-incorporated 
cells were indeed neurons (Kaplan and Hinds, 1977). However, adult neurogenesis 
was still refuted until the phenomenon was demonstrated in adult songbirds (Alvarez-
Buylla et al., 1988; Nottebohm, 1989), and the subsequent isolation and culturing of 
adult NSCs in vitro (Reynolds and Weiss, 1992).  
 
It is now accepted that there are two neurogenic zones in the adult CNS, the SVZ and 
subgranular zone (SGZ) of the dentate gyrus in the hippocampus. New neurons born 
in the SVZ migrate along the rostral migratory stream to the olfactory bulb to replace 
the granule and periglomerular neurons. Newborn neurons from the SGZ migrate a 
much shorter distance into the granular cell layer of the dentate gyrus to become 
granule neurons. The SVZ has been shown to contain four cell types (Figure 1.11); 
neuroblasts (Type A cells), SVZ astrocytes (Type B cells), immature precursors (Type 
C cells) and ependymal cells (Doetsch et al., 1997). The type B cells are thought to be 
stem cells since they are less susceptible to antimitotic treatment and may be 
relatively quiescent. After antimitotic treatment of the SVZ, type B cells are re-
activated to repopulate the SVZ (Doetsch et al., 1999). The type B cells in turn give 
rise to neuroblasts via rapidly dividing transit amplifying type C cells. 
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Figure 1.11. The SVZ niche, cell types and stem cell lineage. 
(a) Frontal schematic of the adult mouse brain showing the location of the SVZ in 
orange between the lateral ventricle (LV) and the striatum. The corpus callosum is 
depicted in dark gray. The box in (a) is expanded in (b). (b) Blood vessels (BV) are 
common in the SVZ and endothelial cells lining the blood vessels are likely a source 
of signals for adult neurogenesis. A specialized basal lamina (BL) extends from blood 
vessels into the SVZ and terminates in small bulbs adjacent to the ependymal cells 
(E), which line the lateral ventricle. (c) Cross-sectional schematic showing the cell 
types and their organization in the SVZ. Multi-ciliated ependymal cells (E, gray) line 
the lateral ventricle. Chains of neuroblasts (A, red) travel through tunnels formed by 
the processes of SVZ astrocytes (B, blue). Focal clusters of rapidly dividing Type C 
cells (C, green) are scattered along the network of chains of neuroblasts. SVZ 
astrocytes occasionally extend a process to contact the lateral ventricle and exhibit a 
short single cilium. An ECM-rich basal lamina (BL, black) makes extensive contact 
with all SVZ cell types, terminating in ‘bulbs’ adjacent to ependymal cells and forms 
an essential part of the SVZ stem cell niche. SVZ astrocytes (GFAP+) act as stem 
cells in this region and divide to generate transit-amplifying Type C cells (GFAP–
/Dlx2+), which in turn divide to generate the neuroblasts (GFAP–Dlx2+PSA–
NCAM+) that migrate to the olfactory bulb (Doetsch, 2003). 
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The SGZ has a similar cellular arrangement where the astrocytes are also the primary 
precursors, giving rise to granular neurons via type D cells (Seri et al., 2001). Thus 
the adult neurogenic zones consist of a heterogeneous population of NSCs, 
progenitors and differentiated cells, similar to the embryonic neurogenic zone.  
 
1.6.3. Neural stem cell applications 
Although the adult CNS has the capacity to generate new neurons this is restricted to 
the two neurogenic zones discussed above. Neurons loss from diseases such as PD 
and Alzheimer’s disease (AD) as well as from injuries such as stroke and spinal cord 
injuries cannot be replaced. Thus cell replacement therapy may be the potential 
solution. It was first demonstrated more than a decade ago that multipotent NSCs 
transplanted into the adult brain can differentiate into neurons that integrate into 
experimentally induced lesion sites (Snyder et al., 1997). Since then, many 
transplantation studies have been done with variable results. In a rat model of PD, 
transplantation of human embryonic NSCs produced neurons and astrocytes that 
migrate and integrate into the lesion site, resulting in some functional recovery 
(Svendsen et al., 1997). Similarly, rescue of spinal cord injury has been demonstrated 
with human NSC transplants (Cummings et al., 2005). On the other hand, other 
reports demonstrate that grafted cells form mostly glial cells rather than neurons 
(Vroemen et al., 2003; Wu et al., 2001). This experimental area has not been 
standardized and many factors including the source of stem cells and the environment 
into which they are placed will be important in determining the outcome. In humans, 
transplantation of foetal dopaminergic neurons to treat PD was first performed in 
1990 (Lindvall et al., 1990). Since then a number of clinical trials have evaluated this 
form of therapy with mixed results, from significant improvement to no effect and 
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even negative effects such as graft induced dyskinesia (Deierborg et al., 2008). One 
important factor governing the success of transplants is the purity of the dopaminergic 
neuron graft. Another obstacle for this therapeutic method is the limited availability of 
foetal tissues. Directed differentiation of NSCs into dopaminergic neurons by over 
expression of Nurr1 and Ngn2 (Andersson et al., 2007) can be a potential solution for 
such problems. Prior to differentiation, NSCs can be expanded in culture to generate 
the large quantities of cells required as a lot of cell death occurs during the 
transplantation procedure. In addition to cell replacement, NSC transplants have also 
been shown to deliver trophic factors such as glial cell derived neurotrophic factor 
(GDNF) to rescue dopaminergic neurons in experimental lesion models (Ourednik et 
al., 2002). NSCs display impressive migratory properties and can be attracted to 
injury sites in the CNS by the inflammatory cytokine SDF1-α (Imitola et al., 2004). 
This opens up the possibility of exploiting migratory NSCs to deliver therapeutic 
molecules. The lysosomal storage disease Mucopolysaccharidosis type VII is caused 
by a deficiency in the β-glucuronidase (GUSB) enzyme. This disease results in 
progressive neurodegeneration and mental retardation. NSCs engineered to express 
GUSB were able to migrate extensively after transplantation and corrects lysosomal 
function in mutant host cells (Snyder et al., 1995). Other genetic diseases that have 
been studied with similar approaches include Tay-Sachs disease and Niemann-Pick 
disease (Lacorazza et al., 1996; Shihabuddin et al., 2004). To improve the utilization 
of NSCs for therapeutic purposes it is essential to understand how they behave in vitro 
and in vivo in terms of survival, proliferation and differentiation.  
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1.7. Methods to study neural stem cells 
1.7.1. Identifying neural stem cells in vivo 
In vivo NSCs are located in specific neurogenic zones, thus the location of the cell can 
be used to identify it. In the adult CNS most cells are postmitotic so cell proliferation 
and incorporation of bromodeoxyuridine (BrdU) can be used to find neurogenic 
regions (Figure 1.12). Incorporation of BrdU or tritium-labelled thymidine was 
traditionally used for birthdating neurons, the time point at which the NSC exits the 
cell cycle and differentiates into a neuron. These labelled nucleotides are incorporated 
into newly synthesized DNA in actively dividing cells. The labelled probe is only 
available for a short time after injection, so if a stem cell continues to divide, the level 
of probe labelling will be diluted. On the other hand, if the label is incorporated when 
a cell is undergoing the final round of cell division to produce the neuroblast (a 
precursor that will differentiate into a neuron), a high level of label will be retained. 
By injecting the probes at different times it is possible to map the time points at which 
different populations of neurons arise. This approach showed that the cerebral cortex 
develops in an inside-out fashion, with the youngest neuron residing near the 
subventricular zone, while the oldest neurons migrate to the superficial layers (Rakic, 
1974). As BrdU is incorporated into the nucleus of the cell, the morphology of the cell 
cannot be observed. In lineage marking experiments, a retrovirus is used to introduce 
a transgene such as β-galactosidase or green fluorescence protein (GFP) into 
proliferating NSCs. Subsequently when the NSC differentiates, the type of cell it 
develops into can be monitored with expression of the transgene (Figure 1.12F & G) 
(Sanes, 1989). 
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Figure 1.12. Neurogenesis in the adult rodent brain 
(A) Depictions of sagittal and coronal views of mouse brain in areas where 
neurogenesis occurs. Red areas indicate the germinal zones in the adult mammalian 
brain: the subgranular zone (SGZ) of the dentate gyrus in the hippocampus and the 
subventricular zone (SVZ) of the lateral ventricles. Neurons generated in the SVZ 
migrate through the rostral migratory stream and are incorporated into the olfactory 
bulb. (B–E) Neurogenesis revealed by BrdU incorporation in the olfactory bulb (B), 
rostral migratory stream (C), SVZ (D), and dentate gyrus (E). Inset in (C) is a sagittal 
view of rostral migratory stream before reaching the olfactory bulb, and inset in (E) is 
a high-magnification view of the area indicated by the arrow in (E). Colours indicate 
the following: red, BrdU; green, NeuN. (F and G) Newborn neurons in the olfactory 
bulb and dentate gyrus labelled by retrovirus-mediated expression of green 
fluorescent protein (GFP). Insets are high-magnification views of the cells indicated 
by arrows. Colours indicate the following: red, NeuN; green, GFP; blue, DAPI. (Zhao 
et al., 2008). 
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The neurogenic zones of both the embryo and the adult are heterogeneous, consisting 
of NSCs, lineage restricted progenitors and differentiated cells. Cell morphology and 
position alone cannot differentiate between NSCs and more restricted progenitors. 
Thus, expression of specific markers will be critical for studying these cell 
populations. Although there is currently no definitive marker(s) for NSCs, a number 
of proteins have been well associated with these cells. These include nestin, Sox2, 
Hes1/5, Bmi1, musashi and prominin-1 (CD133).  
 
Nestin is an intermediate filament protein expressed in neuroepithelial cells (Lendahl 
et al., 1990) and is found mainly in proliferating cells of the CNS during early 
development (Dahlstrand et al., 1995). In the adult, nestin expression is detected in 
the SVZ and SGZ as well as in different populations of neocortical cells (Ernst and 
Christie, 2005, 2006; Fukuda et al., 2003). Its expression is down regulated in 
differentiated cells, thus making it useful as a marker for progenitor cells. However, 
nestin is by no mean specific to the CNS and can be found in peripheral tissues such 
as muscle (Lendahl et al., 1990) and skin (Medina et al., 2006) where they also mark 
precursor cells in these tissues. In addition, nestin can be re-expressed by reactive 
astrocytes at lesion sites (Clarke et al., 1994). Thus, nestin may mark precursor cells 
in general, and is not specific to NSCs.  
 
Sox2 is a transcription factor of the SoxB1 family, which has been shown to be 
expressed in embryonic and adult NSCs (Graham et al., 2003; Wang et al., 2006). The 
SoxB1 genes are critical in maintaining the NSC state. The main mechanism seems to 
be through inhibition of differentiation since suppression of SoxB1 genes result in 
precocious differentiation and depletion of the progenitor pool, whereas over 
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expression of these genes can inhibit differentiation and maintains the progenitor 
population (Bylund et al., 2003; Ferri et al., 2004; Graham et al., 2003). However, 
Sox2 is also not specific to NSCs as it is expressed in ESCs (Avilion et al., 2003). It 
may be a protein that confers precursor identity in general since it is one of four genes 
that can be use to generate IPS cells from reprogramming of fibroblasts (Takahashi et 
al., 2007; Wernig et al., 2007). 
 
The basic helix loop helix (bHLH) transcription factors, Hes1 and Hes5 are the main 
targets of the notch signalling pathway. Like the SoxB1 genes, Hes1/5 maintains the 
progenitor population by repressing differentiation (Hatakeyama et al., 2004; Kabos et 
al., 2002; Kageyama and Ohtsuka, 1999). Recent work has shown that Hes1 
expression in NSCs is dynamic. This oscillating pattern of expression is required to 
maintain NSCs in an undifferentiated state, whereas sustained upregulation of Hes1 
inhibits proliferation (Shimojo et al., 2008). However, the notch signalling pathway is 
ubiquitous during development, regulating cell fate decisions in almost every tissue. 
Evolutionarily conserved, notch signalling can be found in organisms ranging from 
sea urchins to humans (Artavanis-Tsakonas et al., 1999). Hes1 is involved in 
regulating expansion of T-cell precursors (Tomita et al., 1999), specification of the 
pancreas (Fukuda et al., 2006), specification of retinal cell types (Hatakeyama et al., 
2001) and development of inner ear hair cells (Zine et al., 2001).  
 
The polycomb transcription repressor Bmi1 regulates NSC proliferation and self-
renewal (Molofsky et al., 2003; Zencak et al., 2005) via suppression of the cyclin-
dependent kinase inhibitors p16Ink4a and p19Arf (Bruggeman et al., 2005; Molofsky 
et al., 2005). Bmi1 can reprogramme astrocytes into stem-like cells (Moon et al., 
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2008). In addition to the CNS, Bmi1 is expressed in many tissues including ESCs, 
placenta, thymus, heart, and testis (van Lohuizen et al., 1991). The Bmi1-Ink4a 
pathway was originally identified in HSCs where it is also involved in the self-
renewal capacity of HSCs (Jacobs et al., 1999; Park et al., 2003; van der Lugt et al., 
1994).  
 
Musashi is an RNA-binding protein expressed in cells of the VZ during embryonic 
development (Kaneko et al., 2000) as well as the SVZ of the adult brain (Sakakibara 
and Okano, 1997). Musashi can bind and suppress m-numb, a repressor of notch 
signalling, thus leading to the activation of Hes1 (Imai et al., 2001). Disruption of 
both musashi-1 and -2 inhibits NSC self-renewal in vitro (Sakakibara et al., 2002). 
Musashi-1 is also correlated with development of other tissues such the hair follicles 
(Sugiyama-Nakagiri et al., 2006), stomach (Nagata et al., 2006) and intestine (Asai et 
al., 2005). 
 
Prominin-1, also known as CD133, is a glycoprotein found on the apical surface of 
neuroepithelial and RGCs (Weigmann et al., 1997), and also expressed on HSCs 
(Miraglia et al., 1997). This marker has been used to isolate stem cells from both the 
CNS (Uchida et al., 2000) and the haematopoietic system (Yin et al., 1997). Human 
foetal liver cells positive for prominin-1 (Hao et al., 2003) and skin-derived prominin 
positive cells (Belicchi et al., 2004) can differentiate into neurons and astrocytes. 
Prominin has been widely used to isolate NSCs from both the embryo and adult CNS. 
However, recent observations indicate that prominin is present in embryonic but not 
adult NSCs (Pfenninger et al., 2007). Prominin negative cells are also clonogenic and 
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tripotent (Sun et al., 2009), suggesting that prominin expression may not be necessary 
for stem cell properties. 
 
A common feature shared by all of these protein markers is they are found in 
precursor cells of many tissues. During development, the ectoderm from which NSCs 
arise is formed from epiblast cells that did not migrate into the mesoderm and 
endoderm layers. So the ectoderm can be considered as the predecessor of the 
mesoderm and endoderm. It is possible that these proteins are originally present in the 
epiblast, and as cells migrate to form the mesoderm and endoderm they express 
additional proteins specific to their lineage while still retaining expression of these 
ancestral proteins. Currently, there are no NSC-specific markers.  
 
Another issue is differentiating between an NSC and a progenitor. Recently, adult 
NSCs and their progeny were simultaneously isolated from the SVZ based on three 
markers, glial fibrillary acid protein (GFAP), epidermal growth factor (EGFR) and 
CD24, expressed individually and in combination (Figure 1.13). Cells expressing only 
GFAP are normal astrocytes, while those positive for both GFAP and EGFR are 
activated astrocytes that have stem cell properties of self-renewal and multipotency. 
Cells positive for only EGFR represent the transit amplifying C cells of the adult SVZ 
as they no longer show astrocytic properties. These cells also have self-renewal and 
multipotent properties, but they generate significantly fewer neurospheres in culture 
compared to the astrocytic stem cells. Finally the CD24 positive cells express the 
neuronal marker β-III tubulin, do not form neurospheres and thus represent 
neuroblasts (Pastrana et al., 2009).  
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Figure 1.13. Prospective isolation of stem cells and their progeny from the adult 
SVZ. 
Schema of a sagittal section of the adult mouse brain showing the lateral 
ventricle/SVZ (purple) and the SVZ stem cell lineage. Other SVZ astrocytes and 
ependymal cells lining the ventricles are also present in this region. Table shows the 
expression of markers used for the prospective isolation of each SVZ cell type 




In the rodent embryonic CNS, classical markers for RGCs such as nestin, RC2 and 
GLAST stain the entire VZ and do not distinguish RGCs from other neuron 
progenitors. Instead, gene promoter activity has been used to differentiate between 
these two cell populations. When electroporated with GFP transgene constructs driven 
by various promoters, RGCs were found to display GLAST and BLBP promoter 
activity, while neuron progenitors preferentially activate the promoter of tubulin α-1 
normally associated with neurons (Gal et al., 2006). Activity of the notch effector C-
promoter binding factor 1 (CBF1) has also been used to distinguish NSCs from neural 
progenitors (Mizutani et al., 2007). Transgenic mice expressing enhanced green 
fluorescence protein (EGFP) driven by the CBF1 promoter displayed varying levels 
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of EGFP expression amongst VZ cells. CBF-1 activity was found predominantly in 
cells with elevated GLAST promoter activity and not tubulin α-1 promoter activity. 
Short hairpin RNA (shRNA) knockdown of CBF1 promotes cell migration into the 
SVZ and increases tubulin α-1 promoter activity in VZ cells. Thus loss of CBF1 
promotes differentiation of NSCs. Fluorescence assisted cell sorting (FACS) based on 
the level of EGFP and expression of prominin demonstrate that cells with high level 
of EGFP (thus high CBF1 activity) form more neurospheres than cells with low EGFP 
expression. Transplantation of these two cell populations show that cells expressing 
high levels of EGFP produce neurons, oligodendrocytes and astrocytes, while cells 
with low EGFP expression produce only neurons and oligodendrocytes. Thus NSCs 
express high CBF1 promoter activity, and low CBF1 promoter activity is correlated 
with neuron progenitors. 
 
1.7.2. In vitro analysis – the neurosphere assay 
In vitro, NSCs can be grown as adherent cultures or as free floating clusters of cells 
called neurospheres. Developed in the 1990s by Reynolds and Weiss, the neurosphere 
assay (NSA) is a simple culturing system that allows propagation of NSCs in vitro 
and assessment of their self-renewal and differentiation characteristics (Reynolds and 
Weiss, 1992). The neurosphere forming unit (NFU) is used to describe the percentage 
of cells that can give rise to neurospheres i.e. one NFU would be one neurosphere 
formed from 100-cells plated. Self-renewal is generally defined as the ability to form 
secondary neurospheres upon dissociation and replating of primary neurospheres. 
NSCs can be maintained in culture for at least ten passages without changes to their 
karyotype (Fenggang Yu, unpublished work). When combined with differentiation at 
each passage to demonstrate multipotency, these cells can meet four of the five 
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functional criteria for stem cells, i.e. the ability to proliferate, self-renew, differentiate 
into multiple progeny and maintain multipotency over time. The remaining criterion 
of functionally reconstituting the tissue from which the stem cell is derived is very 
difficult to meet due to the complexity of the nervous system. Formation of the brain 
not only depends on the multiple types of neurons and glia but requires establishment 
of appropriate connections between these cells. Experiments that will help to evaluate 
whether NSCs have such capacities include determining whether different types of 
neurons can be derived (Artinger et al., 1995), whether they have any functional 
activity such as the ability to fire action potentials (Klein et al., 2005), and finally 
whether transplanted NSCs can differentiate and integrate into the CNS (Ader et al., 
2004; Campbell et al., 1995). 
 
Demonstration of clonality is central to stem cell biology as this is the only way to 
determine whether a cell has renewed itself and can give rise to differentiated 
progeny. In the NSA, NSCs grow as colony-like structures thus it is tempting to 
equate the generation of an individual neurosphere with the presence of a single stem 
cell, i.e. one NFU equals one stem cell (Capela and Temple, 2002; Kim and 
Morshead, 2003; Rietze et al., 2001). However, the NSA cannot be used to quantify 
the number of NSCs for the following reasons. Firstly, neurospheres can also form 
from cells aggregating together rather than from proliferation of a single cell, 
particularly when cells are seeded at high density (Coles-Takabe et al., 2008; Mori et 
al., 2006; Singec et al., 2006). To overcome this aggregation problem, one solution 
would be to perform clonal assays. This can be done in two ways, growing a single 
cell in isolation, or growing cells at a density low enough to avoid cell aggregation. 
The first method is the most stringent as there is no possibility of aggregation. In 
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practice, this is very difficult to do as cell survival and growth is greatly 
compromised, likely due to the lack of cell-cell communication and extrinsic 
supportive factors (Engstrom et al., 2002; Gritti et al., 1999). Thus the second method 
is preferentially used. However, this clonal cell density (density sufficient to avoid 
cell aggregation) is variable, ranging from two to 50 cells/μl (Garcion et al., 2004; 
Hitoshi et al., 2002a; Morshead and van der Kooy, 2004; Tropepe et al., 1999). Based 
on two recent reports, the percentage of aggregation for cells plated at a density of 2 
cells/μl is estimated to be between 2.2% and 70% depending on whether the culture 
dish has been moved or not i.e. to observe cells during the culturing period (Coles-
Takabe et al., 2008; Singec et al., 2006). An alternative method is to immobilize the 
NSCs in a gel matrix to prevent aggregation (Golmohammadi et al., 2008; Louis et 
al., 2008). This method works well provided that the initial seeding density is 
sufficiently sparse to reduce the chance of neurospheres forming from closely plated 
cells. However, the disadvantage of this method is the difficulty in re-extracting the 
clonal neurospheres for further analysis such as differentiation.  
 
In addition to the cell density and aggregation problem, neurosphere formation is also 
not limited to NSCs as progenitors also have this capacity (Reynolds and Rietze, 
2005). For example, adult dentate gyrus cells can form neurospheres when first 
isolated from the mouse brain. However, they are unable to form secondary 
neurospheres upon passaging, and only give rise to neurons or glia when 
differentiated (Seaberg and van der Kooy, 2002). Similarly, hippocampal progenitors 
can form neurospheres, but these neurospheres cannot be passaged beyond three 
passages. Thus they do not have the stem cell characteristic of extended self-renewal 
(Bull and Bartlett, 2005). For these reasons, the NSA when used alone, cannot be use 
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to quantify NSCs in vitro. Additional experiments include demonstration of clonality, 
extended passagability and multipotency are required. Despite these limitations, the 
NSA is still a useful tool in providing an indication of the presence of NSCs, and it is 
the only method currently available to assess the self-renewal capacity of stem cells. 
 
The neurosphere system can also be used as a model to study neurogenesis and neural 
development. NSCs isolated at different stages of development and expanded as 
neurospheres retain their in vivo characteristics such as responsiveness to extrinsic 
factors. For example, the fibroblast growth factor receptor (FGFR) is expressed earlier 
in development than EGFR. When fibroblast growth factor 2 (FGF2) and epidermal 
growth factor (EGF) was used to culture NSCs isolated at different developmental 
stages, cells from E8.5 can only be grown in the presence of FGF, while those isolated 
at E14.5 can be cultured with EGF alone or EGF and FGF (Tropepe et al., 1999). 
NSCs isolated from different developmental stages can also be studied in vitro to 
determine how intrinsic and extrinsic factors regulate cell fate choices of progenitors 
during development (Irvin et al., 2003). Furthermore, neurospheres cultured from 
different regions of the developing brain express region specific genes and 
differentiate into neurons appropriate for that region (Hitoshi et al., 2002b; Klein et 
al., 2005; Parmar et al., 2002) 
 
1.8. The stem cell niche 
In vivo, stem cells reside in tightly regulated microenvironments known as the stem 
cell niche. This niche is composed of supporting niche cells, extrinsic signals, 
membrane bound molecules and the ECM that can protect stem cells from 
differentiation signals, apoptosis stimuli and excessive proliferation which can result 
 Introduction:  39 
in cancer formation (Li and Xie, 2005). For NSCs, the stem cell niche is often 
discussed with reference to the adult neurogenic zones as the cellular architecture, and 
the relationship between stem cells and niche cells are clearer than the embryonic 
system. In both the SVZ and SGZ, niche cells include astrocytes, ependymal cells, 
endothelial cells of the blood vessels and the basal lamina (Doetsch, 2003). In the 
following sections, I will introduce some of the signalling pathways as well as the role 
of the ECM in regulating NSC self-renewal, proliferation and differentiation.  
 
1.8.1. The Notch pathway 
Notch signalling is an evolutionarily conserved pathway that mediates cell fate 
decision via cell-cell interactions. Notch is a transmembrane receptor. In vertebrates, 
its ligands, delta and jagged, are also transmembrane proteins expressed on adjacent 
cells. Interaction between notch and its ligands leads to the cleavage of notch at the 
intracellular domain by γ-secretases such as presenilin. The notch intracellular domain 
(NICD) then translocates to the nucleus where it activates the transcription factor 
CBF1 and results in the upregulation of target genes such as Hes1/5 (Mumm and 
Kopan, 2000). The function of Notch in regulating the NSC pool during development, 
including regulation of NSC numbers, inhibition of neurogenesis and acquisition of 
glial identity is well established (Androutsellis-Theotokis et al., 2006; Gaiano and 
Fishell, 2002; Hitoshi et al., 2002a). VZ cells express all the components of the notch 
pathway including ligands, receptors, modulators and targets (Corbin et al., 2008). 
Gain- and loss-of-function studies showed that notch activation inhibits neuronal 
differentiation and promotes stem cell maintenance (Gaiano et al., 2000; Hitoshi et al., 
2002a; Mizutani and Saito, 2005). Notch activity has also been used to differentiate 
between different progenitors in the CNS as the canonical notch-CBF1-Hes pathway 
 Introduction:  40 
is not uniformly utilized in the VZ. NSCs derived from transgenic mice expressing 
GFP driven by the Hes1/5 promoter showed asymmetric division in culture, 
producing a numb-positive neuronal daughter and a GFP-positive progenitor cell 
(Ohtsuka et al., 2006). Similarly, Basak and Taylor also showed that Hes1/5 promoter 
activity can be used to isolate different population of cells from the neural tube. Cells 
displaying high Hes expression are multipotent and can self-renew, while those 
lacking Hes5 expression do not form neurospheres. Active notch signalling was 
correlated with neuroepithelial cells and RGCs while basal progenitors and 
differentiated motor neurons do not express Hes5-GFP. Further, Hes5 expression is 
better correlated with NSC potentials than Hes1 expression (Basak and Taylor, 2007). 
As discussed previously, the CBF1 promoter activity has also been used to distinguish 
between NSCs and progenitors [see section 1.7.1; (Mizutani et al., 2007)].  
 
This heterogeneous notch activity in the VZ results in a ‘salt-and-pepper’ pattern of 
gene expression. Formation of this pattern is thought to arise from notch-mediated 
lateral inhibition. The classical view is that expression of proneural and notch ligand 
genes in a cell e.g. cell A, activates notch signalling in an adjacent cell, e.g. cell B, 
resulting in inhibition of neurogenesis in cell B. The increase in notch signalling in 
cell B also reduces notch ligand expression, thus notch signalling is not activated in 
cell A, and cell A can continue to differentiate (Kageyama et al., 2008). However, 
recent work suggests that notch activity is dynamic in NSCs with Hes1 expression 
oscillating every two to three hours. This in turn drives the oscillation of proneural 
and notch ligand genes to result in the ‘salt-and-pepper’ pattern of notch expression 
and maintenance of NSCs (Shimojo et al., 2008). 
 Introduction:  41 
1.8.2. The canonical Wnt pathway 
The canonical Wnt pathway involves binding of Wnt to its receptor complex frizzled 
and lipoprotein receptor related protein 5/6 (LRP5/6). This leads to the cytoplasmic 
accumulation of β-catenin, which translocates to the nucleus to activate the 
transcription factors T-cell factor/lymphoid enhancer factor (TCF/LEF) (Michaelidis 
and Lie, 2008). Mutation of β-catenin results in brain malformation (Brault et al., 
2001), decrease in the overall size of the nervous system and the neuronal precursor 
pool (Zechner et al., 2003). Conversely, constitutive activation of β-catenin expanses 
the progenitor pool resulting in enlarged brains (Chenn and Walsh, 2002). Wnt 
responsive cells have also been visualised in the embryonic SVZ, and exogenous Wnt 
protein can stimulate neurosphere formation, suggesting a role for Wnt signalling in 
self-renewal (Kalani et al., 2008). Wnt signalling also have a role in differentiation 
depending on the developmental stage. For example, at E10.5, Wnt/β-catenin has 
been shown to stimulate proliferation of neural precursors, whereas at E13.5, 
activation of this pathway resulted in the activation of the proneural transcription 
factor neurogenin 1 and directed neural differentiation (Hirabayashi et al., 2004).  
 
1.8.3. The sonic hedgehog pathway 
The sonic hedgehog (Shh) signalling pathway involves binding of Shh to its receptors 
patch and smoothen which leads to the activation of the Gli family of transcription 
factors (Fuccillo et al., 2006). Null mutations in the Gli2 and Gli3 genes are 
embryonically lethal, with mutants displaying significantly reduced SVZ/VZ as well 
as cortex (Matise et al., 1998; Theil et al., 1999). These mutant neural progenitors 
show reduced cell proliferation and neurosphere formation in culture (Palma and Ruiz 
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i Altaba, 2004). Null mutation in the Gli1 gene did not affect neural development and 
the progenitor population (Galvin et al., 2008). However, shRNA knockdown of this 
gene impaired NSC proliferation and neurosphere formation, whereas inducible 
expression of Gli1 stimulated neurosphere formation dose-dependently (Stecca and 
Ruiz I Altaba, 2009). Over expression of Gli1 in vivo also stimulated expansion of the 
precursor pool, resulting in enlarged brains.  
 
1.8.4. Epidermal growth factor and fibroblast growth factor 
Two growth factors, EGF and FGF2 are central to the maintenance of NSCs. During 
development, FGFR is expressed predominantly in the VZ as early as E8.5 – E9.5 
(Wanaka et al., 1991). Defects in cell proliferation and mesoderm patterning are 
observed with null mutation of FGFR1, and the embryos die between E7.5 and E9.5 
(Deng et al., 1994; Yamaguchi et al., 1994). The EGFR appears later in development, 
around E11 (Eagleson et al., 1996; Kornblum et al., 1997). Null mutation of the 
EGFR did not cause any neurological defect in early development. During later 
embryonic and early postnatal stages, increased cortical cell death, neurodegeneration 
of the frontal cortex and thalamus could be seen (Sibilia et al., 1998; Threadgill et al., 
1995). Both EGF and FGF have been used in the isolation of NSCs from the 
embryonic and adult brain, as well as maintenance of NSCs in culture (Gritti et al., 
1996; Reynolds et al., 1992; Reynolds and Weiss, 1992; Vescovi et al., 1993). 
Responsiveness to either growth factor is thought to depend on developmental stage, 
with FGF2-responsiveness occurring as early as E8.5, and EGF-responsiveness 
arising later at E14.5 (Tropepe et al., 1999). In vitro, EGF and FGF-responsive cells 
are lineage related with FGF-responsive cells acquiring EGF responsiveness to give 
rise to cells that respond to both mitogens (Ciccolini and Svendsen, 1998). Cells 
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responsive to both EGF and FGF can also be isolated from the striatum at E18 
(Ciccolini, 2001). Thus these two growth factors distinguish different populations of 
NSCs.  
 
1.8.4.1. EGFR signalling in neural stem cells 
EGFR is a member of the tyrosine kinase family that also includes erbB2, erbB3 and 
erbB4. EGFR homo- or heterodimerises after ligand binding and its intrinsic tyrosine 
kinase activity phosphorylates specific tyrosine residues on the C-terminal 
cytoplasmic tail. Phosphorylated tyrosine residues act as docking sites for proteins 
with Src homology domain 2 or phospho-tyrosine binding domains. These proteins go 
on to activate different downstream pathways to regulate cell migration, survival, 
proliferation, and differentiation. These signalling pathways include the Ras/MAPK 
(mitogen activated protein kinase) cascade that activates ERK1/2 (extracellular 
signal-regulated kinase), PI3K (Phosphoinositide 3-kinase)/Akt and JAK/STAT3 
(Janus kinase/Signal transducers and activator of transcription 3) (Schlessinger, 
2000). In NSCs ligands for EGFR include EGF, transformation growth factor α 
(TGFα) and heparin-binding EGF-like growth factor (HB-EGF) (Ayuso-Sacido et al., 
2006). The Ras/MAPK cascade is involved in proliferation and migration in many 
cell types, and similar functions have been demonstrated in NSCs. ERK1/2 is 
activated during semaphorin3A induced repulsion of NSCs (Bagnard et al., 2004). 
Interleukin-6 and EGF induction of spinal cord NSC proliferation is mediated via 
MAPK (Kang and Kang, 2008). ERK1/2 signalling has also been demonstrated in 
FGF regulation of neural specification (Stavridis et al., 2007). The PI3K/Akt pathway 
is primarily involved in cell survival. For example, TGF-β induced NSC survival is 
mediated by PI3K/Akt (Park et al., 2008). Insulin can also rescue ESC-derived NSC 
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from apoptosis via activation of Akt (Zhao et al., 2007). Unlike the MAPK and PI3K 
signalling cascades, activation of JAK/STAT leads to the direct translocation of 
STAT into the nucleus to activate gene transcription. The JAK/STAT pathway is 
known to mediate cytokine signalling in both adult and embryonic NSCs (Bauer, 
2009; Yoshimatsu et al., 2006). It is involved in NSC proliferation and differentiation 
(Gouti and Gavalas, 2008; Ke et al., 2007) 
 
1.8.5. Neural stem cell conditioned medium  
In vitro stem cells also secrete factors that can regulate their survival and 
proliferation. NSC-conditioned medium (NSC-CM) can increase survival and clone 
formation 2 of the same cells (Chang et al., 2003). Hippocampal progenitors were 
shown to secrete cystatin C, which supports bFGF induced NSC proliferation (Taupin 
et al., 2000). In addition to regulating cell survival and proliferation, factors within the 
NSC-CM can regulate cell fate decisions. NSC-CM can induce ESCs to differentiate 
into neural progenitors (Zhang et al., 2006). This could be due to cystatin C which can 
support differentiation of ESCs into NSCs (Kato et al., 2006). Factors in hippocampal 
tissue CM can also induce MSCs to acquire a neural lineage and differentiate into 
neurons (Rivera et al., 2006). Thus studying NSC secreted soluble factors in the NSC-
CM will provide important insights into how stem cells maintain stemness and make 
lineage choices. Neurotrophic factors secreted by NSCs also have therapeutic 
potentials as recent observations show that post-mortem brain tissue from aged and 
AD patients co-cultured with rat embryonic NSCs show significantly more viable 
cells (Wu et al., 2008). Beside soluble factors, the ECM including proteoglycans, is 
                                                 
2 Cells were grown as adherent cultures rather than neurospheres 
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also an important component of the stem cell niche. They act as reservoirs for growth 
factors and matrices for cell attachment and migration. 
 
1.9. Proteoglycans 
Proteoglycans are glycoproteins originally identified in the ECM of cartilage. 
However, they are now known to be in the matrices of all tissues. Proteoglycans are 
proteins with covalently bound sulfated glycosaminoglycans (GAGs). GAGs are long 
unbranched polysaccharides containing repeated disaccharide units consisting of a 
hexosamine and an uronic acid. There are four basic disaccharide units, chondroitin 
sulfate/dermatan sulfate (CS/DS), heparin/heparan sulfate (HS), keratan sulfate (KS) 
and hyaluronic acid (HA). They differ in the combination of hexosamine and uronic 
acid, and the sulfation pattern (Table 1.1).  
 
Proteoglycans are highly complex macromolecules (Figure 1.14). They can differ at 
the core protein level with proteins ranging from 30kDa (syndecan-4) to more than 
500kDa (versican). The GAG chains they carry can vary in length (20-200 
disaccharide units) and in number (3-4 chains for phosphacan, ~100 for aggrecan). 
The proteins may be modified with only one type of GAG (neurocan only carry CS-
GAGs) or may carry different side chains (phosphacan can carry CS only chains or 
carry both CS and KS chains). In the CNS proteoglycans carry mainly CS- or HS-
GAGs. They may be transmembrane proteins, bound to the cell surface by 
glycosylphosphatidylinositol (GPI), or components of the ECM. They have many 
ligands including growth factors, cell adhesion molecules and matrix components 
(Bandtlow and Zimmermann, 2000).  
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         Table 1.1 Composition of glycosaminoglycan chains and their modifications. 
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Figure 1.14. Structure of proteoglycans 
Proteoglycans consist of a protein core (blue) and one or more covalently attached 
glycosaminoglycan chains ([red] HS; [orange] CS/DS; [green] linker region). 
Membrane proteoglycans either span the plasma membrane or are linked by a GPI 
anchor (black). ECM proteoglycans are usually secreted, but some proteoglycans can 
be proteolytically cleaved and shed from the cell surface. 
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1.9.1. Heparan sulfate proteoglycans 
Heparan sulfate proteoglycans (HSPGs) have been documented in early development. 
Glypican-1 is the most prominent family member expressed during embryogenesis. 
Its transcripts can be found in the ventricular zone where active proliferation occurs 
(Litwack et al., 1998). In Drosophila, the Dally gene encodes for Drosophila 
glypican. Mutation of this gene affects lamina precursor cell division (Nakato et al., 
1995), indicating an important role for glypican in regulating precursor cell cycle. 
Other HSPGs including glypican-4 (Hagihara et al., 2000), syndecan-1 (Ford-Perriss 
et al., 2003) and perlecan-related molecule (Joseph et al., 1996) are also expressed in 
the neuroepithelium and may modulate NSC proliferation. HSPGs isolated from the 
early embryonic mouse telencephalon promote FGF2-mediated proliferation of 
neuroepithelial cells (Nurcombe et al., 1993). More recently, changes in HSPG 
sulfation pattern has been linked with transition of ESCs to NSCs (Johnson et al., 
2007).  
 
The most well documented mechanism of action for HSPG is the interaction with 
FGF. In fact, HSPG is critical for FGF signalling since FGFR cannot bind nor respond 
to its ligand in the absence of HSPG (Rapraeger et al., 1991; Yayon et al., 1991). 
HSPG can protect FGF from proteolysis and thermal denaturation (Saksela and 
Rifkin, 1990). HSPG can oligomerise ligands leading to receptor dimerisation to 
facilitate subsequent signalling (Pantoliano et al., 1994; Rapraeger et al., 1994; 
Schlessinger et al., 1995). Interactions between HSPG and FGF can lead to an 
increase in the local concentration of FGF and enhance their affinity for their 
receptors (Rapraeger et al., 1994; Vlodavsky et al., 1996). 
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1.9.2. Chondroitin sulfate proteoglycan 
Chondroitin sulfate proteoglycans (CSPGs) in the brain include aggrecan, versican, 
neurocan, brevican, neuroglycan D, NG2, the receptor-type protein tryrosine 
phosphatase β/ζ (RPTPβ/ζ) and its splice variant phosphacan (Bandtlow and 
Zimmermann, 2000). In the nervous system, CSPGs act mainly as barrier molecules 
involved in axon growth, cell migration and plasticity (Carulli et al., 2005). In this 
regard, they are traditionally associated with CNS injury where they are an inhibitory 
component of the glial scar preventing axon regeneration (Properzi et al., 2003). 
CSPG has been shown to directly repel extending axons as well as cause collapse of 
the growth cone (Borisoff et al., 2003; Snow et al., 2001). Degradation of CSPGs with 
chondroitinase has been explored extensively as potential therapy to assist 
neuroregeneration (Bradbury et al., 2002; Cafferty et al., 2007; Moon et al., 2001; 
Rolls et al., 2004; Steinmetz et al., 2005). However, not all CSPGs inhibit neurite 
outgrowth. For example, the small leucine rich proteoglycan decorin has been shown 
to inhibit TGFβ (Yamaguchi et al., 1990) and EGFR (Csordas et al., 2000), both of 
which regulate synthesis of inhibitory CSPGs. In addition, decorin can suppress 
production of inhibitory CSPGs at the spinal cord injury site (Davies et al., 2004), and 
promotes neurite extension on inhibitory CSPGs and myelin substrates (Minor et al., 
2008). The inhibitory effect of CSPG may also be cell type dependent as two reports 
have shown that ascending sensory axons can regenerate into areas of high CSPG 
expression following spinal cord injury (Inman and Steward, 2003; Pasterkamp et al., 
2001). 
 
CSPGs also have important roles to play during neural development. CSPG has been 
shown to regulate cell division in C. elegans. RNAi depletion of chondroitin synthase, 
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the enzyme responsible for synthesizing chondroitin GAGs (in C. elegans, this GAG 
is unsulfated), depleted chondroitin chains in the worm. This caused fusion of recently 
divided cells, resulting in multinucleate cells (Mizuguchi et al., 2003). Chondroitinase 
ABC (chABC) digestion of cell surface chondroitin chains also produced similar 
effects. In addition, there are eight squashed vulva (sqv) genes in C. elegans that 
encode enzymes involved in the biosynthesis of either HS- or chondroitin GAGs. 
Mutations in these genes have all been linked with abnormal cytokinesis and vulval 
morphogenesis (Hwang et al., 2003). 
 
During development, CSPGs also act as repulsive cues to guide neural crest cell 
migration. Inhibition of CS synthesis or inappropriate expression can cause neural 
crest cells to deviate from their migratory route (Kubota et al., 1999; Perissinotto et 
al., 2000). Axon pathfinding is an important aspect of early development and CSPG 
has been implicated in guiding this process. The notochord is particularly rich in 
CSPGs and serves as a barrier for extending axons. Digestion of notochord CSPGs 
with chondroitinase resulted in aberrant growth of embryonic motor nerves and dorsal 
root ganglion axons (Bernhardt and Schachner, 2000; Masuda et al., 2004). 
Development of the optic pathway involves CSPG guidance at several points. In the 
retina, CSPG guides axons towards the optic nerve (Brittis et al., 1992). At the 
chiasma and in the optic tract, chondroitinase treatment has been shown to disrupt 
axon navigation across the midline and towards the tectum (Chung et al., 2000; Ichijo 
and Kawabata, 2001). 
 
In addition to these well documented roles of CPSG, it is increasingly being shown to 
regulate survival, proliferation and differentiation of many cell types ranging from 
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fibroblasts to stem cells (Aoyama et al., 2005; Manton et al., 2007; Sheng et al., 2005; 
Wu et al., 2004a; Wu et al., 2004b). Phosphacan is expressed in proliferating cells of 
the ganglionic eminence, embryonic precursors of the basal ganglia, ependymal layer 
surrounding the central canal of the spinal cord (Engel et al., 1996), and the 
ventricular zone of the cerebrum (Milev et al., 1998a). The NG2 proteoglycan was 
originally correlated with oligodendrocyte progenitors in the developing rat brain 
(Nishiyama et al., 1996), but has also been used as a marker for multipotent neural 
precursors in the postnatal neurogenic zones (Belachew et al., 2003). Neural precursor 
cells have been demonstrated to synthesize many CSPGs including phosphacan, 
aggrecan and neurocan, which are secreted into the NSC-CM (Kabos et al., 2004). CS 
polysaccharides isolated from the embryonic CNS can stimulate NSC proliferation in 
culture (Ida et al., 2006). Thus CSPG is likely to play important roles in regulating 
NSC survival and proliferation. 
 
1.9.2.1. CSPG signalling mechanisms 
Within the CSPG family, the GAG subunits can be CS, where the hexosamine is N-
acetylgalactosamine (GalNAc) and the uronic acid is glucuronic acid (GlcA), or DS, 
where the uronic acid is epimerised to iduronic acid. The CS/DS disaccharides can 
also be sulfated at multiple sites, giving rise to at least five different subunits in each 
category (Figure 1.15). Sulfate groups are transferred from 3’- phosphoadenosine 5’-
phosphosulfate to the specific acceptor sites in CS/DS chains by C/D-
sulfotransferases that are located in the Golgi apparatus (Habuchi, 2000; Kusche-
Gullberg and Kjellen, 2003).  
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Figure 1.15. Disaccharide coding system 
The coding system for the typical disaccharide units found in CS and DS chains and 
their unsaturated derivatives generated by digestion with chondroitinases. CS chains, 
characterized by GlcA-containing CS disaccharide units (left panel), are often found 
as CS/DS hybrid chains with IdoA-containing disaccharide units (middle panel). 
Their sugar residues can be substituted with sulfate groups at various positions as 
indicated by ‘S’. 2S, 4S, and 6S represent the 2-O-sulfate group, 4-O-sulfate group, 
and 6-O-sulfate group, respectively. Chondroitinases depolymerize CS/DS polymers 
to produce unsaturated disaccharide ΔO–ΔE units (right panel) from the respective 
parent disaccharides on the same line in the left and middle panels (for example, ΔA 
from A and/or iA units). ΔHexA stands for Δ4,5unsaturated hexuronic acid. (Sugahara 
and Mikami, 2007)  
 
 
One of the main mechanisms by which CSPGs function is via their CS-GAG chains. 
Ida et al. (2006) has shown that CS-B, -D and –E units can promote FGF-2 mediated 
NSC proliferation. Using carbohydrate microarray platforms and chemical 
modification of sulfation sites, specific sulfation motifs were shown to function as 
molecular recognition sites for different growth factors that modulate neurite 
outgrowth (Gama et al., 2006; Shipp and Hsieh-Wilson, 2007). Many sulfotransferase 
enzymes are also expressed in the embryonic germinal zones as well as in 
neurosphere cultures, and inhibition of GAG sulfation by sodium chlorate treatment 
significantly inhibits neurosphere formation (Akita et al., 2008).  
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Although not as well documented as the interaction between HSPG and FGF2/FGFR, 
CSPG is known to interact with growth factors and their receptors. An example of this 
is the interaction with the EGFR. The versican isoform V1 can stimulate NSC 
differentiation by enhancing EGFR and integrin expression, and facilitate sustained 
phosphorylation of ERK (Wu et al., 2004b). The G3 domain of versican can bind and 
activate EGFR, leading to phosphorylation of ERK and enhanced neural outgrowth 
(Xiang et al., 2006). CSPG is known to inhibit axon regeneration and this process has 
been linked to CSPG activation of EGFR. Inhibition of EGFR kinase activity by 
PD168393 significantly reduced the inhibitory effect of CSPG and promoted optic 
nerve regeneration (Koprivica et al., 2005) In addition to signalling through the 
EGFR, CSPG has also been shown to function through the Rho/ROCK pathway to 
inhibit neurite outgrowth (Monnier et al., 2003). Inhibition of Rho GTPase with C3-
transferase, and ROCK with Y27632 can block the inhibitory effect of CSPG on 
retinal ganglion cell axon growth. CSPG can also inhibit neurite extension in PC12 
cells via phosphorylation of myosin phosphatase and cofilin, both downstream 
effectors of ROCK. This effect can again be blocked by Y27632 (Gopalakrishnan et 
al., 2008). 
 
The Wnt signalling pathway is essential for development, NSC proliferation and self-
renewal as discussed in section1.8.2. A number of studies also support interaction 
between Wnt and proteoglycans. Early work in Drosophila showed that the activity of 
wingless (WG), the Drosophila homologue of Wnt-1, is modulated by both HSPG 
and CSPG. The mode of interaction is via the GAG chains as enzymatic removal of 
HS- and CS-GAGs greatly reduced WG activity. Exogenous addition of both GAGs 
were also able to displace cell surface bound WG (Reichsman et al., 1996). The 
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Drosophila Ska or Sugarless mutant has a defect in UDP-glucose dehydrogenase, an 
enzyme required for the production of glucuronic acid which is essential for HS and 
CS synthesis. This mutant showed developmental defects similar to WG mutants, 
suggesting an in vivo link between proteoglycans and WG function (Haerry et al., 
1997). However, the authors only showed reduced HS level in these mutants and did 
not address the involvement of CS. This was only resolved later by Toyoda et al. 
showing that CS synthesis was also compromised in Sugarless mutants (Toyoda et al., 
2000).  
 
Much of the literature has concentrated on elucidating the role of HS in Wnt 
signalling, and it is now well established that Wnt belongs to the class of heparin-
binding growth factors. However, a couple of recent publications provide support for 
CS regulation of Wnt signalling. Shortkroff et al. showed that articular chondrocytes 
respond to canonical Wnt signalling. This requires CS-GAG as enzymatic removal or 
decreased sulfation of CS-GAG result in reduced β-catenin activation by Wnt 
(Shortkroff and Yates, 2007). Manton et al. on the other hand, showed that in MSCs, 
disruption of CS-GAG result in increased activation of LEF1, a downstream effector 
of β-catenin (Manton et al., 2007). These discrepancies may lie in the use of different 
cell types. Nevertheless, they provide evidence of a relationship between CS-GAG 
and Wnt signalling. The latter reference is of particular interest as the CS/Wnt 
interaction is demonstrated in stem cells. 
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1.10. Aims of current work 
NSCs can be used to enhance our understanding of neurodevelopment and have the 
potential for therapeutic applications. Two cardinal properties of NSCs are the ability 
to self-renew and multipotency, the ability to differentiate into the three neural cell 
types of the nervous system. Due to a lack of appropriate assays, self-renewal cannot 
be measured directly. In vitro, self-renewal is followed by measuring the formation of 
secondary neurospheres from dissociated primary neurospheres. Thus the ability to 
passage neurospheres over an extended period of time, as well as demonstration of 
multipotency defines the presence of NSCs. To improve the utilization of NSCs it is 
essential to understand the mechanisms that regulate NSC survival and proliferation. 
In vitro, the NSC-CM is an important part of the NSC niche as it contains cell-
secreted factors that can regulate neural precursor cell survival and proliferation. The 
current work began with the observation that NSC-CM can stimulate neurosphere 
formation. Thus the two main aims of this thesis are: 
 
1) Identify soluble factors in the NSC-CM that regulate NSC survival and 
proliferation. 
2) Understand the mechanisms by which these soluble factors regulate NSC 
survival and proliferation. 
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2. MATERIALS AND METHODS 
 
2.1. Isolation of NSCs and the NSA  
NSCs from the forebrain of embryonic (E14) C57BL/6 mice were isolated as describe 
previously with some modifications (Jurvansuu et al., 2008). Pregnant C57BL/6 mice 
were sacrificed by cervical dislocation and the embryos were aseptically removed and 
transferred to a Petri dish containing ice-cold Hanks’ balanced salt solution. 
Subsequently, the cerebral cortices were rapidly excised from the embryos and 
triturated into a single cell suspension. Dissociated cells were seeded at a density of 
2x105 cells/ml into 10 cm culture dishes (NUNC) in NSC growth medium (GM) 
consisting of Dulbecco’s Modified Eagle’s Medium (DMEM)/nutrient mixture F-12 
(1:1) medium (Invitrogen), N2 supplement (Invitrogen), 20ng/ml EGF (Invitrogen) 
and 1% penicillin/streptomycin (Invitrogen). Cells were grown as neurospheres for 5-
7 days at 37oC in a 5% CO2 atmosphere in a humidified incubator. Neurospheres were 
passaged every 5-7 days by dissociating with 0.025N sodium hydroxide and 
neutralizing with 0.025N hydrochloric acid. Single cells were plated at a density of 
2x104 cells/ml (bulk-density) at each passage. Neurospheres before passage 8 were 
used for subsequent experiments. 
 
2.1.1. Clonal hydrogel culture 
Hydrogel (a gift from Dr Kurasawa) was dissolved in GM at 1.2% by warming at 
37ºC. Dissociated cells were added at a density of 2.5x103 cells/ml. The 
polymerisation solution was added along with 2% hydrogen peroxide and the mixture 
was plated immediately into the culture well. The hydrogel was allowed to solidify at 
37ºC followed by overlaying of GM. 
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2.1.2. Adherent culture 
For adherent cultures, the culture plate was coated with 0.1% poly-L-lysin (PLL) to 
induce cell attachment. Neurospheres were dissociated as above and plated at a 
density of 1x104 cells/ml.  
 
2.2. NSC-Conditioned medium 
To test the effect of NSC-CM on neurosphere formation, NSC-CM was collected on 
day 5 and filtered through a 0.2µm filter (Sartorius) to remove cells. A 1:1 dilution is 
then made with growth medium (GM) and used for cell culture at various plating 
densities as stated on the figure. Following identification of CSPG as a possible 
candidate for the stimulatory effect of NSC-CM, all NSC-CM experiments were 
performed using the >100kDa fraction of the NSC-CM as CSPG resides in this 
fraction. NSC-CM was concentrated 10 times using a 100kDa Amicon filter 
(Millipore), then reconstituted back into GM at the original concentration and used for 
cell culture. All subsequent experiments were performed at low plating density of 
2x103 cells/ml. Neurosphere formation was assessed after 5 or 6 days. 
 
For mass spectrometry, samples from NSC-CM and GM were filtered, concentrated 
and fractionated into proteins greater than or less than 30kDa using Amicon filter 
units (Millipore). The same fractions from NSC-CM were compared to GM using a 
Q-STAR liquid chromatography mass spectrometer. 
 
To confirm that CSPG in the CM is responsible for the neurosphere stimulatory effect 
of CM, the >100kDa fraction of CM was digested with 5mU/ml of chABC (Sigma) 
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overnight at 37oC. The digested CM was heated for 5min at 100oC to inactivate 
chABC prior to using for cell culture as described above. For controls, GM treated in 
the same manner was used to ensure complete inactivation of chABC, and heat 
treatment of CM alone to ensure that the reduced stimulatory effect was not due to 
this process. 
 
2.3. CSPG and inhibitors on neurosphere formation and proliferation 
Unless stated otherwise, all experiments with CSPG (Proteoglycan from bovine nasal 
septum; Sigma) and CS-GAGs were done in low-density cultures (2x103 cells/ml) to 
assess their stimulatory effect, while all CSPG inhibitor were tested in bulk-density 
cultures (2x104 cells/ml) to see their effect on endogenous CSPG. CSPG was used at a 
concentration of 50µg/ml, chABC (Sigma) 10–50mU/ml, sodium chlorate (Sigma) 
20–50mM, 4-methylumbelliferyl-β-D-xyloside (Sigma) 150µM. Heparinase II, 
hyaluronidase and keratanase (Sigma) were used at 10–500mU/ml. Chondroitin 
sulfate A & C (Sigma), B, D & E (US Biological), HSPG and hyaluronic acid (Sigma) 
and keratan sulfate (US Biological) were used at 50µg/ml. All reagents were added at 
time of cell plating and left for the duration of the culture. Cultures were set up in 12-
well plates (BD) and 5 or 6 days following treatment, cultures were assessed for 
neurosphere formation by manually counting and sizing all the neurospheres in the 
well under a standard tissue culture brightfield microscope.  
 
Chondroitin-4/6-sulfatase (Associate of Cape Cod) were use at 10 – 50mU/ml in both 
low and bulk-density cultures. The enzyme activity was assessed using the protocol 
from Sigma. The method is based on the turbidity method of Dodgson and Saito et al. 
(Dodgson, 1961; Saito et al., 1968). Briefly, CS-A, CS-C or CSPG was pre-digested 
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with chABC (50mU/ml) at 37ºC for 1 hour, or used undigested as substrates for the 
sulfatases. The enzymatic release of sulfate from these substrates were carried out in a 
buffer containing 200mM Tris, 250mM sodium acetate, 250mM sodium chloride and 
0.05% bovine serum albumin (BSA). A 1.47mM cetylpyridinium in 300mM 
hydrochloric acid solution was added to collate undigested polysaccharides. The free 
sulfates were detected by formation of a turbid solution upon addition of a 20mM 
barium chloride / 4.8% gelatin solution and quantified by spectrometry at 360nm. 
 
2.4. ATP assay and estimation of population doubling time 
To estimate population doubling time or growth rate of NSCs the CellTitre Glo cell 
viability assay (Promega) was used to measure the total ATP level of viable cells over 
the growth period of 7 days. Cells were either plated into 96-well plates (NUNC) and 
the CellTitre reagents added directly into the wells on the appropriate days to assess 
viable cell number, or cells were plated into 12-well plates and harvest on the 
appropriate days and transferred to a 96-well plate for ATP level assessment. Signals 
were quantified by a luminometer (Promega). 
 
The luminescence readings were plotted against time to generate a growth curve. An 
exponential equation was fitted for the growth curve using Excel with the equation 
format y = Ce(ax) which can be rewritten as y = C2(log2eax), where C and a are constants. 
The population doubling time (x) was obtained by solving the equation 1 / (log2ea). 
 
2.5. Apoptosis and survival assays 
Apoptosis in chABC, sodium chlorate and xyloside treated cells were assessed using 
the DeadEnd Fluorometric TUNEL kit (Promega). Dissociated single cells were 
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plated onto PLL coated coverslips at a density of 5x105 cells/13mm coverslip in GM 
containing chABC (20mU/ml), chlorate (50mM) or xyloside (150μM). Cells were 
incubated at 37ºC for 24 hours, followed by fixation with 4% paraformaldehyde 
(PFA) and used for TUNEL staining as per the manufacturer’s instructions. Images 
were taken with the Zeiss Axioimager Z1 wide field fluorescence microscope. Cells 
were counted from 10 random fields using the Metamorph software.   
 
Levels of active caspase 3/7 were evaluated using the Caspase-Glo 3/7 kit (Promega). 
Dissociated cells were plated into 96-well plates (NUNC) in bulk-density (2x104 
cells/ml, 100μl/well) with CSPG or CS-A to –E all at 50μg/ml; chABC (20mU/ml), 
chlorate (50mM) or xyloside (150μM). After incubating at 37ºC for 24 hours, the 
Caspase-Glo reagent was added, and the relative active caspase 3/7 was quantified in 
a luminometer (Promega).  
 
For total cellular protein analysis, dissociated cells were plated in GM at a density of 
2x105 cells/ml, with or without CSPG (50μg/ml) for 1 to 6 hours. Cells were 
harvested in lysis buffer [20mM HEPES pH7.5, 137mM NaCl, 1% Triton-X 100, 
10% glycerol, 1.5mM MgCl2, 1mM EGTA pH8, 1mM sodium orthovanadate pH10, 
1X protease inhibitor cocktail (Roche)], placed on ice for 15 minutes, and centrifuged 
at 13,000 rpm, 4ºC for 15 minutes. The supernatant was collected and the total protein 
quantified using the Bio-Rad protein assay reagent.  
 
To demonstrate that CSPG can stimulate neurosphere formation in the absence of 
growth factor, dissociated cells were plated at bulk-density in GM(-) (GM without 
EGF), with and without CSPG (50μg/ml). Neurospheres were assessed after six days. 
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2.6. Serial passaging 
To demonstrate extensive self-renewal property of NSCs, dissociated cells were 
plated at low-density (2x103 cells/ml) in 10cm culture plates (NUNC) with/without 
CSPG (50μg/ml) and cultured for 6 days. Control and CSPG generated neurospheres 
were harvested, dissociated and a subset replated at low-density to form secondary 
neurospheres. CSPG generated cells were maintained in CSPG at each passage. This 
process was repeated for 7 passages. The total cell generated at each passage was 
calculated using the following formula: 
 
Total cell (tc) = cell count per plate (present passage) X possible number of plate (p) 
Where p = total cell (previous passage) / 2x104 
i.e. P is the possible number of plates if all cells from previous passage were plated at 
2x103 cells/ml, 10ml/plate. 
 
At each passage a subset of cells were plated into 12-well plates for evaluation of 
neurosphere numbers. CSPG generated cells were replated with/without CSPG 
(50μg/ml) to evaluate effect of CSPG removal. For chABC, chlorate or xyloside 
treated cells, serial passage was not performed. Inhibitor treated cells were replated 
with/without the inhibitors to evaluate effect of inhibitor removal. 
 
2.7. Differentiation 
For dissociated cell differentiation, neurospheres were dissociated into single cells 
and seeded onto PLL (0.01%; Sigma) and laminin (10µg/ml; Invitrogen) coated glass 
coverslips at a density of 5x105 cells/13mm coverslip. Cells were cultured in 
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differentiation medium [Dulbecco’s Modified Eagle’s Medium (DMEM)/nutrient 
mixture F-12 (1:1) medium (Invitrogen), N2 supplement (Invitrogen), 1% 
penicillin/streptomycin (Invitrogen) and 0.5% foetal bovine serum (Invitrogen)] for 7 




Figure 2. Protocol for single neurosphere differentiation. 
 
For single neurosphere differentiation, each neurospheres was transferred under a 
microscope to a single well of a 50-well coverglass (Sigma) coated with PLL and 
laminin as above （Figure 2）. Wells were top up with differentiation medium, and 
the neurosphere were allowed to settle over night at 37oC. In parallel, bulk culture 
generated neurospheres were harvested and plated into a 10cm culture dish (NUNC) 
coated with PLL and laminin in differentiation medium and incubated at 37oC 
overnight. Generally, the number of neurospheres generated from 3x105 cells (plating 
density of 2x104 cells/ml) after 6 days is sufficient. The following day, medium from 
the 10cm differentiating plate was filtered with a 0.2μm filter (Sartorius) to remove 
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any cell debris and replaced back into the same plate. The 50-well coverglass 
containing the attached single neurospheres was then inverted onto the 10cm 
differentiating plate with the neurospheres in contact with the differentiation medium 
but not the differentiating cells beneath. In this way, differentiating neurospheres from 
the 10cm plate conditions the medium with neurotrophic factors that helps to support 
differentiation of the single neurospheres on the coverglass. Single neurospheres 
plated alone without such supporting cells often die and only give rise to astrocytes if 
differentiation does occur. For comparison between control and CSPG generated 
neurospheres, control and CSPG cells were placed in different 10cm plates for 
differentiation to ensure that there is no cross talk between these cells. However, to 
ensure that both treatment groups received similar neurotrophic support signals, 
support cells were plated from the same source at the same time into separate plates. 
Thus any differences observed are likely due to intrinsic differences in the cells and 
not to extrinsic factors during the differentiation process. Neurospheres were 




After differentiation, medium was removed and the cells were washed with phosphate 
buffered saline (PBS) prior to fixation with 4% PFA in PBS (Sigma). Cells were 
blocked and permeablised with 3% BSA and 0.5% triton-X 100 in PBS, and stained 
individually with the following antibodies: anti-βIII tubulin (1:200; Sigma), anti-O4 
(1:300; Chemicon) or anti-GFAP (1:400; Sigma). In the case of anti-O4, no 
permeablisation was required as it is a surface antigen. The secondary antibody used 
was Alexa Fluor 488 goat anti-mouse (1:500; Invitrogen). The nucleus was counter 
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stained with 4',6'-diamidino-2-phenylindole dihydrochloride (DAPI; Invitrogen). 
Coverslips were mounted with Hydromount (National Diagnostics) and dried prior to 
imaging. Images were taken with the Zeiss Axioimager Z1 wide field fluorescence 
microscope. Cells expressing each antigen were counted from 10 random fields using 
the Metamorph software.  
 
For triple staining of differentiated neurospheres, cells were fixed and blocked as 
above. Sequential staining was performed with mouse IgM anti-O4 (1:300; 
Chemicon), followed by Alexa Fluor 488 goat anti-mouse IgM (1:500; Invitrogen). 
Cells were then permeablised with 0.5% triton-X 100, followed by simultaneous 
staining with mouse anti-Tuj1 (βIII-tubulin) IgG2a (1:250; Covance) and rabbit anti-
GFAP IgG (1:1000; Dako). The secondary antibodies to recognize these primary 
antibodies were Alex Fluor 594 goat anti-mouse IgG2a and Alexa Fluor 647 donkey 
anti-rabbit IgG respectively (1:500; Invitrogen). Finally, cells were counter stained 
with DAPI and mounted for viewing. The entire coverglass was screened manually 
and the number of each type of neurosphere (tripotent, bipotent or unipotent) was 
scored. Images were taken with the Olympus point scanning FV-1000 confocal 
microscope. 
 
2.9. Neural colony forming cell assay (NCFCA) 
Control and CSPG neurospheres generated from low-density cultures were harvested, 
dissociated into single cells and plated into the NCFCA collagen medium according to 
the manufacturer’s instruction (StemCell Technologies). Culture was continued for 
three weeks with weekly replenishment of medium and EGF. At the end of the culture 
period, colonies were counted and sized manually using the Olympus StereoZoom 
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microscope. Neurospheres from chABC, chlorate and xyloside treated bulk-density 
cultures were also harvested for this assay in the same way with untreated bulk-
density cells as control. 
 
2.10. Single neurosphere gene profiling 
Individual control and CSPG generated neurospheres were picked under the 
microscope and place directly into the reverse transcription reaction mix [gene 
specific primers (Taqman), CellsDirect reaction mix (Invitrogen), Taq polymerase 
(Invitrogen)] to pre-amplify genes of interest. Cells were freezed and thawed to 
induce cell lysis. The reverse transcription reaction [50°C for 20 minutes, 13 cycles at 
95°C for 15 seconds each, and 60°C for 4 minutes] was carried out to generate 
cDNAs. The pre-amplified cDNAs were diluted and used for PCR reactions using the 
BioMark chip (Fluidigm) which allows simultaneous analysis of 48 genes in 48 
samples. CT values collected by the Biomark software were exported to Excel and the 
relative expression calculated using the ABI Relative Quantitation Algorithm 
(Applied Biosystems, user bulletin July 2007). For combining multiple experiments a 
stratified t-test (Salter, 2007) was performed. The Excel spreadsheet for the stratified 
t-test was kindly provided by Dr Mikael Huss. 
 
2.11. CSPG signalling  
2.11.1. Chemical inhibitor studies  
All compounds were from Calbiochem except for Dkk-1 and Wnt3a (R&D Systems), 
cell permeable C3 transferase (Cytoskeleton), Y27632, sodium orthovanadate and 
okadaic acid (Sigma). All reagents were added at the time of cell plating with/without 
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50μ/ml CSPG, at the concentrations stated on the graphs. Neurosphere number and 
size were recorded after 5 – 6 days in culture. 
 
2.11.2. Western analysis 
For short-term experiments, dissociated cells were plated into 6cm culture plates 
(NUNC) at approximately 2 million cells per plate. Cells were plated in GM without 
EGF for 3 hours to induce quiescent. A subset of cells was also digested with chABC 
(20mU/ml) at the same time. Subsequently cells were stimulated with EGF (20ng/ml), 
CSPG (50μ/ml) or CSPG and EGF for the length of time stated on the graph. For 
assessment of STAT3 stimulation, CSPG was added at the time of cell plating. After 3 
hours cells were stimulated with EGF for 30 minutes. The stimulation was terminated 
by collecting the culture medium and any floating cells into ice-cold 15ml centrifuge 
tubes (Falcon). Cells attached to the plate were washed with ice cold PBS, detached 
with a cell scraper and collected into the centrifuge tube. Cells were centrifuged at 
1000rpm for 5 minutes at 4ºC. The supernatant was removed and lysis buffer [20mM 
HEPES pH7.5, 137mM NaCl, 1% Triton-X 100, 10% glycerol, 1.5mM MgCl2, 1mM 
EGTA pH8, 1mM sodium orthovanadate pH10, 1X protease inhibitor cocktail 
(Roche)] was added, followed by incubation on ice for 15 minutes, and centrifuged at 
13,000 rpm, 4ºC for 15 minutes. The supernatant was collected and the total protein 
quantified using the Bio-Rad protein assay reagent. Equal amounts of protein were 
separated on 10% polyacrylamide gel and transferred to PVDF membrane (Bio-Rad). 
Membranes were block with 5% non-fat milk in 1X PBS/0.1%Tween (PBST) or 1% 
BSA in PBST (for PY20 antibody) and immunoblotted with the following antibodies: 
anti-phosphotyrosin (PY20) and anti-EGFR (BD Pharmingen); anti-phospho-STAT3 
(Tyr 705), anti-STAT3, anti-phospho-Akt (Thr308), anti-Akt, anti-phospho-p38, anti-
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p38, anti-phospho-ERK1/2 and anti-ERK (Cell Signalling). Primary antibodies were 
incubated at 4ºC overnight or room temperature for 1.5 hours. After washing, 
membranes were incubated with horseradish peroxidase (HRP) conjugated secondary 
antibodies for 1 hour at room temperature, followed by incubation with enhanced 
chemiluminescence (ECL) reagent (Pierce) and the signals were visualised by 
exposure to Hyperfilm (Amersham). Signals were quantified using the Image J 
software. For long-term experiments, neurospheres generated with/without CSPG 
(50μg/ml) were harvest after six days in culture. Protein extraction and 
immunoblotting were as described. 
 
2.12. Cytokine array 
NSC-CM was screened for unique cytokines using mouse cytokine antibody array III 
(Raybiotech). 5-day NSC-CM was filtered with a 0.2μm filter to remove cell debris. 
Both NSC-CM and normal growth medium was concentrated 15 folds with a 5kDa 
Amicon filter (Millipore), and incubated with the antibody array at 4°C overnight. 
The following day, the membranes were washed and incubated with the cytokine 
antibody cocktail at room temperature for 1 hour. The membranes were washed and 
incubated with HRP-conjugated secondary antibody at room temperature for 1 hour. 
Finally, the ECL reagent was applied and the signals detected by exposure to 
Hyperfilm. 
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3. RESULTS 
 
3.1. NSC conditioned medium stimulates neurosphere formation 
CM is known to promote proliferation of different cell types (Chang et al., 2003; 
Rivera et al., 2006; Taupin et al., 2000). I began by testing the effect of NSC-CM on 
neurosphere formation, and found that NSC-CM was able to increase neurosphere 
formation. The greatest effect was observed in low density cultures of 2x103 cells/ml, 
where NSC-CM was able to increase neurosphere formation by more than 3-fold 
compared to the control (Figure 3.1). In untreated cultures, neurosphere formation 
rate 3  increased with increased cell density. Conversely, the effect of NSC-CM 
decreased with increased cell density. To identify novel factors in the NSC-CM that 
may be responsible for this neurosphere stimulatory effect, mass spectrometry was 
used to compare proteins in the NSC-CM and growth medium (GM). DSD-1-
proteoglycan was identified as a unique factor present in the NSC-CM and not in the 
GM (Ashray Ramachandran, unpublished data). DSD-1-proteoglycan is a CSPG 
known to be expressed by NSCs and important for their proliferation and 
differentiation (von Holst et al., 2006). A large number of CSPGs have also been 
reported to be secreted by neurospheres in culture (Ida et al., 2006; Kabos et al., 
2004). Thus neural precursors may secrete CSPG into the NSC-CM and this is 
responsible for the neurosphere stimulatory effect of NSC-CM. 
 
                                                 
3 Measured by the neurosphere formation unit (NFU), where one NFU is the formation of one 
neurosphere from 100 cells plated. 
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Figure 3.1. NSC-CM stimulates neurosphere formation.  
There is a gradual increase in neurosphere formation rate with increasing cell density, 
whereas NSC-CM effect decreased. Single cells were seeded at the stated densities in 
growth medium (GM) or NSC-CM. Neurospheres were counted 5 days after seeding 
and expressed as neurosphere forming units (NFU = number of neurospheres/number 
of cells seeded x 100). (Mean ± SEM; n ≥ 6 from 3 experiments; a = CM vs GM of 
each density; b and c = CM (marked concentration) vs CM (previous concentration); 
P ≤ 0.01; d and e = GM (marked concentration) vs GM (previous concentration); P ≤ 
0.05) 
 
Figure 3.2. CSPG is responsible for CM stimulation of neurosphere formation. 
ChABC digestion of CM reduced its neurosphere stimulatory effect by 50%. CM was 
treated with 5mU/ml of chABC overnight, followed by heat inactivation of the 
enzyme. GM was also treated the same way to show full inactivation of chABC. 
Heating alone did not affect the function of the CM or the GM. Cells were seeded at 
2x103/ml. Neurospheres were counted after 5 days (Mean ± SEM, n ≥ 11 from 4 
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3.2. CSPG is responsible for the NSC-CM stimulation of neurosphere 
formation 
To test the hypothesis that CSPG in the NSC-CM is responsible for stimulating 
neurosphere formation, I treated NSC-CM with chondroitinase ABC (chABC) to 
digest the GAGs on CSPG. This treatment resulted in a 50% reduction of the NSC-
CM stimulatory effect (Figure 3.2). The same concentration of chABC was used to 
treat normal growth medium followed by heat inactivation similar to the treatment of 
NSC-CM. This had no effect on the normal neurosphere formation rate, indicating 
that chABC is fully inactivated. Additional control experiments also showed that 
heating alone did not compromise the NSC-CM stimulatory effect. Thus the reduction 
in the NSC-CM stimulatory effect is due to chABC digestion of NSC-CM and not to 
the enzyme acting directly on the cells or heat inactivation of the NSC-CM.  
 
Having established that CSPG is responsible, at least in part, for the neurosphere 
stimulatory effect of NSC-CM, I next focused on the function of CSPG in regulating 
neurosphere formation and proliferation. To understand how CSPG may function in 
the context of NSCs growth and neurosphere formation I used a combination of 
exogenous CSPG to mimic the effect of NSC-CM as well as CSPG inhibitors to 
inhibit endogenous CSPG. 
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3.3. CSPG is essential for neurosphere formation  
3.3.1. Exogenous CSPG stimulates neurosphere formation 
When a commercial CSPG mix was added to low density cultures (2x103 cells/ml), it 
was able to stimulate neurosphere formation in a dose-dependent manner (Figure 
3.3A). When compared with the effect of NSC-CM, the exogenous CSPG is slightly 
less effective in stimulating neurosphere formation when the percentage of 
neurosphere formation (NFU) is compared (NSC-CM: 11.8 ± 0.1.8 NFU, CSPG: 8.9 
± 0.2 NFU) (Figure 3.3B). However, when the effects of NSC-CM and CSPG were 
compared based on folds relative to control (the NFU of treated cultures were 
normalised to the NFU of the control for each set of experiment), there was no 
significant difference. NSC-CM stimulated neurosphere formation by 3.55 ± 0.39 fold 
compared to the CSPG stimulation of 2.97 ± 0.2 fold. The greater difference between 
the NSC-CM and CSPG effect observed with the NFU measurement was likely due to 
the range of the CM data as shown by the bigger error bar. Thus the normalised data 
provides a more accurate comparison between the effects of NSC-CM and CSPG, and 
shows that they are comparable with each other.  
 


































Figure 3.3. Comparing exogenous CSPG and NSC-CM.  
A) CSPG stimulates neurosphere formation dose-dependently. Cells were seeded at 
2x103/ml. CSPG was added at the indicated concentration at the beginning of culture. 
Neurosphere formation was evaluated on day 5. (Mean ± SEM; n = 6 from 2 
experiments; ** P ≤ 0.01). 
 
B) The neurosphere stimulatory effect of CM and CSPG were compared in terms of 
NFU and fold relative to control, where control is set at 1 and the NFU for treated 
cultures were normalised to the NFU of control. 5-day CM was concentrated with a 
100kDa filter and the >100kDa fraction was reconstituted back into GM to the same 
original concentration. CSPG was added at the time of cell plating at 50µg/ml. 
Number of neurospheres was counted after 5 days. (Mean ± SEM; n ≥ 30 from 10 
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3.3.2. CSPG stimulates neurosphere formation in clonal assays 
In standard neurosphere assays, cells are grown as free-floating cultures. In this 
setting cell aggregation is prevalent particularly in bulk-density cultures (2x104 
cells/ml). Even in low-density cultures (2x103 cells/ml) aggregation can still occur 
(Hariharan, Sankaran and Ahmed, unpublished data; Coles-Takabe et al., 2008; 
Singec et al., 2006). Aggregation of single cells can increase cell-cell signalling and 
promote neurosphere formation in cells that may not have intrinsic neurosphere 
forming abilities. This will give rise to more neurospheres. When a compound is 
tested in free floating cultures, the neurosphere stimulatory effect can be due to direct 
stimulation of neurosphere formation or stimulation of cell aggregation. Thus it is 
crucial to determine whether CSPG directly stimulates neurosphere formation or 
merely promotes cell aggregation. 
 
To test whether NSC-CM and CSPG can stimulate neurosphere formation in clonal, 
non-aggregating conditions, a hydrogel culturing system was used to prevent 
neurosphere formation as a result of cell aggregation. As in low density suspension 
cultures, both NSC-CM and CSPG stimulated neurosphere formation in the hydrogel 
culture, and their effects were comparable (Figure 3.4). However, the NFU is lower in 
hydrogel cultures compared to suspension cultures, indicating that fewer neurospheres 
formed in hydrogel cultures. When the fold-relative-to-control was compared the 
effects of NSC-CM and CSPG in hydrogel cultures were comparable with that of 
suspension cultures (hydrogel culture, NSC-CM: 3.37 ± 0.07 fold, CSPG: 3.67 ± 0.18 
fold; suspension culture, NSC-CM: 3.55 ± 0.39, CSPG: 2.97 ± 0.2 folds). Thus both 
NSC-CM and CSPG can directly stimulate neurosphere formation in the absence of 
cell aggregation. 
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Figure 3.4. NSC-CM and CSPG stimulate neurosphere formation in clonal 
hydrogel culture. 
Cells were plated at 2.5x103 cells/ml in 1.2% gel. 5-day NSC-CM was concentrated 
with a 100kDa filter and the >100kDa fraction was reconstituted back into GM to the 
same original concentration. CSPG was added at the time of cell plating at 50µg/ml. 
Number of neurospheres was counted after 5 days. (Mean ± SEM, n ≥ 3 from 2 












Figure 3.5. Comparing the effect of CSPG with other proteoglycans.  
A) Heparan sulphate proteoglycan (HSPG) inhibited neurosphere formation. Keratan 
sulfate (KS) and hyaluronic acid (HA) did not affect neurosphere formation. Cells 
were plated at 2x103 cells/ml with 50µg/ml of each proteoglycan. Neurospheres were 
counted after 5 days (Mean ± SEM, n = 3 from 1 experiment). HSPG treatment 
induced cells to attach to the culture dish. Some of the cells appeared to have 
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3.3.3. Stimulation of neurosphere formation is specific to CSPG 
In addition to CSPG, other important members of the proteoglycan family are heparan 
sulfate proteoglycan (HSPG) and keratan sulfate proteoglycan (KSPG), and 
hyaluronic acid (HA) which is a closely related GAG that is not bound to a protein 
core. The HSPG in particular is well known to regulate bFGF signalling in NSCs. To 
determine whether these proteoglycans/GAGs can also stimulate neurosphere 
formation, I evaluated the effect of exogenous HSPG, KS (KSPG was not available 
commercially) or HA on neurosphere formation. KS and HA did not stimulate 
neurosphere formation (Figure 3.5A). HSPG, on the hand, inhibited neurosphere 
formation. In addition, HSPG treatment induced cells to attach to the culture dish and 
differentiate into neurons and astrocytes (Figure 3.5B). These data indicate that the 
neurosphere stimulatory effect is specific to CSPG. 
 
3.3.4. Endogenous CSPG is essential for neurosphere formation 
To understand how endogenous CSPG may regulate neurosphere formation, I 
inhibited endogenous CSPG with chABC, sodium chlorate and 4-methylumbelliferyl-
β-D-xyloside treatment. 
 
Digestion of the GAG chains of CSPG into disaccharide subunits with chABC 
resulted in a dose dependent reduction in neurosphere formation in bulk density 
cultures (Figure 3.6A). Any neurospheres formed eventually broke down. The 
neurospheres either lose their tight 3-dimensional (3D) structure, becoming loose cell 
clumps (Figure 3.6B), or attached to the culture dish and the cells migrate away from 
the sphere, eventually forming a monolayer culture (Figure 3.6C). 
























Figure 3.6.Effect of chABC on neurosphere formation and structure.  
A) ChABC inhibits neurosphere formation dose-dependently. Cells were plated at 
2x104 cells/ml. ChABC was added at the time of plating at the stated concentrations. 
Neurospheres were counted after 5 days (Mean ± SEM, n = 12 from 4 experiments). 
B) ChABC induces breakdown of the 3-D neurosphere into loss cell clusters (arrows). 
C) ChABC induces cell attachment and proliferation as an adherent layer. D) When 
ChABC was added to 4-day old neurospheres at 10, 20 and 50mU/ml, a dose-
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Approximately five percent of these cells differentiate into neurons and astrocytes, 
with the majority of the cells remaining nestin positive, similar to the control. When 
chABC was added to neurospheres that had already formed it also induced 
neurosphere breakdown in a dose-dependent manner (Figure 3.6D). Thus the GAG 
chains of CSPG are required for neurosphere formation and involved in maintaining 
the neurosphere structure. 
 
To rule out the involvement of other proteoglycans, dissociated cells were cultured in 
the presence of heparinase II (digests both heparin and HS-GAG), keratanase (digests 
KS-GAG) or hyaluronidase (digests HA). None of these GAG-degrading enzymes 
had any effect on neurosphere formation or maintenance even when used at 10 times 
the maximum concentration of chABC (Figure 3.7). Thus neurosphere formation and 
maintenance requires specifically CS-GAGs.  
 
Since chABC breaks down the neurosphere structure, it is difficult to assess the role 
of endogenous CSPG in neurosphere formation with this inhibitor. So CSPG 
biosynthesis was perturbed using sodium chlorate to block sulfation of the GAG 
chains, and β-D-xyloside to prime GAG synthesis, thus competing with the 
proteoglycan protein core for GAG synthesis (Sobue et al., 1987). Both chlorate and 
xyloside treatment reduced neurosphere formation without breaking down the 
neurosphere structure (Figure 3.8). This suggests that the full proteoglycan structure is 
required for neurosphere formation, whereas the intact GAG chain is sufficient for 
maintaining the neurosphere structure. Of the three CSPG inhibitors, xyloside showed 
the least inhibitory effect. ChABC and chlorate produced greater inhibition and were 
comparable with each other. The effect of all three inhibitors can be rescued with 













Figure 3.7. Other GAG enzymes have no effect on neurosphere formation. 
Cells were plated at 2x104 cells/ml. All enzymes were added at time of plating at the 
stated concentrations. Neurospheres were counted after 5 days (Mean ± SEM, n = 3 
from 1 experiment). 
 
 
Figure 3.8. Inhibition of endogenous CSPG inhibits neurosphere formation.  
Inhibition of neurosphere formation by xyloside (150µM), chlorate (50mM) and 
chABC (50mU/ml) could be rescued by CSPG (50µg/ml). Cells were plated at 2x104 
cells/ml. All reagents were added at the time of plating. Neurospheres were counted 
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 exogenous addition of CSPG (Figure 3.8). CSPG treatment produced a complete 
rescue of xyloside inhibition and approximately 35% and 70% recovery for chlorate 
and chABC inhibitions respectively. Note that CSPG does not stimulate neurosphere 
formation in bulk density cultures. This is similar to the inability of the NSC-CM to 
stimulate neurosphere formation under such conditions. 
 
3.3.5. Glycosaminoglycan sulfation and neurosphere formation 
Experiments with sodium chlorate above indicate that sulfation of the CS-GAG chain 
is important for CSPG function. To further understand the role of sulfation, I tested 
whether differentially sulfated GAG chains (Figure 3.9B) can stimulate neurosphere 
formation similar to CSPG. CS-A, -B and -E were found to stimulate neurosphere 
formation whereas CS-C and –D had no effect (Figure 3.9A). CS-B showed a small 
but significantly greater stimulation than CS-A, whereas the greatest stimulation was 
observed with CS-E. However, this is still lower than the stimulatory effect of CSPG. 
 
In cells, there are natural enzymes known as sulfatases that selectively remove sulfate 
from proteoglycan GAGs. I employed two of these enzymes, chondroitin-4-sulfatase 
(Ch-4-sul; removes sulfate from the 4-O position of N-acetylgalactosamine) and 
chondroitin-6-sulfatase (Ch-6-sul; removes sulfate from the 6-O position of N-
acetylgalactosamine) to see how sulfation may affect the function of endogenous 
CSPGs. In bulk density cultures, neither sulfatases had any effect on neurosphere 
formation (Figure 3.10A). However, in low-density cultures, Ch-6-sul but not Ch-4-
sul was able to stimulate neurosphere formation (Figure 3.10B). To determine 
whether the effect is specifically due to the release of sulfate from the appropriate 
sites, the enzymes were tested with CS-A, CS-C and CSPG as the substrate. Neither 
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sulfatase was able to release detectable quantity of sulfate unless the substrates were 
pre-digested with chABC (Figure 3.10C). Thus both sulfatases can only release 
sulfate from GAG disaccharides, and not from intact polysaccharides. The 



































Figure 3.9. Differentially sulfated GAGs can stimulate neurosphere formation.  
A) CS-A, -B and –E stimulated neurosphere formation with increasing effect. Cells 
were plated at 2x103 cells/ml. All reagents were added at the time of plating at 
50µg/ml. Neurospheres were counted after 5 days (Mean ± SEM; n ≥ 6 from 2 
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Figure 3.10. Effect of Chondroitin-4 and -6-sulfatases on 
neurosphere formation.  
A) Ch-4-sul and Ch-6-sul have no effect on neurosphere formation in 
bulk-density. B) In low-density cultures both sulfatases stimulated 
neurosphere formation. Cells were plated at 2x104 cells/ml (bulk-
density) or 2x103 cells/ml (low-density). Sulfatases were added at the 
time of plating at the stated concentrations. Neurospheres were counted 
after 5 days (Mean ± SEM; n ≥ 9 from 3 experiments; * P ≤ 0.05, ** P 
≤ 0.01 compared to control (w/o)). C) Sulfatase assay to determine 
sulfatase activity. Sulfatases were unable to release sulfate from 
polysaccharides. Sulfatases were added to undigested (poly) or chABC 
digested CS-A (DCS-A), CS-C (DCS-C) or CSPG (DCS). Release of 
free sulfate was detected by absorbance at 360nm. Red line denotes 
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3.4. CSPG is essential for neural precursor proliferation 
There are a number of parameters that can be assessed in an NSA. Neurosphere 
formation provides an indication of the presence of potential stem cells particularly 
when performed in clonal conditions. A neurosphere may contain NSCs, progenitors 
and differentiated cells. Since differentiated cells do not proliferate, the increase in 
neurosphere size will indicate proliferation of neural precursors, i.e. both NSCs and 
progenitors. Having shown a role for CSPG in stimulating neurosphere formation, I 
next assessed whether CSPG is involved in neural precursor proliferation. 
 
3.4.1. Exogenous CSPG stimulates neural precursor proliferation 
Exogenous CSPG was found to increase neurosphere size (Figure 3.11A), suggesting 
a role for CSPG in neural precursor proliferation. In suspension culture, there was a 
significant increase in the percentage of neurospheres >100μm in diameter, from 13.4 
± 8.3% to 39.4 ± 15.8%. In addition, there was a significant decrease in the 
percentage of <50μm (32.7 ± 13.1% to 16.5 ± 8.2%) and 50-100μm (53.9 ± 8.4% to 
44.1 ± 9.6%) neurospheres. In clonal hydrogel cultures, there was also a significant 
increase in the percentage of neurospheres >100μm from 8.5 ± 3.4% to 24.2 ± 1.8%. 
Thus CSPG is likely to increase neurosphere size as a result of increased proliferation 
and not increased aggregation.  
 
Another method to evaluate cell proliferation is to measure the total number of viable 
cells and generate a growth curve (Figure 3.11B) from which the population doubling 
time can be estimated (see method). The population doubling time for cells cultured in 
low density cultures was estimated to be 37.2 ± 2.3 hours (Figure 3.11C).  
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Figure 3.11. CSPG treatment increased neural precursor 
proliferation.  
A) CSPG increased neurosphere size in both low density hydrogel and 
suspension cultures. (Mean ± SEM; n = 6 from 2 experiments; *P≤0.05, 
**P≤0.01 compared to control in the respective size category). B) 
Growth curve for cells cultured with and without CSPG. The luminescent 
signals correspond to cellular ATP level. Equations generated from the 
fitted trendlines were used to calculate the average population doubling 
time. C) Comparison of population doubling time under different culture 
conditions. CSPG added to low density culture significantly reduced the 
population doubling time to levels of bulk-density cultures. Control (L) 
and (B) denote plating densities of 2x103 cells/ml and 2x104 cells/ml 
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When CSPG was added to low density cultures it was able to reduce the population 
doubling time to 29 ± 0.9 hours. This resembled the population doubling time of bulk 
density cultures which was estimated to be 29.5 ± 0.7 hours. Thus addition of 
exogenous CSPG increases neural precursor cell proliferation rate. CSPG did not 
change the population doubling time of bulk density cultures. This is consistent with 
the observation that CSPG does not stimulate neurosphere formation in bulk density 
cultures. 
 
3.4.2. Endogenous CSPG is required for neural precursor proliferation 
Inhibiting endogenous CSPG with chABC, sodium chlorate and xyloside also 
inhibited precursor proliferation. This can be seen in the growth curve plotted from 
total number of viable cells (Figure 3.12A). However, since these inhibitors also 
reduced neurosphere number, it is possible that the decreased total cell number is due 
to reduced neurosphere formation. Thus I measured the size of the neurospheres and 
found that these inhibitors did indeed inhibit proliferation resulting in smaller 
neurospheres (Figure 3.12B). For all three inhibitors there was a significant increase 
in the percentage of <50µm neurospheres and reduction in the percentage of >50µm 
neurospheres. When CSPG was added with sodium chlorate, there was a significant 
reduction in the percentage of <50µm spheres with a concomitant increase in 
percentage of >50µm neurospheres. Thus CSPG was able to rescue the inhibitory 
effect of chlorate. For both xyloside and chABC, addition of CSPG did not 
significantly affect neurospheres in the <50 and 50-100µm categories. However, a 
significant rescue was observed for neurospheres in the >100µm category. 






































Figure 3.12. CSPG inhibitors decreased neural precursor proliferation.  
A) Growth curve for neural precursors in the presence of chABC (20mU/ml), chlorate 
(50mM) and xyloside (150μM). Cells were plated at 2x104 cells/ml. All reagents were 
added at the time of plating. ATP levels were determined at the time points indicated. 
The luminescent signals correspond to cellular ATP level (representative figure, mean 
± SEM; n = 3 from 1 experiment). 
 
B) CSPG inhibitors decreased neurosphere size, which can be rescued by CSPG. Cells 
were plated as above with the same concentration of inhibitors added at the time of 
plating. CSPG was also added at the time of plating at 50μg/ml. Neurosphere 
diameter was measured after 5 days (Mean ± SEM; n = 6 from 2 experiments; a = P ≤ 
0.01 compared to control and b = P ≤ 0.01 compared to inhibitor only cultures at the 
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3.4.3. Inhibition of CSPG in adherent culture inhibit neural precursor 
proliferation 
The ability of chABC to break down the 3D structure of the neurosphere suggests that 
CSPG has a role in maintaining neurosphere structure. It is possible that the effect of 
endogenous CSPG on cell proliferation is a result of its function in maintaining the 
neurosphere structure, i.e. holding the cells in close contact allows cell-cell signalling 
to stimulate proliferation. To attempt to rule out this possibility, dissociated neural 
precursors were plated on poly-L-lysine (PLL) and grown as an adherent culture.  
 
When induced to grow as an adherent culture the neural precursors proliferated slower 
than in suspension cultures (Figure 3.13A) and a higher plating density (1x104 
cells/ml) was required for optimal proliferation. They also did not proliferate as a 
uniform monolayer but would tend to form clusters (Figure 3.13B), indicating that 
neural precursors preferentially grow as clusters of cells similar to the neurosphere 
system. Addition of CSPG to the adherent cultures induced formation of neurosphere-
like structures that remain attached to the culture surface (Figure 3.13B), thus lending 
support to the hypothesis that CSPG is involved in the structural component of the 
neurosphere. 
 
Using adherent cultures I tested the effect of chABC, chlorate and xyloside on neural 
precursor proliferation. All three inhibitors were found to inhibit neural precursor cell 
proliferation, while CSPG was able to increase proliferation (Figure 3.13C). 
Therefore, CSPG has a role in neural precursor proliferation, neurosphere formation 
and maintenance. 
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Figure 3.13. Neural precursor proliferation in adherent culture.  
A) Adherent cultures have slower proliferation rate than suspension 
cultures. B) Representative images of cells grown as adherent cultures. 
CSPG promotes neurosphere formation even in adherent cultures. C) 
Inhibition of CSPG in adherent cultures also reduced proliferation, 
while addition of CSPG increased proliferation. Cells were plated at 
1x104 cells/ml on PLL coated culture dishes (adherent), or in non-coated 
dishes (suspension). CSPG (50μg/ml), chABC (20mU/ml), chlorate 
(50mM) and xyloside (150μM) were added at the time of plating. 
Proliferation was assessed with luminescence read out of ATP level 
(representative figures, mean ± SEM; n = 3 from 1 experiment). Scale 
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3.5. CSPG is essential for neural precursor survival 
Exogenous CSPG can stimulate neurosphere formation, and inhibition of endogenous 
CSPG resulted in reduced neurosphere formation. This suggests that CSPG may 
regulate neural precursor survival. To determine whether CSPG can protect neural 
precursors from apoptosis I performed TUNEL assays on chABC, chlorate and 
xyloside treated cells. All three inhibitor treatments significantly increased TUNEL 
staining after 24 hours (Figure 3.14A). ChABC induced a 10 ± 2.4% increase, 
chlorate 17 ± 2.1% and xyloside 4.2 ± 1.8%. I also evaluated an earlier marker of 
apoptosis, the level of active caspase 3/7. ChABC, chlorate and xyloside treated cells 
showed no significant changes in the level of active caspase 3/7 compared to 
untreated cells (Figure 3.14C). 
 
Cells do not attach well to coverglass in the presence of CSPG, thus it was difficult to 
perform TUNEL staining. Instead I performed caspase assays and found that cells 
incubated with CSPG for 24 hours showed significantly less active caspase 3/7 
compared to untreated cells (Figure 3.15A). Thus CSPG protects cells from apoptosis. 
In support of a protective role for CSPG, I found that total cellular protein level was 
significantly higher in cells incubated with CSPG for one to six hours (Figure 3.15B). 
This indicates that CSPG protected cells immediately after passaging and plating 
when a lot of cell death is likely to occur. A gradual increase in control cell protein 
levels was observed with time indicating that cells are recovering from the initial 
manipulations. CS-A to –E treatment also reduced active caspase 3/7 levels (Figure 



















































Figure 3.14. Inhibiting endogenous CSPG increased apoptosis.  
A) CSPG inhibitors induced significant increase in the percentage of TUNEL 
positive cells as compared to control. B) Representative images of TUNEL 
positive cells (green) with/without CSPG inhibitors. 5x105 cells were plated onto 
PLL coated coverglass and incubated with ChABC (20mU/ml), chlorate (50mM) 
or xyloside (150mM) for 24 hours, followed by TUNEL staining. Nuclei were 
counterstained with DAPI (blue). Cells were counted from 10 random fields 
(Mean ± SEM; n ≥ 12 from 5 experiments; * P ≤ 0.01, ** P ≤ 0.01). 
 
C) CSPG inhibitor did not alter active caspase 3/7 levels. Cells were plated at a 
density of 2x104 cells/ml in the presence of the same inhibitors as above for 24 
hours. Levels of active caspase 3/7 were determined by luminometric method 
and expressed relative to the untreated control, which was set as 1 denoted by the 















































































































Figure 3.15. CSPG reduced apoptosis  
A) CSPG and CS-GAGs decreased levels of active caspase 3/7. Cells were plated at a 
density of 2x104 cells/ml with 50μg/ml of CSPG for 24h. Levels of active caspase 3/7 
were determined by luminometric method and expressed relative to the untreated 
control, which was set at 1 (Mean ± SEM; n ≥ 9 from 4 experiments; * P ≤ 0.05, ** P 
≤ 0.01). 
 
B) CSPG treatment resulted in significant increase in total cellular protein recovered. 
Cells were plated at 2x105 cells/ml, with/without 50μg/ml of CSPG. Cells were 
harvested at the stated time for protein extraction and quantification (Mean ± SEM, n 
≥ 3 from 5 experiments; a = P ≤ 0.01 comparing CSPG treatment with control at the 
respective time point; b = P ≤ 0.01 comparing control at 3h and control at 1h; c = P ≤ 
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Neurospheres do not form in the absence of EGF, presumably due to the inability of 
cells to survive in the absence of this growth factor. However, CSPG was able to 
induce neurosphere formation in the absence of EGF (Figure 3.16A). The NFU was 
significantly reduced compared to control cells grown in the presence of EGF. In 
addition, neurospheres generated by CSPG in the absence of EGF resembled small 
cell aggregates (Figure 3.16C) rather than the large tight spherical structures normally 
seen in the presence of EGF (Figure 3.16B). Nevertheless, the result indicates that 
CSPG is a survival factor for neural precursors. 
 
To determine whether CSPG stimulates neurosphere formation beyond the initial 
protective period, CSPG was added to cells at various times after cell plating. As can 
be seen from Figure 3.17, the stimulatory effect of CSPG is greatest when added at 
the time of plating. However, CSPG addition as late as three days post plating can 
stimulate neurosphere formation. When compared with CSPG addition at time of cell 
plating, late addition of CSPG reduced its stimulatory effect. 
 
3.6. Characterisation of CSPG generated cells 
As CSPG can stimulate neurosphere formation and proliferation, it is important to 
address whether CSPG is stimulating NSCs or lineage restricted progenitors. Thus, I 
assessed the ability of CSPG generated neurospheres in terms of self-renewal 
capacity, differentiation potential and gene expression profile. 
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Figure 3.16. CSPG promotes neurosphere formation in the absence of 
EGF.  
A) Cells were plated 2x104 cells/ml in growth medium containing EGF 
(GM), growth medium without EGF [GM(-)] and GM(-) with 50μg/ml of 
CSPG (GM(-)+CSPG). Neurospheres were counted after 5 days (Mean ± 
SEM; n = 12 from 4 experiments; ** P ≤ 0.01). The lower panel showed 
representative images of neurospheres grown in GM (B) and in GM(-) 
+CSPG (C) In the absence of EGF, CSPG promotes formation of very 





















Figure 3.17 CSPG stimulates neurosphere formation at 
different time point. 
Cells were plated at 2x103 cells/ml. CSPG (50μg/ml) was 
added at time of plating (0 DIV), 1 day (1 DIV), 2 days (2 DIV) 
or 3 days (3 DIV) after plating. Neurospheres were counted 
after 5 days (representative figure, mean ± SEM; n = 3 from 1 
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3.6.1. CSPG and NSC self-renewal 
An important feature of NSCs is the ability to self-renew to generate a large number 
of cells. Self-renewal in the strictest sense means that the cell must make an exact 
replicate of itself. However, as there are currently no definitive marker(s) that can 
identify a NSC, it is not possible to measure self-renewal directly. Thus, the accepted 
method for demonstrating self-renewal in vitro is through secondary neurosphere 
formation, whereby the neurospheres generated in the first passage are dissociated and 
replated to form new neurospheres. However, progenitors are also known to have 
limited self-renewal capacities. Thus to differentiate between NSCs and progenitors, it 
is necessary to demonstrate long-term self-renewal by serial passaging. 
 
I serially passaged CSPG treated cells and found that they passaged as well as control 
cells for at least seven passages. The only difference being that CSPG treatment 
generated more cells than control cultures (Figure 3.18A). This stimulated self-
renewal occurred only while CSPG was in the culture medium. When CSPG 
generated neurospheres were dissociated and replated at low density without CSPG, 
they formed similar number of neurospheres as the control (Figure 3.18B). This 
suggests that CSPG acts as a survival factor for NSCs and does not increase the 
number of NSCs per se. I did not serially passage chABC, chlorate or xyloside treated 
cells since these inhibitors reduce neurosphere formation, thus making these 
experiments impractical. However, when I replated inhibitor treated cells to form 
secondary neurospheres without these inhibitors, I found that the cells again recovered 
their neurosphere forming potential and gave rise to similar percentage of 
neurospheres as the control (Figure 3.18C). Thus, these inhibitors only reduce self-
renewal transiently. 
   
R














































Figure 3.18. Self-renewal characteristic of CSPG generated cells.  
A) CSPG treated cells can passage as well as control cells for at least seven 
passages, but gave rise to more cells. B) The neurosphere stimulatory effect of 
CSPG was temporary. After CSPG removal, cells returned to the normal rate of 
neurosphere formation. C) The neurosphere inhibitory effect of CSPG inhibitors 
was also temporary. After inhibitor removal, NSCs were able to recover and form 
neurospheres at the normal rate. Cells were plated at 2x103 cells/ml (A & B) or 
2x104 cells/ml (C). CSPG (50μg/ml), chABC (10mu/ml), chlorate (20mM) and 
xyloside (100μM) was added at the time of plating. CSPG generated cells 
continued to be maintained in CSPG for serial passaging. Total cell number was 
calculated as described in the Materials and Methods. Neurospheres generated in 
the presence of treatment were passaged and replated at the same density without 
treatment. Control cells were treated with the same reagents in parallel for 
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3.6.2. CSPG and multipotency 
The second feature of NSCs is the ability to give rise to the three neural cell types, 
neurons, oligodendrocytes and astrocytes. Initially, I performed dissociated cell 
differentiation where all of the neurospheres were pooled, dissociated and replated as 
single cells in differentiation conditions. Figure 3.19A showed that treatment with 
CSPG did not alter the percentage of neurons, oligodendrocytes or astrocytes 
compared to the control.  
 
When differentiation is performed using dissociated cells, or a pool of neurospheres, it 
is not possible to determine whether the multiple cell types obtained came from 
unipotent, bipotent or tripotent neurospheres. It is important to characterize the 
potential of individual neurospheres as this gives an indication of whether the 
neurosphere contains multipotent stem cells or are made up of lineage restricted 
progenitors. However, if the neurosphere is composed of progenitors of each of the 
cell types, i.e. neuron progenitors and glial progenitors, it would appear to be 
multipotent upon differentiation. Thus, an additional criterion for this experiment is 
that the neurospheres should be generated under clonal conditions. As it was not 
possible to extract intact neurospheres generated from the clonal hydrogel cultures 
used earlier, I used neurospheres generated from low-density cultures (2x103 cells/ml, 
or 350cells/cm2). Based on a recent publication, the estimated aggregation rates for 
cells cultured at 1x103 cells/ml (250cells/cm2) and 5 x103 cells/ml (1250cells/cm2) are 
1.6% and 8% respectively, when cells were not disturbed during the culturing period 
(Coles-Takabe et al., 2008). Thus there is a five-fold increase in aggregation rate with 
a five-fold increase in cell density. For my experiments, the cell density is 1.4-fold 
higher than the lower density used by Coles-Takabe et al. (2008). In addition, my 
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cells were also not disturbed during the culturing period, thus the aggregation rate in 
my cultures is estimated to be 2.2% (i.e. 1.4-fold higher than the 1.6% aggregation 
rate for cells cultured at 1x103 cells/ml). This indicates that approximately 98% of the 
neurospheres used for differentiation were likely to be clonal. 
 
Upon differentiation, CSPG generated neurospheres were found to be multipotent, 
producing neurons, oligodendrocytes and astrocytes similar to the control (Figure 
3.19B). The percentage of each type of neurosphere is summarized in Figure 3.19C. 
In control cultures, approximately 17% (17.8 ± 4.3%; mean ± SEM) of the 
neurospheres were tripotent, 35.4 ± 3.5% were bipotent, positive for neurons and 
astrocytes or oligodendrocytes and astrocytes4, and the remaining 46.8 ± 6.5% were 
unipotent, positive only for astrocytes. CSPG treatment induced a significant increase 
in the percentage of tripotent neurospheres to 29.5 ± 5.7% and a significant decrease 
in the percentage of unipotent neurospheres to 36.2 ± 5.2%. The percentage of 
bipotent neurospheres remained similar to the control at 34.2 ± 2.2%. This result can 
be more clearly visualized when plotted as fold relative to control in Figure 3.19D. 
                                                 
4 Astrocytes were always present, thus there are no neuron/oligodendrocyte bipotent neurospheres 
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Figure 3.19. Differentiation of CSPG treated cells 
A) Dissociated cell differentiation showed that CSPG treatment did not change 
the lineage potential of neural precursors. Neurospheres generated with/without 
CSPG (50μg/ml) were dissociated and plated onto PLL/laminin coated 
coverslips at 5x105 cells/coverslip. Cells were differentiated in differentiation 
medium for 7 days. Cells were fixed and immunostained for markers of neurons, 
oligodendrocytes (Olig) and astrocytes (Astro). Cells from 10 random fields were 
counted (Mean ± SEM, n ≥ 30 from 3 experiments). B) Representative images of 
multipotent neurospheres generated with CSPG. Single neurospheres were 
differentiated and immunostained for following markers O4 (oligodendrocytes), 

























































































Figure 3.19C. Percentage of each type of neurospheres generated with/without 
CSPG. CSPG increased the percentage of tripotent neurospheres and reduced the 
percentage of unipotent neurospheres. The percentage of bipotent neurospheres 
(oligodendrocytes/astrocytes, or neurons/astrocytes) remained unchanged (Mean ± 
SEM; n ≥ 347 from 6 experiments; * P ≤ 0.05, ** P ≤ 0.01). The same data was 
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Since the chABC, chlorate and xyloside treatments were carried out in bulk-density 
cultures where cell aggregation is prevalent, it is not necessary to then differentiate 
these cells as single neurospheres. When differentiated as dissociated cells the 
chABC, chlorate and xyloside treated cells showed a significant reduction in the 























Figure 3.20. CSPG inhibitors inhibit differentiation.  
Inhibitor treatment reduced neuron and oligodendrocyte differentiation and increased 
astrocyte differentiation. Neurospheres generated with chABC (10mU/ml), chlorate 
(20mM) and xyloside (100μM) were dissociated and plated onto PLL/laminin coated 
coverslips at 5x105 cells/coverslip. Cells were differentiated in differentiation medium 
for 7 days. Cells were fixed and immunostained for neurons, oligodendrocytes (Olig) 
and astrocytes. Cells from 10 random fields were counted (Mean ± SEM; n ≥ 25 from 
4 experiments; * P ≤ 0.05 and ** P ≤ 0.01 as compared to control for each cell type in 
each condition). Percentage of neurons and oligodendrocytes are shown on the left 
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In bulk-density cultures, the aggregation rate is at least 20%, whereas in low density 
cultures the aggregation rate is likely to be 2.2% (Coles-Takabe et al., 2008; Singec et 
al., 2006). To determine whether the increased aggregation in bulk culture affects the 
differentiation potential of neurospheres, I compared bulk density neurospheres with 
low density neurospheres by single neurosphere differentiation. I found that there was 
no significant difference in the percentages of tripotent neurospheres, 
oligodendrocyte/astrocyte forming neurospheres, and neurospheres that form only 
astrocytes, between the two culturing conditions (Figure 3.21A). However, there was 
a significant increase in the percentage of neuron/astrocyte forming neurospheres 
from 8.6 ± 3.6% in low-density cultures to 13.7 ± 4.9% in bulk-density cultures.  
 
Since the bulk density neurospheres appeared to behave similarly to low density 
neurospheres, I evaluated the multipotency of chABC, chlorate and xyloside treated 
bulk density neurospheres by single neurosphere differentiation. Xyloside treated 
neurospheres showed a significant decrease in the percentage of tripotent (4.1 ± 
1.2%), bipotent (neuron/astrocyte: 3.7 ± 1.8%; oligodendrocyte/astrocyte: 4.6 ± 7.6%) 
neurospheres, and an increase in the percentage of unipotent (12.5 ± 7.4%) 
neurospheres (Figure 3.21B). Chlorate treatment decreased the percentage of 
oligodendrocyte/astrocyte forming neurospheres (8.1 ± 4.6%) without significantly 
affecting neurospheres in the other categories. ChABC treatment, on the other hand, 
did not significantly affect the potential of the neurospheres. These changes can be 




















Figure 3.21. Single neurosphere differentiation of inhibitor treated cells  
(A) Comparison of single neurosphere differentiation of low and bulk 
density neurospheres. Culture density did not affect the percentage of 
tripotent, unipotent and oligodendrocyte/astrocyte (O4/GFAP) bipotent 
neurospheres. Bulk-density culture increased the percentage of 
neuron/astrocyte (Tuj/GFAP) bipotent neurospheres (B) CSPG inhibitors 
altered the percentage of each type of neurosphere. Neurospheres generated 
from chABC (10mU/ml), chlorate (20mM) and xyloside (100μM) treatment 
were differentiated as single neurospheres. Xyloside treatment decreased 
the percentages of tripotent and bipotent neurospheres and increased the 
percentage of unipotent neurospheres. Chlorate treatment only reduced the 
oligodendrocyte/astrocyte (O4/GFAP) bipotent neurospheres (Mean ± 
SEM, n ≥ 112 from 3 experiments, * P ≥ 0.05, ** P ≤ 0.01). The same data 
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3.6.3. Neural colony-forming cell assay 
CSPG generated neurospheres showed extensive self-renewal and multipotent 
capacities, suggesting that CSPG is stimulating NSCs survival. To find further 
support for this hypothesis, I utilised the neural colony-forming cell assay (NCFCA). 
This assay is based on the hypothesis that NSCs have greater proliferative potential 
than progenitor cells, and proliferate for a longer period in culture compared to 
progenitors. So when cultured over an extended period of time (three weeks), colonies 
derived from NSCs will be larger than those derived from progenitors (Louis et al., 
2008). Cells are immobilised in a collagen gel matrix to prevent aggregation and thus 
ensure clonality of the colonies. The colonies derived are scored based on the 
following categories, diameters <0.5mm, 0.5-1mm, 1-2mm and >2mm. Colonies 
>2mm in diameter are defined as NSC-derived colonies, while those <2mm are 
defined as progenitor-derived colonies 
 
Neurospheres generated from low density cultures with or without CSPG were 
dissociated and used for the NCFCA as described in the Materials and Methods. I 
found that the percentage of colonies generated from control and CSPG treated cells 
was similar in each of the size categories defined by the protocol (Figure 3.22A). 
However, when colonies >0.5mm were re-analysed by subdividing them into smaller 
size categories, it can be seen that CSPG treated cells generated fewer colonies 
between 0.5 and 0.8mm, with a significant increase in colonies between 0.8 and 
1.2mm as compared to the control (Figure 3.22B). An increase in the percentage of 
1.6 – 2mm colonies was also observed with CSPG cells, but this was not significant 
(P = 0.068).  
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Figure 3.22. Neural colony-forming cell assay.  
A) CSPG treated cells generated similar percentage of colonies as the 
control for each of the size categories of the NCFCA protocol B) When 
colonies >0.5mm were categorized into finer categories, CSPG treated 
cells gave rise to significantly fewer 0.5-0.8mm colonies and more 0.8-
1.2mm colonies as compared to the control in the same categories. C) 
CSPG inhibitors increased <0.5mm colonies and decreased 0.5-1mm 
colonies. Control, CSPG (50µg/ml), chABC (10mU/ml), chlorate 
(20mM), and xyloside (100µM) generated neurospheres were dissociated 
and plated into collagen matrix for colony formation over 3 weeks 
(Means ± SEM; n ≥ 20 from 5 experiments; * P ≤ 0.05 and ** P ≤ 0.01 
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The decrease in 0.5-0.8mm colonies and increase in 0.8-1.2mm colonies suggests that 
CSPG treated cells may have slightly higher proliferative potential than control cells. 
 
I also tested the chABC, chlorate and xyloside generated neurospheres using the 
NCFCA. The inhibitor treatments increased the percentage of colonies smaller than 
0.5mm in diameter, and decreased the percentage of colonies in the 0.5-1mm 
category. Colonies in the 1-2mm category were not affected (Figure 3.22C), but their 
overall percentage was very low (3-4%). Thus inhibition of endogenous CSPG 
compromised colony proliferation. 
 
3.6.4. Genetic profiling of CSPG generated neurospheres 
To determine whether there are differences between control and CSPG generated 
neurospheres at the genetic level, I performed genetic profiling of single neurospheres 
generated by CSPG. A panel of 59 genes was evaluated and it was found that these 
genes remained largely unchanged, and any changes were relatively small (Figure 
3.23 and Table 3.1). In the Sox family, Sox3, 5, 9, 11 and 14 all showed significant 
increase, while Sox2 remain unchanged (Figure 3.23A). Very few neurospheres, 
treated or untreated, were found to express Sox1. Thus expression level of this gene 
was not plotted. In the notch signalling pathway, there was a significant increase in 
Hes1, Hes 6 and the notch ligand Jag1 (Figure 3.23B). For the panel of cell cycle 
related genes, a significant decrease in the telomerase protein, Tert, was observed, 
along with a significant increase in the proliferative marker Ki-67 (Figure 3.23C). The 
cyclin-dependent kinases (CDK) 2 and 4, as well as cyclinD1 showed an increase. 
However, the cell cycle inhibitors p16, p21 and p27 were also upregulated. For the 
receptor genes profiled, FGFR1 and FGFR2 showed upregulation, while PDGFR 
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showed down regulation (Figure 3.23D). In the Wnt signalling pathway, Wnt1 and 
Wnt3a could not be detected, but an upregulation of the non-canonical Wnt5a was 
observed (Figure 3.23D). Figure 3.23E are genes that have been well linked with NSC 
biology. Amongst these, only nestin was significantly upregulated. Figure 3.23F and 
G show additional genes that have been linked to NSCs, but have not been widely 
used as NSC markers. A significant upregulation was observed in the Pou factors 
(Pouf) 1, 3 and 4; DNA methyltransferase (Dnmt) 1 and 3a; REI silencing 
transcription factor (REST) and the nuclear factors (NF) 1a and 1b. In the final panel, 
lineage markers were analyzed and an upregulation of the glia marker GLAST and 
neuronal marker MAP2 (microtubule associated protein) was observed (Figure 
3.23H). 
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Figure 3.23. Single neurosphere gene profiling.  
Neurospheres generated with/without CSPG (50µg/ml) were analyzed using the Biomark gene profiling system. A) The Sox family, B) the notch 
family, C) proliferation and cell cycle genes, D) NSC receptors and the Wnt family. Graphs show expression of each gene relative to control 
which is set as 1 denoted by the red line. Means ± 95% confidence interval (error bars that do not cross the red line is statistically significant); n 
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Figure 3.22. Single neurosphere gene profiling. Neurospheres generated with/without CSPG (50µg/ml) were analyzed using the Biomark gene 
profiling system. E) Well known NSC related genes, F) the POU class III factor and DNA methyltransferase, G) general stem cell related genes 
H) lineage markers. Graphs show expression of each gene relative to control which is set as 1 denoted by the red line. Means ± 95% confidence 



























































































































































































 Results: 108  
 
Table 3.1. Summary of gene profiling results. 
Increase (fold increase) and decrease (fold decrease) in gene expression of CSPG 
generated neurospheres relative to control.
Fold decrease No change Fold increase 
Tert 0.26 Sox2 Sox14 0.74
PDGFR 0.09 CBF1 Hes6 0.58
    Hes5 Sox3  0.55
    Notch Wnt5a 0.54
    Dll1 Nestin 0.38
    Dll3 Sox11 0.34
    PCNA Sox5 0.34
    CyclinE1 Jag1 0.34
    EGFR p21 0.32
    B-Catenin Pou3f3 0.31
    Wnt4 Hes1 0.31
    Bsyl Nfib 0.30
    Musashi CyclinD1 0.28
    Prominin MAP2 0.27
    Bmi1 Pou3f1 0.25
    C-kit Ki67 0.25
    Endoglin Dnmt1 0.23
    Pou3f2 CDK4 0.21
    Dnmt3b p16 0.20
    Foxg1 FGFR1 0.20
    Id2 Pou3f4 0.18
    Pax6 FGFR2 0.18
    Myc CDK2 0.16
    Smad5 Dnmt3a 0.15
    BLBP REST 0.14
    GFAP Sox9 0.11
    Olig1 p27 0.11
    Olig2 Nfia 0.11
      GLAST 0.08
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3.7. CSPG signalling 
To begin to understand the possible mechanism by which CSPG increases 
neurosphere formation and neural precursor proliferation, a number of pathways 
known to be involved in neural precursor proliferation and CSPG function were 
explored. Since the cells that I have used are maintained in the presence of EGF, the 
EGFR signalling pathways are likely crucial for the survival and proliferation of these 
cells. CSPG has also been showed to bind and activate EGFR (Feugaing et al., 2007; 
Koprivica et al., 2005; Sheng et al., 2005; Wu et al., 2004a; Wu et al., 2004b). Thus 
the most obvious question would be whether CSPG acts through the EGFR signalling 
pathways to stimulate neurosphere formation and proliferation. The EGFR signalling 
cascades are well characterized. Receptor activation leads to the activation of three 
main pathways, PI3K/Akt, JAK/STAT and the MAP kinases ERK1/2. The PI3K/Akt 
pathway is mainly involved in cell survival, ERK1/2 is involved in cell proliferation, 
and JAK/STAT in involved in both cellular activities (Schlessinger, 2000). All three 
signalling cascades downstream of EGFR, as well as the activity of EGFR itself were 
evaluated to see whether they are involved in CSPG stimulation of neurosphere 
formation and proliferation. 
 
In addition to the EGFR signalling cascades the following pathways were also 
explored. The p38 MAPK is a stress induced MAPK and has been shown to be 
involved in apoptosis/survival of NSCs (Androutsellis-Theotokis et al., 2006). Since 
CSPG seems to increase NSC survival and reduce apoptosis, it would be interesting to 
see whether it functions through the p38 MAPK pathway. In NSC biology, three well-
known pathways are involved in cell proliferation and self-renewal, namely notch, 
Wnt and Shh. These pathways were also investigated for their involvement in CSPG 
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stimulation of neurosphere formation and proliferation. CSPG has traditionally been 
associated with CNS injury and inhibition of neuronal regeneration. In this context, 
CSPG has been shown to signal via the Rho/ROCK pathway (Monnier et al., 2003). 
Thus this pathway was investigated to determine whether it also applies to NSCs. 
Finally, the phosphatase pathway also warrants investigation since the main CSPG in 
NSC-CM is DSD-1-proteoglycan/phosphacan (results above and Kabos et al., 2004). 
This proteoglycan is also known as an RPTP, and may trigger intracellular signalling 
via its phosphatase activity.  
 
All of the above signalling pathways were explored using a combination of chemical 
inhibitors to see how they affect neurosphere formation and proliferation, and 
Western analysis to evaluate the effect of CSPG on protein expression. These 
pathways and their inhibitors are summarized in Table 3.2. The concentrations of 
inhibitors used in the current study are comparable with previous published works. 
Therefore, the effects observed are likely due to inhibition of specific pathways rather 
than cytotoxicity. 
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Table 3.2. Signalling pathways. 
Summary of pathways related to NSC survival and proliferation, CSPG signalling and the inhibitors used to explore these pathways. The 
inhibitor concentration range used in the current study is comparable with previous published works. Thus the effects observed are specific. 
NSC survival and proliferation pathways 
Pathway Inhibitor 
Concentrations using in 
current work Concentrations in other published works 
EGFR PD168393 50pM – 50nM 25nM, NSC (Nagao et al., 2007) 
PI3K LY294002 25nM – 25µM 2.5µM, NSC (Campos et al.,2004) 
JAK2 AG490 6.25nM – 6.4µM 10µM, NSC (Yoshimatsu et al., 2006) 
ERK PD98059 100nM – 200µM 50µM, NSC (Campos et al.,2004) 
P38 MAPK SB203580 2 – 10µM 10µM, NSC (Sato et al., 2008) 
Notch L685,458 (γ-secretase inhibitor) 25nM – 12.5µM 5µM, NSC (Mori et al., 2006) 
Wnt Dkk-1 50 – 300ng/ml 100ng/ml, hESC (Davidson et al., 2007) 
Shh Cyclopamine 250nM – 5µM 10µM, NSC (Palma et al., 2004) 
CSPG signalling pathways   
Rho GTPase C3 transferase 0.2 – 1µg/ml 5µg/ml, retinal explant (Monnier et al, 2003) 
ROCK Y27632 10 -50µM 50µM, retinal explant (Monnier et al, 2003) 
Tyrosine phosphatase Sodium orthovanadate (SOV) 25nM – 25µM 10µM, PC12 cells (Wu and Bradshaw, 1993) 
Serine/threonine phosphatase Okadaic acid (OA) 25pM – 25nM 7nM, PC12 cells (Chiou and Westhead, 1992) 
 Results:  112 
3.7.1. Chemical inhibitor studies  
3.7.1.1. CSPG stimulates neurosphere formation via EGFR 
Inhibition of EGFR kinase activity with PD168393 inhibited neurosphere formation in 
normal neurosphere cultures (Figure 3.24A), indicating that the EGFR kinase activity 
is important for neurosphere formation. The IC50 values for neurosphere formation 
(IC50NF) of PD168393 for control and CSPG treated cells are 5.87 ± 1.7nM and 2.83 
±0.89nM respectively. This is statistically significant at P≤ 0.05. This means that the 
concentration of PD168393 required to reduce the percentage of neurosphere 
formation by 50% is less for CSPG treated cells compared to the control, suggesting 
that PD168393 is preferentially inhibiting the neurosphere stimulatory effect of 
CSPG. The IC50 values for all inhibitor compounds are summarized in Table 3.3. 
 
PD168393 treatment also affected neurosphere size in both control and CSPG treated 
cultures (Figure 3.24B). There is a progressive decrease in the percentage of 
neurospheres >50μm in diameter and an increase in the percentage of neurospheres 
<50μm in diameter with increasing concentration of the PD168393. At concentrations 
of 0.8nM and above, all neurospheres in control cultures were less than 50μm, while 
in CSPG treated cultures approximately 10% of >50μm neurospheres still remained. 
The IC50 values for neurosphere proliferation (IC50NP) for control and CSPG treated 
cells are estimated to be 2.23 ± 1.82nM and 6.37 ± 5.03nM respectively. Thus, CSPG 
can still stimulate neurosphere proliferation in the presence of PD168393. Together 
these results indicate that EGFR kinase activity is important for both neurosphere 
formation and neural precursor proliferation. PD168393 preferentially inhibit CSPG 
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stimulation of neurosphere formation but is less effective against CSPG stimulation of 


































Figure 3.24. Effect of PD168393 on neurosphere formation and proliferation.  
A) The EGFR kinase inhibitor PD168393 inhibited neurosphere formation in control 
and CSPG (50µg/ml) treated cultures. Neurosphere formation rate of CSPG treated 
cultures decrease at a faster rate than that of control cultures. Cells were plated at 
2x103 cells/ml, with/without CSPG addition at the time of plating. Neurospheres were 
counted and sized after 5 days (representative figure, means ± SEM, n = 3 from 1 
experiment).  
 
B) Neurospheres were categorised by diameter into those <50µm and those >50µm in 
diameter. PD168393 treatment decreased the percentage of neurospheres >50µm and 
increased the percentage of neurospheres <50µm in both control and CSPG treated 
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Table 3.3. IC50 values of inhibitors for neurosphere formation and proliferation.  
For the EGFR inhibitor PD168393, the JAK inhibitor AG490 and the PI3K inhibitor LY294002 the IC50NF was significantly less for CSPG 
treated cells as compared to control (* P ≤ 0.05). Thus these three inhibitors selectively inhibit the stimulatory effect of CSPG on neurosphere 
formation (Mean ± SEM, n ≥ 6 from at least 2 experiments). 
Neurosphere formation IC50 (IC50NF; M) Neurosphere proliferation IC50 (IC50NP; M) Compound 
Control CSPG Control CSPG 
PD168393 5.87x10-9 ± 1.7x10-9 2.83x10-9 ± 8.9x10-10 (*) 2.23x10-9  ± 1.82x10-9 6.37x10-9  ± 5.03x10-9 
LY294002 3.78x10-6 ± 3.86x10-7 2.97x10-6 ± 2.31x10-7 (*) 4.01x10-6 ± 3.51x10-7 1.29x10-5 ± 1.77x10-6 (*) 
AG490 3.95x10-7 ± 5.86x10-8 3.31x10-7 ± 6.49x10-8 (*) 3.74x10-7 ± 5.82x10-8 8.14x10-7 ± 3.46x10-7 
PD98059 1.24x10-5 ± 1.75x10-7 1.28x10-5 ± 6.9x10-6 1.72x10-6 ± 1.37x10-06 9.89x10-6 ± 1.94x10-6 
L685,458 2x10-6 ± 5.44x10-7 2.72x10-6 ± 8.1x10-7 2.34x10-9 ± 4.64x10-10 4.05x10-7 ± 3.55x10-7 
Insufficient data to calculate IC50 using GraphPad 




-6 ± 3.29x10-7 1.59x10-6 ± 1.86x10-7 Inhibit neurosphere proliferation slightly. Not sufficient data to estimate IC50 
Okadaic acid 9.28x10-10 ± 1.29x10-10 1.25x10-9 ± 4.2x10-11 Does not inhibit neurosphere proliferation 
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3.7.1.2. CSPG stimulates neurosphere formation via PI3K/Akt 
Inhibition of this pathway with LY294002 resulted in a dramatic reduction in the 
stimulatory effect of CSPG on neurosphere formation (Figure 3.25A). At a 
concentration of 3.2μM where the NFU in the control cells was not affected, the 
stimulatory effect of CSPG was completely inhibited such that the NFU is the same as 
control. The average IC50NF values of LY294002 for control and CPSG treated cells 
are 3.78 ± 0.4μM and 2.97 ± 0.23μM respectively. This is statistically significant with 
P ≤ 0.05.  
 
LY294002 treatment also inhibited neurosphere proliferation (Figure 3.25B). 
However, LY294002 did not abolish the CSPG stimulated proliferation as it did for 
the CSPG stimulated neurosphere formation. The IC50NP values for control and 
CSPG treated cells are 4.01 ± 0.35μM and 12.9 ± 0.18μM respectively (mean ± SEM, 
P ≤ 0.05). Together these data suggest that CSPG may stimulate neurosphere 
formation via the PI3K pathway, but its effect on proliferation may be contributed by 
other signalling pathways. 
 
3.7.1.3. CSPG stimulates neurosphere formation via JAK/STAT  
Inhibition of this pathway with AG490 produced similar results as with LY294002, 
and a dramatic reduction in the neurosphere stimulatory effect of CSPG was observed 
(Figure 3.26A). The IC50NF values of AG490 for control and CSPG treated cells are 
0.4 ± 0.069μM and 0.33 ± 0.064 μM respectively. This is statistically significant at 
P≤ 0.05. Thus AG490 can preferentially inhibit the neurosphere stimulatory effect of 
CSPG. 



































Figure 3.25. Effect of LY294002 on neurosphere formation and proliferation.  
A) The PI3K inhibitor LY294002 inhibited neurosphere formation in control and 
CSPG (50µg/ml) treated cultures, and selectively abolished the CSPG stimulatory 
effect. Cells were plated at 2x103 cells/ml, with/without CSPG addition at the time of 
plating. Neurospheres were counted and sized after 5 days (representative figure, 
means ± SEM, n = 3 from 1 experiment).  
 
B) Neurospheres were categorised by diameter into those <50µm and those >50µm in 
diameter. LY294002 treatment decreased the percentage of neurospheres >50µm and 
increased the percentage of neurospheres <50µm. CSPG treated cells showed slower 
decrease in neurosphere size compared to control. Thus LY294002 blocked CSPG 
stimulation of neurosphere formation but not proliferation (representative figure, 








































Figure 3.26. Effect of AG490 on neurosphere formation and proliferation.  
A) The JAK inhibitor AG490 inhibited neurosphere formation in control and CSPG 
(50µg/ml) treated cultures, and selectively abolished the CSPG stimulatory effect. 
Cells were plated at 2x103 cells/ml, with/without CSPG addition at the time of 
plating. Neurospheres were counted and sized after 5 days (representative figure, 
means ± SEM, n = 3 from 1 experiment).  
 
B) Neurospheres were categorised by diameter into those <50µm and those >50µm in 
diameter. AG490 treatment decreased the percentage of neurospheres >50µm and 
increased the percentage of neurospheres <50µm. CSPG treated cells showed slower 
decrease in neurosphere size as compared to control. Thus AG490 blocked CSPG 
stimulation of neurosphere formation but not proliferation (representative figure, 
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The inhibitory effect of AG490 on CSPG stimulated neurosphere proliferation was 
less than its effect on neurosphere formation (Figure 3.26B). The IC50NP values for 
control and CSPG treated cells are 0.37 ± 0.58μM and 0.81 ± 0.34μM respectively. 
Thus, AG490 showed significant inhibition of CSPG stimulated neurosphere 
formation, but did not affect CSPG stimulated neurosphere proliferation. 
 
3.7.1.4. ERK is involved in neurosphere formation and proliferation 
Inhibition of this pathway with PD98059 inhibited neurosphere formation in control 
cultures. In CSPG cultures, PD98059 also reduced neurosphere formation. The 
IC50NF values for control and CPSG treated cells are 12.4 ± 0.18μM and 12.8 ± 
6.9μM respectively. This indicates that PD98059 inhibits neurosphere formation at 
similar rates in both culture conditions, although CSPG treated cultures continue to 
show higher neurosphere formation rate. Thus CSPG can still stimulate neurosphere 
formation at concentrations where neurosphere formation is completely blocked in 
control cultures (Figure 3.27A).  
 
When neurosphere size was measured, an inhibitory effect on proliferation was also 
observed with PD98059 (Figure 3.27B). Again, CSPG stimulated neurosphere 
proliferation in the presence of PD98059. The IC50NP values for control and CSPG 
treated cells are 1.72 ± 1.37μM and 9.89 ± 1.94μM respectively. An important point 
to note here is that for control cultures, the IC50NP value is approximately seven-fold 
lower than the IC50NF value. For CSPG cultures it is approximately 1.3-fold lower. 
Thus PD98059 inhibits neurosphere proliferation before it inhibits neurosphere 
formation. This suggests that the ERK pathway is predominantly involved in neural 
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precursor proliferation rather than neurosphere formation. However, the higher 
IC50NP value for CSPG cultures suggests that this pathway may not be involved in 





























Figure 3.27. Effect of PD98059 on neurosphere formation and proliferation.  
A) The ERK inhibitor PD98059 inhibited neurosphere formation in control and CSPG 
(50µg/ml) treated cultures, but did not abolish the CSPG stimulatory effect. Cells 
were plated at 2x103 cells/ml with/without CSPG addition at the time of plating. 
Neurospheres were counted and sized after 5 days (representative figure, means ± 
SEM, n = 3 from 1 experiment).  
 
B) Neurospheres were categorised by diameter into those <50µm and those >50µm in 
diameter. PD98059 treatment decreased the percentage of neurospheres >50µm and 
increased the percentage of neurospheres <50µm. CSPG treated cells showed slower 
decrease in neurosphere size as compared to control, suggesting that PD98059 do not 
block CSPG stimulation of neurosphere proliferation (representative figure, means ± 
SEM, n = 3 from 1 experiment). 
A 
B 
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3.7.1.5. p38 MAPK inhibits neurosphere formation 
Unlike inhibition of ERK, inhibition of p38 MAPK with SB203580 stimulated 
neurosphere formation (Figure 3.28A). The stimulatory effect was greater than that of 
CSPG (10 ± 1.38 fold above control for SB203580 and 5.92 ± 0.58 fold increase for 
CSPG). However, there did not appear to be a dose-dependent effect suggesting that 
an SB203580 concentration as low as 2μM is sufficient to block p38 kinase activity 
completely. When SB203580 was combined with CSPG, further stimulation of 
neurosphere formation was observed which approximated the sum of the stimulatory 
effects of the individual compounds (CSPG alone: 8.7 ± 0.17 NFU; SB203580 alone: 
14.6 ± 0.69 NFU; combined: 22.6 ± 0.11 NFU).  
 
SB203580 also stimulated neurosphere proliferation without any dose-dependent 
effect (Figure 3.28B). Maximal stimulation was achieved with a concentration of 
2µM. Again, the stimulation was greater than that of CSPG (CSPG: 22.7 ± 4.6%, SB: 
52.8 ± 9.8% increase in neurosphere diameter compared to control), and further 
stimulation was observed when both compounds were added to the culture (98.9 ± 
10.1% increase above control). Since SB203580 was able to stimulate neurosphere 
formation and proliferation, I tested whether it could rescue the neurosphere 
inhibitory effect of chABC and found that it could indeed do this (Figure 3.28C). 
Together these results suggest that CSPG and SB203580 may act through independent 
pathways to regulated neurosphere formation and proliferation. 
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Figure 3.28. Effect of SB203580 on neurosphere formation and 
proliferation.  
The p38 MAPK inhibitor SB203580 stimulated neurosphere formation 
(A) and proliferation (B). Cells were plated at 2x103 cells/ml. CSPG 
(50µg/ml) and SB203580 (SB) was added at the stated concentrations at 
the time of cell plating. Neurosphere number and size was evaluated after 
5 days (Means ± SEM; n ≥ 3 from 2 experiments; a = compared with 
untreated control (w/o), b = compared with CSPG, c = compared with 
SB, all P ≤ 0.01). 
 
C) SB203580 rescued inhibitory effect of chABC. Cells were plated at 
2x103 cells/ml. SB203580 (SB, 2µM), chABC (2mU/ml) or both 
compounds at the same concentration was added together at the time of 
plating. Neurospheres were counted after 5 days (Means ± SEM; n = 6 
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3.7.1.6. Notch is involved in neurosphere formation and proliferation 
The γ-secretase inhibitor L685,458 was used to inhibit the notch signalling pathway. 
It is well known that the notch signalling pathway is crucial for NSC proliferation and 
neurosphere formation. This was confirmed here where L685,458 was able to inhibit 
neurosphere formation in control cultures (Figure 3.29A). L685,458 also reduced 
neurosphere formation in CSPG treated cultures. The IC50NF values for control and 
CPSG treated cells are 2 ± 0.54μM and 2.72 ± 0.81μM respectively, suggesting that 
neurosphere formation is reducing at similar rates in both culture conditions. 
 
The effect of L685,458 on neurosphere proliferation was less dramatic than that of the 
inhibitors of the EGFR signalling pathways used above (Figure 3.29B). There was 
only a 10% reduction of the 50 -100µm neurospheres. The IC50NP values for control 
and CSPG treated cultures are 2.34 ± 0.46nM and 0.4 ± 0.35µM respectively. These 
concentrations are much lower than what was required to reduce neurosphere 
formation by 50%, suggesting that L685,458 actually inhibited proliferation before it 
affected neurosphere formation, although the effect on proliferation is very small. 
Together, these results suggest that the notch signalling pathway is predominantly 
involve in neurosphere formation, and does not account for the stimulatory effect of 
CSPG. 



































Figure 3.29. Effect of L685,458 on neurosphere formation and proliferation.  
A) L685,458 inhibits γ-secretase and interferes with notch signalling. This inhibitor 
inhibited neurosphere formation in control and CSPG (50µg/ml) treated cultures, but 
did not abolish the CSPG stimulatory effect. Cells were plated at 2x103 cells/ml, 
with/without CSPG addition at the time of plating. Neurospheres were counted and 
sized after 5 days (representative figure, means ± SEM, n = 3 from 1 experiment).  
 
B) Neurospheres were categorised by diameter into those <50µm and those >50µm in 
diameter. L685,458 treatment decreased the percentage of neurospheres >50µm and 
increased the percentage of neurospheres <50µm neurospheres slightly. CSPG treated 
cells showed slower decrease in neurosphere size compared to control (representative 
figure, means ± SEM, n = 3 from 1 experiment). 
A 
B 

































Figure 3.30. Effect of cyclopamine on neurosphere formation and proliferation.  
A) The Shh inhibitor cyclopamine inhibited neurosphere formation in control and 
CSPG (50µg/ml) treated cultures, but did not abolish the CSPG stimulatory effect. 
Cells were plated at 2x103 cells/ml with/without CSPG addition at the time of plating. 
Neurospheres were counted and sized after 5 days (representative figure, means ± 
SEM, n = 3 from 1 experiment).  
 
B) Neurospheres were categorised by diameter into those <50µm and those >50µm in 
diameter. Cyclopamine treatment decreased the percentage of >50µm neurospheres 
and increased the percentage of <50µm neurospheres. CSPG treated cells showed 
similar rate of decrease in neurosphere size as control (representative figure, means ± 
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3.7.1.7. Shh is involved in neurosphere formation and proliferation 
Sonic hedgehog signalling can be inhibited by cyclopamine. This compound was able 
to inhibit neurosphere formation in control cells, but again did not abolish the 
stimulatory effect of CSPG (Figure 3.30A). The IC50NF values for control and CSPG 
treated cells are 4.14 ± 0.82μM and 4.99 ± 1.33μM respectively, indicating that 
cyclopamine is inhibiting control and CSPG cultures at the same rate. Cyclopamine 
also inhibited NSC proliferation (Figure 3.30B). As the data was insufficient for the 
GraphPad software to estimate the IC50NP values, these values were manually 
estimate from the graph instead, and they are 1.99µM and 3.98µM for control and 
CSPG treated cells respectively. 
 
3.7.1.8. Phosphatases are involved in neurosphere formation and 
proliferation 
Both phosphatase inhibitors sodium orthovanadate (SOV) and okadaic acid (OA) 
inhibited neurosphere formation, but did not abolish CSPG stimulation of neurosphere 
formation (Figure 3.31A. and Figure 3.32A). For SOV the IC50NF values for control 
and CSPG treated cells are 1.22 ± 0.33μM and 1.59 ± 0.19μM respectively. For OA 
the IC50NF values for control and CSPG treated cells are 0.93 ± 0.13nM and 1.25 ± 
0.04nM respectively. This indicates that both inhibitors inhibited control and CSPG 
cultures at similar rates. When neurosphere size was evaluated, OA treatment did not 
inhibit neural precursor proliferation (Figure 3.32B). SOV does have an inhibitory 
effect on neural precursor proliferation, but again did not inhibit CSPG stimulation of 
proliferation (Figure 3.30B). The data obtained was insufficient to allow estimation of 
IC50NP.  

































Figure 3.31. Effect of SOV on neurosphere formation and proliferation.  
A) The tyrosine phosphatase inhibitor sodium orthovanadate (SOV) inhibited 
neurosphere formation in control and CSPG (50µg/ml) treated cultures, but did not 
abolish the CSPG stimulatory effect. Cells were plated at 2x103 cells/ml with/without 
CSPG addition at the time of plating. Neurospheres were counted and sized after 5 
days (representative figure, means ± SEM, n = 3 from 1 experiment).  
 
B) Neurospheres were categorised by diameter into those <50µm and those >50µm in 
diameter. SOV treatment decreased the percentage of >50µm neurospheres and 
increased the percentage of <50µm neurospheres. CSPG treated cells showed slower 
decrease in neurosphere size as compared to control (representative figure, means ± 







































Figure 3.32. Effect of okadaic acid on neurosphere formation and proliferation.  
A) The serine/threonine phosphatase inhibitor okadaic acid inhibited neurosphere 
formation in control and CSPG (50µg/ml) treated cultures, but did not abolish the 
CSPG stimulatory effect. Cells were plated at 2x103 cells/ml with/without CSPG 
addition at the time of plating. Neurospheres were counted and sized after 5 days 
(representative figure, means ± SEM, n = 3 from 1 experiment).  
 
B) Neurospheres were categorised by diameter into those <50µm and those >50µm in 
diameter. Okadaic acid did not affect neurosphere proliferation (representative figure, 
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Thus these data suggest that the tyrosine phosphatase pathway (inhibited by SOV) is 
involved in both neurosphere formation and neural precursor proliferation. The 
serine/threonine phosphatase pathway (inhibited by OA) on the other hand, is only 
involved in neurosphere formation. Neither pathway appeared to be involved in the 
stimulatory effect of CSPG. 
 
3.7.1.9. Wnt inhibits neurosphere formation 
The Dickkopf related protein 1 (Dkk-1) antagonizes Wnt signalling by directly 
binding to LRP5/6, a co-receptor for Wnt, thus inhibiting formation of the Wnt 
signalling complex. Recombinant Dkk-1 at concentrations up to 300ng/ml showed no 
significant effect on neurosphere formation in control as well as CSPG treated 
cultures (Figure 3.33A). Interestingly, recombinant Wnt3a appeared to inhibit 
neurosphere formation (Figure 3.33B) and induced cells to proliferate as an adherent 
layer (Figure 3.33C). However, Wnt3a did not affect CSPG stimulation of 
neurosphere formation. 
 
3.7.1.10. Rho/ROCK is involved in neurosphere formation 
Rho signalling can be inhibited by cell permeable C3 transferase or the Rho kinase 
(ROCK) inhibitor Y27632. In both cases there was a dramatic inhibition in 
neurosphere formation in control cells, but the stimulatory effect of CSPG was largely 
unaffected (Figure 3.34A & B). In Y27632 treated control cultures the cells appeared 
to proliferate as a monolayer (Figure 3.34C). In the presence of CSPG monolayer 
proliferation was also present, but more neurospheres formed (Figure 3.34D). C3 
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Figure 3.33. Wnt and neurosphere formation and proliferation.  
A) The Wnt inhibitor Dkk-1 did not affect neurosphere formation in control or CSPG 
cultures. On the other hand, recombinant Wnt3a inhibited neurosphere formation of 
control cultures (B), but did not affect CSPG stimulation of neurosphere formation. 
C) Wnt3a induced cells to adhere to the culture dish and proliferate as an adherent 
layer.  
 
Cells were plated at 2x103 cells/ml. Dkk-1 (at the concentrations stated), Wnt3a 
(100ng/ml), CSPG (50µg/ml) or both at the same concentrations were added at the 
time of plating. Neurospheres were counted after 5 days (Means ± SEM, n = 3 from 1 









































































Figure 3.34. Rho/ROCK and neurosphere formation and proliferation.  
The Rho inhibitor C3 transferase (A) and the ROCK inhibitor Y27632 (B) inhibited 
neurosphere formation, but did not abolish the stimulatory effect of CSPG. Cells were 
plated at 2x103 cells/ml. CSPG (50µg/ml), C3 or Y27632 was added at the stated 
concentrations at time of cell plating. Neurospheres were counted after 5 days (Means 
± SEM; n = 6 from 2 experiments). C) Y27632 treatment inhibits neurosphere 
formation and induced cells to attach to the culture dish and proliferate as an adherent 
layer. D) CSPG can stimulate neurosphere formation in the presence of Y27632. 









w/o CSPG 0.2 0.5 1
C3 concentration (μg/ml) 
NF
U
















Control Y27632 Y + CSPG
B 
 Results:  131 
In summary, studies using chemical inhibitors indicated that the EGFR signalling 
pathways are central to neurosphere formation (likely via PI3K and JAK) and 
proliferation (likely via ERK). Inhibition of EGFR, PI3K and JAK had the greatest 
effect on CSPG stimulated neurosphere formation. Although ERK signalling is 
central to NSC proliferation, it did not seem to be involved in CSPG stimulation of 
NSC proliferation. The remaining pathways, p38 MAPK, notch, Wnt, Shh, 
phosphatases and Rho/ROCK, are all involved in neurosphere formation and 
proliferation, but they may not be critical for CSPG signalling. 
 
3.7.2. Biochemical analysis of CSPG signalling 
3.7.2.1. CSPG upregulates EGFR and phospho-EGFR expression 
The inhibitor studies above suggest that CSPG may be signalling via the EGFR, 
particularly the PI3K and JAK pathways. So I evaluated changes in protein expression 
by Western analysis to explore how CSPG may regulate components of these 
pathways.  
 
In short term experiments, CSPG alone directly stimulated EGFR phosphorylation 
(Figure 3.35). A small but significant stimulation was observed at the 30min time 
point (1.4 ± 0.08 fold relative to control, P < 0.05). However, when CSPG was added 
together with EGF, it did not enhance EGF stimulation of EGFR. Pre-treatment of 
cells with chABC also did not affect EGF stimulation of EGFR phosphorylation.  
 



































Figure 3.35. CSPG stimulates EGFR phosphorylation.  
A) Stimulation of EGFR phosphorylation (PY20) was monitored for 10, 30 and 
60min. CSPG stimulated EGFR phosphorylation at the 30min time point. CSPG did 
not enhance EGF stimulation of EGFR (CSPG + EGF). chABC pre-treatment did not 
affect EGF stimulation of EGFR (representative image). Cells were plated at 105 
cell/ml in GM- (without EGF) with/without chABC (20mU/ml) for 3h, followed by 
addition of EGF (20ng/ml), CSPG (50µg/ml) or both and harvested at the indicated 
times for immunoblotting against EGFR and PY20. 
 
B) Densitometric measurement of (A). Protein expression shown as folds relative to 
control which is set at 1 denoted by the red line (Mean ± SEM, n ≥ 2 from 3 
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Since the short term experiments showed that CSPG has minimal effect on EGFR 
signalling, I evaluated how EGFR might change in cells after six days of culturing 
with CSPG. This time point was selected for two reasons. Firstly, this is the normal 
culture period for the cells used in this work, and it is when I quantify the effect of 
CSPG in all the preceding experiments. Secondly, CSPG can be seen to stimulate 
NSC proliferation from 3 to 4 days in culture (see Figure 3.11B). However, it is 
technically difficult to generate sufficient number of cells for protein analysis at this 
time point since these cells are cultured at low density.  
 
After six days in culture, CSPG treated cells showed a significant increase in the level 
of EGFR (Figure 3.36A & D). In the absence of any treatment, bulk-density cultures 
expressed significantly more EGFR than low density cultures. CSPG added to low 
density cultures stimulated neurosphere formation and increased EGFR expression in 
these cells. On the other hand, chABC treatment of bulk density cultures, which 
inhibits neurosphere formation and proliferation, also reduced EGFR expression 
compared to control cultures of the same density. In addition to increasing EGFR 
protein level, CSPG treatment also resulted in a significant increase in phospho-EGFR 
level (Figure 3.36A & D). ChABC treatment of bulk density cultures did not 
significantly alter the level of phospho-EGFR.  
 







































Figure 3.36. CSPG regulates EGFR and phospho-EGFR expression.  
A) In low density cultures (2x103 cells/ml) CSPG stimulated EGFR pan-protein and 
phosphoprotein (PY20) expression. In bulk-density cultures (2x104 cells/ml) chABC 
treatment reduced EGFR pan-protein expression. B) CSPG stimulated phospho-EGFR 
at tyrosine 1068. C) SB203580 increased phospho-EGFR but not pan-EGFR 
expression (A-C are representative images) Cells were plated at 2x103 or 2x104 
cells/ml and CSPG (50μg/ml), SB203580 (2μM) or chABC (10mU/ml) added at the 
time of plating. Cells were harvested after 6 days and immunoblotted for EGFR, 
PY20 and phospho-EGFR tyrosine 1068. D) Densitometric measurement of (A & C). 
Protein expression shown as folds relative to low-density control set as 1 (Mean ± 
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Thus far I have used an anti-phosphotyrosine antibody in combination with protein 
size to evaluate EGFR phosphorylation state as this antibody gives a very strong 
signal, which is easy to monitor. To confirm that CSPG does indeed affect the 
phospho-EGFR level and to determine which phosphorylation site is involved, I tested 
specific phospho-EGFR antibodies. I found that CSPG treatment resulted in the 
upregulation of EGFR phosphorylation at tyrosine 1068 (Figure 3.36B).  
 
Since the p38 MAPK inhibitor SB203580 was also found to enhance neurosphere 
formation in low density cultures (see Figure 3.28A) I asked whether it also affects 
the expression of EGFR and phospho-EGFR in the same way as CSPG treatment. 
After six days of culturing in the presence of SB203580, neurospheres were found to 
express higher levels of phospho-EGFR, but the level of the EGFR protein remain 
unchanged (Figure 3.36C & D). This indicates that the increase in EGFR expression 
is specific to CSPG treatment 
 
3.7.2.2. CSPG increases phospho-STAT3 expression 
From the inhibitor studies, the JAK inhibitor AG490 was found to inhibit the 
stimulatory effect of CSPG on neurosphere formation. A downstream effector of JAK 
is STAT3. In short term experiments, CSPG was found to stimulate STAT3 
phosphorylation in the absence of EGF (Figure 3.37). This stimulatory effect was 
observed after three hours of incubation with CSPG. EGF alone also stimulated 
STAT3 phosphorylation as expected. In cells pretreated with CSPG, EGF induced 
further stimulation of STAT3. The phospho-STAT3 level approximated the sum of 
the individual stimulants alone, indicating a synergistic effect between CSPG and 
EGF.


























Figure 3.37. CSPG stimulates STAT3 phosphorylation. 
A) CSPG stimulated STAT3 phosphorylation within 3h. In the presence of CSPG, 
EGF induced further stimulation of STAT3 (representative image). Cells were plated 
at 105 cells/ml in GM(-) [no EGF]. CSPG (50μg/ml) was added at time of cell plating. 
Cells with/without CSPG were incubated for 3h followed by addition of EGF 
(20ng/ml) for 30 minutes. B) Densitometric measurement of (A). Protein expression 
shown as folds relative to low-density control set as 1 (Mean ± SEM; n ≥ 4 from 2 
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3.7.2.3.  CSPG increases Akt and phospho-Akt expression 
From the inhibitor studies, the PI3K inhibitor LY294002 was found to inhibit the 
stimulatory effect of CSPG on neurosphere formation. A downstream effector of 
PI3K is Akt. In short term experiments, even though CSPG was able to stimulate 
EGFR phosphorylation, it did not alter phosphorylation of Akt whether alone or 
together with EGF (Figure 3.38A). The stimulation of Akt phosphorylation by EGF 
was slightly affected by chABC pre-treatment at the 30min time point, but this was 
not statistically significant when multiple sets of data were combined. 
 
After six days of culturing in the presence of CSPG a significant increase in Akt total 
protein level was observed (Figure 3.38B and D). SB203580 treatment also induced a 
significant increase in Akt protein level. There were no significant difference between 
bulk and low-density untreated cultures, and chABC treatment did not alter the level 
of Akt. 
 
When the level of phospho-Akt was evaluated, CSPG treatment produced a small 
(1.22 ± 0.11 fold) but significant increase in the level of this protein (Figure 3.38C & 
D). Comparing with the SB203580 compound, even though it produced an increase in 
Akt protein level, there were no changes in the phospho-Akt level. Comparing 
between bulk and low density cultures, a significantly higher level of phospho-Akt 
was observed in untreated bulk density cultures. ChABC treatment of bulk cultures 
did not affect the level of this protein. 
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Figure 3.38. CSPG did not stimulate Akt.  
A) CSPG did not stimulate Akt phosphorylation nor affect EGF stimulation of 
Akt in the short term. ChABC treatment also did not affect EGF stimulation of 
Akt. Cells were plated at 105 cells/ml in GM- for 3h, with/without chABC 
(20mU/ml), prior to stimulation with EGF (20ng/ml) and CSPG (50μg/ml). B) 
CSPG and SB203580 increased Akt expression over six days. ChABC 
treatment did not affect Akt level. C) CSPG but not SB increased phospho-Akt 
expression over days. ChABC treatment did not affect phospho-Akt level (A-C 
are representative images). Cells were plated in GM at 2x103 cells/ml (Con(L)) 
or 2x104 cells/ml (Con(B)). CSPG (50μg/ml), SB203580 (2μM), or chABC 
(10mU/ml) was added at time of plating. Cells were harvested after six days. D) 
Densitometric measurement of (B & C). Protein expression shown as folds 
relative to low-density control set as 1 (Mean ± SEM; n ≥ 4 from 10 
experiments; a = P ≤ 0.01 compared with low-density p-Akt control; b = P ≤ 
0.05 compared with low-density p-Akt control; c and d = P ≤ 0.05 compared 
with low-density Akt control). 
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3.7.2.4. CSPG does not affect ERK and phospho-ERK expression 
From the inhibitor studies above, the ERK signalling pathway did not appear to play a 
significant role in the neurosphere stimulatory effect of CSPG. This observation is 
supported by protein analysis. In short term experiments, CSPG did not stimulate 
ERK phosphorylation either alone or in combination with EGF (Figure 3.39A). Pre-
treatment of cells with chABC also did not affect EGF stimulation of ERK. In long 
term cultures, phospho-ERK level remained unchanged with the various treatments 
(Figure 3.39B & C). For ERK protein level, SB203580 treatment resulted in a 
significant reduction, but CSPG treatment had no effect. Interestingly, bulk culture 
cells showed a lower expression of pan ERK compared to low density control 
cultures. ChABC treatment did not alter this level of expression. 
 
3.7.2.5. CSPG does not affect p38 and phospho-p38 MAPK expression 
The ability of the p38 MAPK inhibitor SB203580 to stimulate neurosphere formation 
and proliferation suggests that p38 MAPK normally inhibits neurosphere formation. 
Thus I evaluated whether CSPG can regulate the expression of this protein. In short 
term experiments, EGF alone did not stimulate p38 phosphorylation, indicating that 
EGF does not signal via this pathway (Figure 3.40A).CSPG and chABC treatment 
also did not affect the expression of phospho-p38. Over a six day culture period, only 
the SB compound produced an increase in the level of phospho-p38 (Figure 3.40B & 
C). For p38, significantly higher levels were observed in untreated bulk density 
cultures compared to low density cultures. ChABC treatment of bulk cultures reduced 
the level of p38 to that of low density cultures.  






































Figure 3.39. CSPG did not stimulate ERK phosphorylation.  
A) In short term experiments, CSPG did not stimulate ERK or alter EGF stimulation 
of ERK. ChABC also did not alter EGF stimulation of ERK. Cells were plated at 105 
cells/ml in GM(-) for 3h, with/without chABC (20mU/ml), prior to stimulation with 
EGF (20ng/ml) and CSPG (50μg/ml). B) In long term experiments, none of the 
treatments affected phospho-ERK levels. Pan ERK levels were lower in control 
(bulk), chABC and SB203580 treated cultures as compared to control (low) (A and B 
are representative images). Cells were plated in GM at 2x103 cells/ml [Con(L)] or 
2x104 cells/ml [Con(B)]. CSPG (50μg/ml), SB203580 (2μM), or chABC (10mU/ml) 
was added at time of plating. Cells were harvested after six days. C) Densitometric 
measurement of (B). Protein expression shown as folds relative to low-density control 
set as 1 (Mean ± SEM; n ≥ 3 from 5 experiments; a & c = P ≤ 0.01, b = P ≤ 0.05 
compared with low-density ERK control). 
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Figure 3.40. CSPG did not stimulate p38 MAPK phosphorylation.  
A) In short term experiments, neither CSPG nor EGF stimulated p38. ChABC 
treatment also had no effect. Cells were plated at 105 cells/ml in GM(-) for 3h, 
with/without chABC (20mU/ml) prior to stimulation with EGF (20ng/ml) and CSPG 
(50μg/ml). B) In long term experiments, only SB203580 increased phospho-p38 
levels. Pan p38 levels were higher in control (bulk) as compared to control (low), but 
the increased level of phospho-p38 was not significant (A and B are representative 
images). Cells were plated in GM at 2x103 cells/ml [Con(L)] or 2x104 cells/ml 
[Con(B)]. CSPG (50μg/ml), SB203580 (2μM), or chABC (10mU/ml) was added at 
time of plating. Cells were harvested after 6 days. C) Densitometric measurement of 
(B). Protein expression shown as folds relative to low-density control set as 1 (Mean 
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However, this effect was not statistically significant. CSPG treatment on the hand had 
no significant effect on the phospho- or the pan protein. 
 
3.7.2.6. CSPG and cell cycle proteins 
Since CSPG stimulates neural precursor proliferation, I evaluated how it may affect 
the level of cell cycle proteins. CSPG was found to increase cyclinD1 levels 
significantly (Figure 3.41). An increase in cyclinD3 was observed but this was not 
significant. There were no significant changes in the cyclin-dependent kinases CDK4 
and 6, nor the cell cycle inhibitors p27 and p15. SB203580 on the other hand 
increased levels of cyclinD1 and D3, as well as significantly decreasing the cell cycle 
inhibitor p15. 
 
In summary, CSPG was able stimulate EGFR and STAT3 phosphorylation directly in 
short-term experiments. Over a six-day culturing period, CSPG increased EGFR, 
phospho-EGFR, Akt, phospho-Akt and cyclinD1 expression. 
 
3.8. Other factors in conditioned medium 
To determine whether there are other factors specific to the NSC-CM, I used an 
antibody array to screen for cytokines. Insulin-like growth factor binding protein – 3 
(IGFBP-3), soluble tumour necrosis factor receptor I (sTNFRI), vascular cell adhesion 
molecule -1 (VCAM-1) and vascular endothelial growth factor (VEGF) was found to 
be present in the NSC-CM and not the growth medium (Figure 3.42). 
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Figure 3.41. CSPG effect on cell cycle proteins.  
A) In long term experiments, CSPG increased cyclinD1 significantly. SB203580 increased both cyclinD1 and D3 while decreasing p15 
(representative images). Cells were plated in GM at 2x103 cells/ml. CSPG (50μg/ml) and SB203580 (2μM) was added at time of plating. Cells 
were harvested after 6 days.  
B) Densitometric measurement of (A). Protein expression shown as folds relative to untreated control set as 1 denoted by the red line (Mean ± 
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 A B C D E F G H I J K L M N 
1 POS POS POS POS Blank Axl BLC CD30L CD30T CD40 CRG-2 CTACK CXCL16 Eotaxin 
2 NEG NEG NEG NEG Blank Axl BLC CD30L CD30T CD40 CRG-3 CTACK CXCL16 Eotaxin 
3 Eotaxin-2 Fas Ligand  Fractalkine GCSF GM-CSF IFN γ IGFBP-3 IGFBP-5 IGFBP-6 IL-1α  IL-1β  IL-2 IL-3 IL-3 Rb 
4 Eotaxin-2 Fas Ligand  Fractalkine GCSF GM-CSF IFN γ IGFBP-3 IGFBP-5 IGFBP-6 IL-1α  IL-1β  IL-2 IL-3 IL-3 Rb 
5 IL-4 IL-5 IL-6 IL-9 IL-10 IL-12 p40/p70 IL-12 p70 IL-13 IL-17 KC Leptin R Leptin LIX L-Selectin 
6 IL-4 IL-5 IL-6 IL-9 IL-10 IL-12 p40/p70 IL-12 p70 IL-13 IL-17 KC Leptin R Leptin LIX L-Selectin 
7 Lymphotactin MCP1 MCP-5 M-CSF MIG MIP-1α MIP-1γ MIP-2 MIP-3β MIP-3α PF-4 P-Selectin RANTES SCF 
8 Lymphotactin MCP1 MCP-5 M-CSF MIG MIP-1α MIP-1γ MIP-2 MIP-3β MIP-3α PF-4 P-Selectin RANTES SCF 
9 SDF-1α TARC TCA-3 TECK TIMP-1 TNFα sTNF RI sTNF RII TPO VCAM-1 VEGF Blank Blank Blank 
10 SDF-1α TARC TCA-3 TECK TIMP-1 TNFα sTNF RI sTNF RII TPO VCAM-1 VEGF Blank POS POS 
 
Figure 3.42. Cytokine screening of conditioned and growth medium.  
A) NSC-CM was found to contain increased levels of insulin-like growth factor binding protein 3 (IGFBP-3), soluble tumour necrosis factor 
receptor I (sTNFRI), vascular cell adhesion molecule -1 (VCAM-1) and vascular endothelial growth factor (VEGF) (representative image). 
Growth medium (GM) and five-day conditioned medium (CM) were concentrated 15 folds and analyzed on a membrane cytokine antibody 
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4. DISCUSSION 
NSC-CM is known to promote cell proliferation and differentiation (Cai and Grabel, 
2007; Hardy et al., 2008; Nicoleau et al., 2009). The present work began with the 
observation that NSC-CM can stimulate neurosphere formation. The identification of 
CSPG as a component of NSC-CM led to the hypothesis that CSPG is responsible for 
the neurosphere stimulatory effect of NSC-CM. ChABC treatment of NSC-CM 
resulted in a 50% reduction of the neurosphere stimulatory effect of NSC-CM, 
indicating that CSPG is responsible, at least in part, for the neurosphere stimulatory 
effect of NSC-CM. Complete elimination of the CM stimulatory effect was not 
achieved possibly because (1) chABC treatment only removes the polysaccharide 
chains, so the protein cores of the CSPGs are still present. Although proteoglycans are 
thought to function primarily via their GAG chains, there is evidence that the protein 
core can also mediate signalling. For example, the versican protein core can bind and 
activate EGFR (Xiang et al., 2006), and the phosphacan protein core can bind FGF-2 
(Milev et al., 1998b). Thus residual CSPG protein cores in the chABC treated NSC-
CM may continue to function and stimulate neurosphere formation. (2) The digested 
disaccharide units themselves may also have stimulatory effects since CS-GAGs are 
known to stimulate proliferation of various cell types (Skandalis et al., 2006; Steer et 
al., 2004; Uygun et al., 2009) although the minimum chain length required is not 
known. Recently, a 6-sulfated disaccharide, CSPG-DS, produced by chABC digestion 
of CSPG was found to stimulate neurotrophic factor secretion by microglia (Rolls et 
al., 2008). Thus even disaccharides may have functional activities. (3) NSCs have 
been shown to secrete a number of factors including cystatin C (Taupin et al., 2000), 
nerve growth factor (NGF), brain derived neurotrophic factor (BDNF) and glial cell 
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derived neurotrophic factor (GDNF) (Fenggang Yu, unpublished data; Llado et al., 
2004; Lu et al., 2003). Thus the inability of chABC to completely eliminate the 
stimulatory effect of the NSC-CM suggests that there are other factors in addition to 
CSPG that may stimulate neurosphere formation. One such factor may be 
apolipoprotein E (ApoE). ApoE is present in the NSC-CM and can stimulate 
neurosphere formation (Hui Theng Gan, unpublished work). I also found a number of 
cytokines including IGFBP-3, sTNFRI, VCAM-1 and VEGF in the NSC-CM. 
Additional experiments will be required to determine whether these cytokines also 
play a role in regulating neurosphere formation.  
 
In this work I have found that CSPG can stimulate neurosphere formation and 
proliferation, and is involved in maintaining the neurosphere structure. But how are 
these findings relate to NSCs and their properties? The defining features of an NSC 
are the ability to self-renew and multipotency i.e. the ability to differentiate into the 
three neural cell types. Self-renewal means the NSC makes an identical copy of itself. 
Due to the lack of appropriate assays, self-renewal cannot be measured directly. So in 
vitro, self-renewal is followed by measuring formation of secondary neurospheres 
from dissociated primary neurospheres. Thus the ability of CSPG to stimulate 
neurosphere formation suggests that it is stimulating self-renewal and increasing NSC 
number. However, neurosphere formation by itself cannot be used as a direct 
measurement of NSC frequency because 1) neurospheres can be formed by cells 
aggregating together rather than from self-renewal and proliferation of a single stem 
cell (Coles-Takabe et al., 2008; Mori et al., 2006; Singec et al., 2006), and 2) 
neurosphere formation is not a property restricted to NSCs as progenitors can also 
form neurospheres in culture (Seaberg and van der Kooy, 2002). To distinguish 
 Discussion:  147  
between NSCs and progenitors, the following experiments are required, 1) 
neurosphere formation under clonal conditions, 2) serial passaging, since progenitor-
derived neurospheres have limited self-renewal capacity (Bull and Bartlett, 2005), and 
3) single neurosphere differentiation to demonstrate the potential of individual clones. 
Multipotency of individual neurospheres needs to be demonstrated since multipotency 
observed from differentiation of dissociated cells can arise from a mixed progenitor 
pool. 
 
4.1. CSPG stimulates NSC survival 
To determine whether CSPG stimulates NSC survival i.e. increases NSC number, I 
evaluated CSPG generated neurospheres in terms of clonality, the ability to survive 
long-term passage and multipotency. 
4.1.1. CSPG stimulates clonal neurosphere formation 
Previously, a number of reports have demonstrated CSPG expression on neural 
precursors (Ida et al., 2006; Kabos et al., 2004; von Holst et al., 2006). von Holst et al. 
showed that radial glial cells expressing the 473HD epitope, associated with the 
CSPG DSD-1-proteoglycan/phosphacan, show increased neurosphere formation. This 
demonstrates that neural precursors expressing CSPGs have greater intrinsic 
neurosphere forming abilities. Ida et al. also showed that CS-GAGs can stimulate 
neurosphere formation. However, this work was performed under non-clonal 
conditions, and thus it is not clear whether CSPG directly stimulates neurosphere 
formation or promotes cell aggregation. Since CSPGs are ECM proteins and function 
as structural components of various tissues, one major concern is that CSPG may 
aggregate cells. Thus a clonal hydrogel culturing system was used to determine 
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whether CSPG can stimulate neurosphere formation in the absence of aggregation. In 
this experiment, dissociated cells were immobilised in a hydrogel matrix and this 
eliminates cell movement that normally occurs in suspension cultures. Under these 
conditions, CSPG was found to stimulate neurosphere formation. This suggests that 
CSPG stimulates neurosphere formation by enhancing neural precursor survival and 
not by increasing cell aggregation. Since both NSCs and progenitors can give rise to 
neurospheres, the next issue to address was: does CSPG stimulate NSCs or 
progenitors? 
 
4.1.2. CSPG promotes extensive self-renewal 
Extensive self-renewal is a property that distinguishes NSCs from committed 
progenitors. To determine whether CSPG generated cells display extensive self-
renewal properties, I serially passaged CSPG generated cells and found that these 
cells can be passaged as well as control cells for at least seven passages. This shows 
that CSPG generated cells have one of the features of NSCs 
 
4.1.3. CSPG increases the percentage of multipotent neurospheres 
The second feature of NSCs is multipotency. So to confirm that CSPG affects NSC 
survival, it is essential to demonstrate that the neurospheres generated in the presence 
of CSPG are multipotent at the single neurosphere level and not as a population. Since 
it was not possible to extract the clonal neurospheres generated from the hydrogel 
cultures, I used neurospheres generated from low-density cultures. The estimated 
aggregation rate in my culture conditions is 2.2% based on calculations from the work 
of Coles-Takabe et al. (2008). Thus approximately 98% of the neurospheres generated 
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in my cultures are clonal. Under these conditions, differentiation of individual 
neurospheres from low density cultures can indicate the percentage of multipotent 
NSCs in the culture. Single neurosphere differentiation showed that CSPG treatment 
increases the percentage of tripotent neurospheres. Combined with the observation 
that CSPG generated neurospheres display extensive self-renewal, these data indicates 
that CSPG specifically increases NSC survival. 
 
4.1.4. CSPG increases neural colony formation 
To find further support for the hypothesis that CSPG stimulates NSC survival, I 
utilised the recently developed NCFCA (Louis et al., 2008). The NCFCA relies on the 
premise that stem cells can proliferate over an extended period of time to generate 
large colonies (>2mm), while progenitors have limited proliferative potential and will 
stop growing after several rounds of cell division. Thus progenitor derived colonies 
will be smaller (<2mm). Using this assay, I found that CSPG generated and control 
cells gave rise to similar colony frequencies for each of the size categories defined by 
the assay protocol. The size categories were further divided to see whether there are 
smaller differences between CSPG treated and control cells that could not be observed 
with the large size categories used. I found that CSPG treatment increases the 
percentage of colonies in the range of 0.8-1.2mm, and reduces the percentage of 
colonies in the 0.5-0.8mm category. This shows that CSPG treatment promotes 
colony proliferation and suggests that CSPG generated cells have a greater 
proliferative potential.  
 
The NCFCA claims that colonies greater than 2mm are generated from stem cells 
while those smaller than 2mm are from progenitors (Louis et al., 2008). In my hands, 
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very few colonies greater than 2mm were observed with or without CSPG treatment. 
The inability of my cells to meet the full criteria of the NCFCA could be due to a 
number of reasons, including the density and the medium in which the original cells 
were maintained. The protocol recommended using NSCs maintained at high density 
(105 cells/ml) in enriched medium including both FGF and EGF as mitogens. 
However, for my experiments it was necessary to use low cell densities and EGF as 
the only mitogen. Although I found very few colonies greater than 2mm, my cells 
(both control and CSPG treated) were nevertheless multipotent and could be serially 
passaged, and are therefore likely to be NSCs. In other published works utilising the 
NCFCA, the size range of the colonies were often not abided to, and researchers used 
size criteria appropriate to their experiments (Bull and Bartlett, 2005; Pluchino et al., 
2008).  
 
4.1.5. Genetic profile of CSPG generated neurospheres 
To evaluate whether there are any differences between CSPG generated and control 
neurospheres at the genetic level, a large panel of genes were analysed. Gene profiling 
of single neurospheres showed that expression levels for most of the genes remained 
unchanged with CSPG treatment, and any changes were relatively small. Of the genes 
that have been well associated with NSCs, including Sox2, Bmi1, musashi, prominin, 
CBF1, Hes1, Hes5 and nestin, only Hes1 and nestin showed a slight increase in level. 
This suggests that neurospheres generated in the presence of CSPG are very similar to 
untreated cells at the genetic level.  
 
The genetic profiles of single neurospheres demonstrate that neurospheres are 
heterogeneous, expressing genes that are associated with precursors as well as genes 
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associated with differentiated cells. Amongst the genes that are increased with CSPG 
treatment, both precursor and differentiated cell-associated genes can be found. For 
example, in the Sox family, CSPG treatment increased Sox3, 5, 9, 11 and 14. Sox3, 5 
and 11 are precursor related genes (Bylund et al., 2003; Stolt et al., 2006; Tanaka et 
al., 2004; Wang et al., 2006), while Sox9 and 14 are known to promote differentiation 
(Stolt et al., 2006; Uchikawa et al., 1999). Similarly, in the notch signalling pathway, 
genes associated with pathway activation (the notch ligand Jag1 and notch effector 
Hes1) as well as pathway inhibitors (Hes6), show increased expression. This trend 
continues in the remaining genes analysed. Thus CSPG generated neurospheres are 
heterogeneous and the increase in markers of both precursor and differentiated cells 
may be due to CSPG stimulation of neural precursor proliferation which gives rise to 
more diverse cell types within the neurosphere. 
 
4.1.6. CSPG reduces apoptosis and stimulates neurosphere formation in 
the absence of EGF 
Additional support for a survival role for CSPG came from apoptosis assays. Both 
CSPG and CS-GAGs decrease active caspase 3/7 level within 24 hours of treatment. 
CS-GAGs have been shown to inhibit apoptosis by phosphorylating the proapoptotic 
protein BAD, and inhibiting cleavage of caspase 3/7 (Cartel and Post, 2005). CSPG 
treatment also increases the yield of total cellular protein. Although not a commonly 
used method, quantification of total cellular protein has been used as a measure of cell 
proliferation (Al-Shanti et al., 2008; Bayraktutan, 2004). However, in my 
experiments, the effect of CSPG on total cellular protein was observed within six 
hours of passaging and plating of cells. Thus CSPG is likely to protect cells from 
dying rather than promote proliferation in this short span of time. In addition, CSPG 
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was found to induce neurosphere formation in the absence of EGF. This reinforces the 
role of CSPG in stimulating NSC survival. 
 
4.2. Enumeration of NSC frequency 
The NSA has been widely used to study NSCs in different settings including studying 
the effects of exogenous factors (Shimazaki et al., 2001; Palma et al., 2004; Palma et 
al., 2005) and genetic modifications (Hitoshi et al. 2002a). As discussed previously, 
the NSA is a method that can isolate, expand and identify the presence of an NSC 
population. But when used alone, it cannot enumerate the NSC frequency. Accurate 
measurement of NSC frequency is required for meaningful interpretation of how 
NSCs respond to the treatment being studied. The enumeration of NSC frequency 
requires demonstration of clonality and multipotency in the same neurosphere. Using 
clonal neurospheres generated at low density where the aggregation rate is estimated 
at 2.2%, I have demonstrated the presence of multipotent neurospheres. Based on 
these data, an estimation of NSC frequency can be calculated from the following 
formula: 
 
NSC frequency = NFU x % of multipotent neurospheres 
 
 NSC frequency (%) NFU (%) % of multipotent neurospheres
Control 0.61 ± 0.3 3.4 ± 0.3a 17.8 ± 4.3b 
CSPG 2.63 ± 0.8 8.9 ± 0.2a 29.5 ± 5.7b 
a from Figure 3.3B, b from figure 3.9C 
 
Based on this equation, the NSC frequency for control and CSPG treated cells are 
estimated as 0.73 ± 0.3% and 2.66 ± 0.8% respectively. The 2.2% aggregation rate 
was not included in the calculation since the standard error of the percentage of 
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multipotent neurospheres is more than 4%. This calculation shows that CSPG 
treatment more than triples the frequency of NSCs, indicating that CSPG is increasing 
NSC survival.  
 
Previously, based on mathematical modelling of serially passaged E14-derived CNS 
cells, the NSC frequency was estimated to be 0.16% of total cells (Reynolds and 
Rietze, 2005). The authors used the expansion rate of bulk cultured cells to estimate 
the NFU, and use this as an estimate of NSC frequency using the formula in Figure 
4.1. The calculation is based on the assumption that NSCs are proliferating at 100% 
efficiency. It is not possible to ascertain whether this is the case since the expansion 
observed is contributed by both NSCs and progenitors. Thus the assumption made by 
this work may be flawed, and the estimate of NSC frequency is therefore inaccurate. 
More recently, an estimate of 0.07% was provided by the NCFCA using passage two 
neurospheres from E14 striatal cells (Louis et al., 2008). In this work clonality was 
demonstrated by growing cells in a collagen gel matrix. Subsequently these colonies 
were extracted from the gel and expanded under normal NSA conditions prior to 
differentiation as a dissociated population to demonstrate multipotency. This work is 
based on the premise that stem cells have greater proliferative potential than 
progenitors, and will thus give rise to bigger colonies when cultured over three week. 
However, it is also possible that a stem cell may initially proliferate, but subsequently 
enters senescence until it receives another stimulus that triggers it to proliferate again. 
This is true in the adult neurogenic zone where the astroglia stem cells are normally 
quiescent and only become activated to repopulate the SVZ after antimitotic treatment 
(Doetsch et al., 1999). Thus colony size may not truly reflect stem cell activity. 
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Figure 4.1. Calculation of sphere-forming unit (SFU) frequency. 
A five-fold expansion of a starting population of 100,000 cells (population 1) will 
generate 500,000 cells (population 2). Given that each sphere is composed of an 
estimated 3,600 cells, population 2 will contain 160 neurospheres. By definition, each 
SFU generates a sphere, so our starting population of 100,000 cells contained 160 
SFUs, or 0.16% (Reynolds and Rietze, 2005). 
 
 
The authors also demonstrated that only cells from colonies >2mm are multipotent 
and can be passaged extensively using the NSA. However, it is uncertain whether 
smaller colonies were unable to demonstrate the same properties because they were 
not derived from bona fide stem cells, or whether the NSCs they contain died during 
this prolonged culture period, or were lost during subsequent manipulations. The 
prolonged culture period means that the cells are no longer in the exponential phase of 
growth and their state of health and differentiation potential may be compromised. 
Thus it is possible that the NCFCA underestimates NSC frequency. Therefore, the 
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data that I present here is the first to demonstrate clonality and multipotency in 
individual neurospheres with no additional manipulation. Importantly, my cells are 
still in the exponential growth phase when harvested for differentiation and are likely 
to have full differentiation potential. Thus the NSC frequency that I have estimated is 
reasonable. 
 
For future analysis, the accuracy of the data can be improved by using neurospheres 
generated from isolated single cells which will eliminate any possibility of 
aggregation. In practice this method is inefficient and cannot generate sufficient 
number of neurospheres for differentiation and further characterization. A possible 
solution for this is to encapsulate single cells in agarose and grow them in normal 
NSA conditions, i.e. in suspension (Coles-Takabe et al., 2008). This is different from 
the hydrogel assay that I have used where cells are grown in a gel matrix and cannot 
be re-extracted without disrupting the neurosphere structure. Here, single cells are 
encapsulated within agarose capsules of approximately 100μm in diameter which 
prevent cell aggregation, but allow growth factors to diffuse freely. The neurospheres 
that form within the capsules are thus clonal. Since the neurospheres formed will be in 
suspension, they can easily be harvested for single neurosphere differentiation. 
Currently, single neurosphere differentiation requires CM from differentiating bulk 
culture cells. Without this differentiation-CM, neurospheres will either die or 
differentiate only into astrocytes. This experiment can be improved by using a defined 
medium which will reduce the variability of the results and eliminate the possibility of 
CM factors altering cell fates during the differentiation process.  
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4.3. CSPG regulation of NSC survival verses NSC self-renewal 
An observation made during serial passaging of CSPG generated cells was that CSPG 
stimulation of neurosphere formation is transient. When CSPG was added at the time 
of cell plating, an increase in neurosphere formation was observed. When CSPG 
generated neurospheres were dissociated and replated without CSPG, they formed 
similar number of neurospheres as the control. There are at least two possible 
mechanisms by which CSPG can increase neurosphere formation. The assumption is 
that not all NSCs that can form neurospheres will do so. The first possibility is that 
CSPG acts as a survival factor for the existing NSCs, allowing more neurospheres to 
form without increasing the total number of NSCs (Ferron et al., 2007). In such a 
scenario, the NFU would be predicted to return to control levels if CSPG is 
subsequently removed from culture (Figure 4.2). The second possibility is that CSPG 
expands the NSC pool to generate more neurospheres. In this case, removal of CSPG 
will not affect the subsequent neurosphere formation rate as there are now more NSCs 
and they are not dependent on CSPG for survival. Since my data showed that the NFU 
of CSPG treated cells returned to control levels after the removal of this compound, 
CSPG is likely to act as a survival factor for NSCs. In addition, CSPG can stimulate 
neurosphere formation when added up to three days after initial cell plating. This 
supports the hypothesis that not all NSCs that can form neurospheres will do so. Some 
of them may have died during passaging while others have entered senescence. CSPG 
may be stimulating this latter population to give rise to the increased neurosphere 
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Figure 4.2. CSPG stimulation of neurosphere formation 
A hypothetical model of mechanisms by which CSPG stimulates neurosphere formation. Not all NSCs that can form neurospheres will do so. 
(A) In passage one CSPG increases neurosphere formation by enhancing survival of existing NSCs so that even senescent NSCs can form 
neurospheres. Removal of CSPG in passage two compromises NSC survival and neurosphere formation rate returns to the control level. (B) In 
passage one CSPG stimulates expansion of the NSC pool to produce more neurospheres without affecting the senescent NSCs. Removal of 
CSPG in passage two does not affect the number of NSCs as they do not rely on CSPG for survival and the enhanced neurosphere formation is 
maintained. 
 Discussion:  158  
The data presented here suggests that CSPG is acting as a survival factor for NSCs 
and is not involved in NSC self-renewal which will result in an expansion of the NSC 
pool. However, the ability of CSPG to stimulate neurosphere formation when added 
late during culture suggests that CSPG can directly stimulate quiescent cells to divide. 
This raises the possibility that CSPG may have a role in maintaining NSC viability as 
well as regulating cell division. Therefore, it is important to determine whether CSPG 
regulates symmetrical or asymmetrical cell division, since the former will implicate a 
direct role for CSPG in NSC self-renewal, while the latter will imply that CSPG is 
only involved in NSC survival. An experiment that can help to shed light on this issue 
would be to evaluate secondary neurosphere formation after delayed CSPG addition. 
If CSPG stimulates symmetrical division a higher NFU will be observed, whereas if 
CSPG triggers asymmetrical division the NFU will be similar to the control. Activity 
of the notch signalling pathway, in particular CBF1 promoter activity has been used to 
distinguish NSCs from progenitors (Mizutani et al., 2007). Real-time monitoring of 
cell division and changes in the CBF1 promoter activity with CSPG treatment may 
also help determine the role of CSPG in regulating NSC division. 
 
4.4. CSPG stimulates neural precursor proliferation 
The effect of CSPG on neural precursor proliferation is demonstrated by the ability of 
CSPG to increase neurosphere size. The increase in neurosphere size was observed in 
both suspension cultures and hydrogel cultures where aggregation does not occur. 
Thus CSPG directly stimulates proliferation rather than induces cell aggregation to 
give rise to larger spheres. In support of this, CSPG was also found to reduce the 
population doubling time of low density cultures. Cell density plays an important role 
in regulating proliferation. In bulk density cultures the large number of cells allows a 
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fast reconstitution of the medium with cell-secreted factors such as CSPG after 
plating. In low density cultures there are much fewer cells, so reconstitution of the 
medium as well as cell-cell signalling will be compromised. Thus, the population 
doubling time for bulk cultures is shorter than that of low density cultures. The ability 
of CSPG to reduce the population doubling time of low density cultures suggests that 
it is able to create an environment similar to that of bulk density cultures, and thus 
enhances the proliferation of neural precursor cells. 
 
4.5. Role of endogenous CSPG 
The function of an endogenous protein may differ from the exogenous molecule. Thus 
I inhibited endogenous CSPG biosynthesis to evaluate its function in neurospheres. 
ChABC, β-D-xyloside and sodium chlorate were used for these experiments. Of the 
three inhibitors, only chABC specifically degrades CSPG. β-D-xyloside can inhibit 
attachment of other non-CS GAGs, and sodium chlorate will inhibit any protein that 
requires sulfation. More specific techniques such as siRNA were not used since this 
requires identification of a CSPG of interest so as to target the protein synthesis. As 
the NSC-CM is known to contain a number of different CSPGs (Kabos et al. 2004), 
targeting the CS-GAG would interfere with all of the CSPGs. In addition, stimulation 
of neurosphere formation is specific to CSPG since enzymatic degradation of HSPG, 
KSPG and HA did not interfere with neurosphere formation. Exogenous addition of 
these proteoglycans/GAGs also did not stimulate neurosphere formation. Thus the 
inhibitory effect of β-D-xyloside and sodium chlorate is likely due to inhibition of 
CSPG rather than other proteoglycans. 
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4.5.1. Neurosphere formation, proliferation and differentiation 
Treatments with chABC to digest CS-GAGs, sodium chlorate to inhibit GAG 
sulfation, and β-D-xyloside to inhibit GAG elongation on proteoglycan protein cores 
all reduced neurosphere formation and proliferation. Results from adherent cultures 
indicate that CSPG regulation of neural precursor proliferation is independent of its 
function in maintaining neurosphere structure. Thus endogenous CSPG is also 
involved in neural precursor cell survival and proliferation.  
 
Inhibition of endogenous CSPG produces only transient inhibition of neurosphere 
formation, such that neurosphere formation recovers upon removal of the CSPG 
inhibitors. Possible explanations for this include (1) cells were replated at bulk density 
following inhibitor treatments, so cell aggregation can stimulate neurosphere 
formation, and (2) Inhibition of endogenous CSPG does not affect NSCs, and the 
reduced neurosphere formation is due to inhibition of progenitor neurosphere 
formation. A recent article showed that formation of secondary neurospheres was 
inhibited after chABC treatment, suggesting that inhibition of endogenous CSPG is 
affecting NSCs (Sirko et al., 2007). However, in this work cells were initially cultured 
in bulk density in the presence of chABC. Subsequently cells were removed from 
chABC and replated at a lower density to assess secondary neurosphere formation. 
Thus changes in cell density will affect the ability of cells to form neurospheres, and it 
is difficult to evaluate the effect of chABC on NSCs. To clarify the role of 
endogenous CSPG in NSCs it will be necessary to determine the effect of CSPG 
inhibitors in non-aggregating cultures and evaluate the self-renewal and multipotent 
properties of inhibitor treated cells.  
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Evidence that supports a role for endogenous CSPG in NSC survival include the 
observation that xyloside treatment reduces the percentage of tripotent and bipotent 
neurospheres, and increases the percentage of unipotent neurospheres. Chlorate 
treatment reduced the percentage of oligodendrocyte/astrocyte bipotent neurospheres. 
However, chABC treatment had no significant effect on the potency of individual 
neurospheres. Although chABC and chlorate treatment did not alter the percentage of 
tripotent neurospheres, they reduced the NFU as a whole. Thus these results suggest 
that inhibition of endogenous CSPG reduces the number of multipotent NSCs. 
However, as discussed above, this experiment will need to be repeated with clonal 
neurospheres to confirm whether CSPG inhibitors affect NSCs or progenitors. In 
addition, inhibition of endogenous CSPG decreased the percentage of 0.5–1mm 
colonies, and increased the percentage of smaller colonies in the NCFCA. This 
suggests that inhibition of endogenous CSPG inhibits the proliferative potential of 
NSCs. ChABC, chlorate and xyloside treatments were also found to increase 
apoptosis. The percentage of TUNEL positive cells increased significantly after 24 
hours of inhibitor treatment, although the level of active caspase 3/7 was unaffected. 
Since caspase 3/7 are relatively early markers of apoptosis, changes in their activity 
level may have occurred at earlier time points that were not evaluated. Alternatively, 
these inhibitors may induce apoptosis via caspase-independent pathways. Additional 
experiments will be required to validate this. 
 
Inhibition of endogenous CSPG reduced the percentage of neurons and 
oligodendrocytes, and increased the percentage of astrocytes when dissociated cells 
were differentiated. This is similar to the results of Sirko et al. (2007). This suggests 
that endogenous CSPG is required for the survival of neuron and oligodendrocyte 
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progenitors. However, differentiation of CSPG generated cells did not produce more 
neurons and oligodendrocytes, suggesting that CSPG is unlikely to promote neuron 
and oligodendrocyte progenitor survival. It is more likely that inhibition of 
endogenous CSPG produces a sub-optimal growth condition in which the neuron and 
oligodendrocyte progenitors are more affected. Generally astrocytes are the 
predominant cell type generated upon differentiation, whereas the generation of 
neurons and oligodendrocytes is more sensitive to environmental changes. 
 
4.5.2. CSPG maintains the neurosphere structure 
In addition to regulating NSC survival and proliferation, CSPG is also involved in 
maintaining the 3D structure of the neurosphere. ChABC treatment was found to 
break down the 3D structure of neurospheres. CSPG is a major component of the 
ECM, which is crucial in maintaining tissue structure. The CNS has a specialised 
ECM in certain areas known as the perineuronal net (PNN). The PNN is a highly 
condensed matrix that surrounds the cell bodies and proximal dendrites of some 
classes of neurons (Celio and Blumcke, 1994; Murakami and Ohtsuka, 2003; 
Yamaguchi, 2000). As with the general ECM, CSPG is also a major component of the 
PNN, but with differing composition of the CS-GAG (Deepa et al., 2006). The PNN 
is involved in both synaptic and structural plasticity of the brain and likely functions 
via CS-GAG chains (Galtrey and Fawcett, 2007). For example, long-term potentiation 
and depression in the hippocampus is disrupted with chABC treatment (Bukalo et al., 
2001). After stroke, a reduction of the PNN as well as a number of CSPGs has been 
reported (Bidmon et al., 1998; Carmichael et al., 2005). This has been correlated with 
reorganisation of cortical maps in the peri-infarct and remote regions, with 
accompanying functional recovery (Carmichael, 2003). Further support for a role for 
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CS-GAGs in the maintenance of cellular structure comes from the work of Sirko et al. 
(2007) where intraventricular injections of chABC disrupted the organisation of the 
embryonic ventricular zone. Thus CS-GAG chains are likely to be crucial for the 
maintenance of the neurosphere structure in vitro and the neurogenic zone in vivo.  
 
I also used an adherent culture system to analyse the role of CPSG in structural 
maintenance. Neural precursors grow preferentially as colonies, so even when forced 
to adhere, clusters of cells formed and typical fibroblast monolayers were not 
observed. In addition, proliferation rate was greatly reduced in adherent cultures 
compared to neurosphere cultures, and a higher cell plating density was required for 
efficient cell growth, indicating that cell-cell contact and signalling is essential for 
neural precursor proliferation. Thus the neurosphere system is likely to be the optimal 
culture condition for these cells. Indeed, the neurosphere system is the most 
commonly used method for propagating neural precursors in culture, although some 
researchers do adopt the adherent culture system (Molofsky et al., 2003; Temple, 
1989). Using adherent cultures I found that CSPG induced formation of neurosphere-
like structures that are attached to the culture surface. This indicates that CSPG 
preferentially induces the formation of cell clusters or neurospheres. Together with 
the ability of chABC to break down the neurosphere structure, these results indicate 
that CSPG is essential for the 3D growth of neurospheres. The niche in which a stem 
cell resides includes supporting cells, the ECM, membrane-bound as well as soluble 
factors. They serve to protect stem cells from differentiation signals, apoptosis stimuli 
and excessive proliferation, thus maintains the stem cell state (Li and Xie, 2005). The 
ability of CSPG to stimulate NSC survival and proliferation, as well as maintain the 
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structure of neurospheres indicates that CSPG is required for the maintenance of the 
NSC niche. 
 
4.6. CSPG structure and function 
CSPGs are complex molecules that can function via their GAG chains as well as their 
core proteins. So how do CSPGs regulate NSC survival and proliferation, as well as 
maintain the structure of neurospheres? The current data indicates that CSPGs use 
different aspects of their structure, including the protein core, the GAG chains and 
specific sulfation motifs to regulate NSC survival, proliferation and neurosphere 
structural maintenance.  
 
4.6.1. Protein verse glycosaminoglycan chains 
Since all three CSPG inhibitors, chABC, chlorate and xyloside, interfered with NSC 
survival and proliferation, the full CSPG structure is likely required for these 
processes. On the other hand, maintenance of the neurosphere structure only requires 
the intact CS-GAG chain since a break down of the neurosphere structure is only 
observed when the GAG chain is digested with chABC. β-D-xyloside primes the 
synthesis of the GAG chains, and thus competes with the proteoglycan protein core 
for chain elongation. The result is the formation of proteoglycans without GAG 
chains and free GAG chains in the cell (Sobue et al., 1987). Treatment with xyloside 
did not result in a breakdown of the neurosphere structure, possibly because intact 
GAG chains are still being produced by cells, which may find their way to the cell 
surface to help maintain the neurosphere structure. In support of this, treatment of the 
monoblastic U-937 cell line with β-D-xyloside results in increased synthesis of free 
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GAG chains that can be detected in both the cell fraction as well as in the medium, 
indicating that free GAG chains can be secreted (Kolset et al., 1990). 
 
Of the three CSPG inhibitors, β-D-xyloside produced the least inhibitory effect on 
neurosphere formation. This is likely due to the increased free GAG chains produced 
by xyloside treatment. Experiments with addition of CS-GAGs showed than even free 
GAGs can stimulate neurosphere formation. Thus inhibition of neurosphere formation 
by the disruption of CSPG synthesis may be compensated by the increase in free 
GAG chains. This trend is also observed in neural precursor proliferation and 
apoptosis assays where xyloside is less inhibitory than chABC and chlorate. The 
inhibitory effect of all three inhibitors on neurosphere formation can be rescued by 
exogenous addition of CSPG. The rescue for xyloside was complete as the inhibitory 
effect of this reagent is relatively mild. For chABC, the recovery was nearly complete 
at 70%. The remaining inhibition may be due to the enzyme continuously degrading 
endogenous CS-GAGs as well as exogenous CSPG. For chlorate, exogenous CSPG 
rescue was less effective. This is likely because chlorate inhibits sulfation in general 
and is not specific to CSPGs. Thus other proteins requiring sulfation will also be 
affected, although CSPGs are one of the most highly sulfated classes of proteins in the 
cell  
 
4.6.2. Sulfation pattern and CSPG function 
The inhibitory effect of sodium chlorate supports the importance of sulfation in CSPG 
function. The function of CS-GAGs is known to be regulated by their sulfation 
patterns (Gama et al., 2006; Shipp and Hsieh-Wilson, 2007). I found that CS-A, -B 
and –E stimulated neurosphere formation whereas CS-C and –D did not. The greatest 
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stimulation was observed with CS-E, but this was still lower than that of CSPG, 
presumably because this is a CSPG mix that will contain many different GAGs as 
well as their respective protein cores. CS-A, –B and -E are all sulfated at the 4-O 
position of N-acetylgalactosamine (GalNAc), suggesting the importance of this 
sulfation site for neurosphere formation. CS-B has additional sulfate groups at the 2-O 
position of glucuronic acid (GlcA) while CS-E also has addition sulfate groups at the 
6-O position of GalNAc. Both CS-B and –E produced significantly greater 
stimulation than CS-A, suggesting that highly sulfated GAGs are important for NSC 
survival. However, CS-D is also a highly sulfated GAG with sulfation at the 6-O 
position of GalNAc and the 2-O position of GlcA, but it did not show any stimulatory 
effect. Likewise, CS-C with sulfation at the 6-O position of GalNAc had no 
stimulatory effect. This indicates that sulfation must occur at least on the 4-O position 
of GalNAc for a stimulatory effect to occur. The stimulatory effect is enhanced if 
sulfation at the 6-O position of GalNAc or 2-O position of GlcA is also present, with 
the former modification producing the most stimulation.  
 
Recently, it has been demonstrated that the CSPGs secreted by NSCs carried 
predominantly CS-A and –C units, and a small percentage of CS-D and –E units 
(Akita et al., 2008). The CS-B unit was not detected, but the authors attributed this to 
the limitation of the detection method since the 473HD antibody can recognise CS-B 
units on neurospheres, and neural precursors positive for this epitope showed 
increased neurosphere formation (von Holst et al., 2006). The CS-E unit appears to 
have the greatest growth promoting activity. It has been shown to promote neurite 
outgrowth (Clement et al., 1999), and is known to bind a number of growth factors 
including FGF2, midkine and pleiotrophin (Deepa et al., 2002) which are all involved 
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in neural precursor survival and proliferation. CS-B, -D and –E units have been 
shown to promote FGF-2 mediated rat embryonic NSC proliferation, but had no effect 
when EGF was used as the mitogen (Ida et al., 2006). The authors did not evaluate the 
effects of these GAGs on neurosphere formation, thus it is difficult to compare my 
data directly. However, the results generally contradict my observation that CS-B and 
–E can stimulate NSCs in the presence of EGF. In addition, I have found that CS-A 
rather than CS-D can also stimulate neurosphere formation. The discrepancy between 
my data and that of Ida et al. (2006) may lie in the different sources of NSCs, I have 
used mouse NSC while Ida et al. (2006) used rat NSCs. Taken together my result 
suggests that CSPG can modulate neurosphere formation and thus NSC survival using 
different sulfation motifs. 
 
To evaluate how sulfation patterns of endogenous CSPGs may contribute to 
neurosphere formation, I attempted to selectively deplete sulfate groups using the 
chondroitin-4/6-sulfatases. However, I found that these enzymes were only able to 
release sulfate groups from chABC digested GAG disaccharides, and not from intact 
polysaccharides. So although chondroitin-6-sulfatase can stimulate neurosphere 
formation, this is unlikely to be a result of sulfate released from the 6-O position of 
GalNAc, and mostly likely due to non-specific interactions. An alternative method to 
further explore the role of CSPG sulfation patterns in NSC biology would be to study 
NSCs from sulfotransferase mutants. The chondroitin-6-sulfotransferase mutant 
shows an almost undetectable level of CS-C and no CS-D in the brain. However, 
brain development was unaffected (Uchimura et al., 2002). I have shown here that 
CS-C and –D do not stimulate neurosphere formation, suggesting that these GAGs 
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may not be essential for NSC survival and proliferation. It would be interesting to 
evaluate whether any significant changes in NSCs occur in these mutants.  
 
4.7. CSPG signalling 
The signalling pathways analysed in this study can be grouped into EGFR and non 
EGFR-related pathways. The first group includes EGFR itself, as well as 
JAK/STAT3, PI3K and ERK, while the latter group includes p38 MAPK, notch, Wnt, 
Shh, phosphatases and Rho/ROCK. Both groups were found to be involved in 
neurosphere formation. CSPG stimulation of neurosphere formation can be correlated 
with the activation of EGFR-related pathways including EGFR, JAK/STAT3 and 
PI3K, while the ERK signalling cascade is unlikely to be involved.  
 
For the non EGFR-related pathways, it is not clear whether they are involved in 
CSPG stimulation of neurosphere formation since the chemical inhibitor studies show 
that the IC50 values for neurosphere formation (IC50NF) for both CSPG and control 
cultures are similar. This means that neurosphere formation is decreasing at the same 
rate in both cultures. Thus it cannot be determined whether the inhibitors are 
inhibiting the stimulatory effect of CSPG or inhibiting baseline neurosphere 
formation.  
 
In terms of neurosphere proliferation, with the exception of the serine/threonine 
phosphatase pathway, all the pathways evaluated are involved in this process. The 
IC50 values for neurosphere proliferation (IC50NP) for CSPG is greater than that of 
the control in all cases, indicating that higher concentrations of inhibitors are required 
to inhibit neurosphere proliferation in the presence of CSPG. This suggests that CSPG 
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stimulation of neurosphere proliferation does not involve any of the pathways 
evaluated. However, the size categories used to monitor the changes in neurosphere 
sizes were very broad, and so does not allow smaller changes in neurosphere size to 
be observed. Additional experiments such as utilising smaller size categories and 
direct quantification of cell numbers will provide more information on how these 
inhibitors affect neural precursor proliferation and whether they are involved in the 
function of CSPG.  
 
4.7.1. EGFR-related pathways mediate CSPG stimulation of 
neurosphere formation 
CSPG stimulation of neurosphere formation is likely to be mediated by EGFR, JAK 
and PI3K since inhibition of these kinases with the chemical inhibitors PD168393, 
AG490 and LY294002 respectively, significantly reduced the stimulatory effect of 
CSPG. In all three cases, the IC50NF for CSPG was less than that of the control, 
indicating that a lower concentration of inhibitors can inhibit neurosphere formation 
in CSPG treated cells compared to the control. Thus the stimulatory effect of CSPG is 
selectively inhibited by all three inhibitors prior to inhibition of neurosphere 
formation in general. Another important mediator of EGFR signalling is ERK. 
Inhibition of this kinase with PD98059 also inhibits neurosphere formation. The 
IC50NF of CSPG is similar to the control. As discussed above it is uncertain whether 
the neurosphere stimulatory effect of CSPG is inhibited by PD98059. These data 
show that CSPG stimulation of neurosphere formation is likely to involve EGFR, 
JAK and PI3K, whereas the role of ERK requires further evaluation. An interesting 
point to note is that PD98059 inhibits neurosphere proliferation at a lower 
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concentration than that required for inhibition of neurosphere formation, suggesting 
that Erk1/2 is preferentially involved in NSC proliferation. 
 
At the protein level, CSPG was able to directly stimulate the phosphorylation of 
EGFR and STAT3 (an effector of JAK), whereas Akt, the effector of PI3K was not 
activated. ERK1/2 was also not activated by CSPG. When combined with the 
chemical inhibitor studies discussed above, this suggests that CSPG does not signal 
via ERK. The stimulation of EGFR by CSPG was relatively mild in comparison with 
the effect of EGF, and CSPG was unable to further enhance the stimulatory effect of 
EGF when used together. This suggests that stimulation of EGFR may not be the 
main mechanism by which CSPG elicits its effect, since activation of EGFR would 
likely be saturated by the EGF normally present in the medium. Expression of EGFR 
and phospho-EGFR was also increased in cells cultured with CSPG for six days. This 
long term increase in EGFR and phospho-EGFR may be due to the increase in cell 
growth with CSPG treatment, or may be a direct result of CSPG stimulation. 
However, both the EGFR and phospho-EGFR signals were normalised to actin. If 
CSPG is increasing cell growth without directly stimulating EGFR, the protein-actin 
ratio should remain the same. Thus the increase in EGFR suggests that it is directly 
due to CSPG. In addition, I also looked at the effect of the p38 MAPK inhibitor 
SB203580 on EGFR and phospho-EGFR expression since this compound also 
stimulates neurosphere formation and proliferation. SB203580 increases phospho-
EGFR expression without affecting the expression of EGFR. This suggests that the 
increase in EGFR with CSPG treatment is likely to result from direct stimulation by 
CSPG rather than as a result of general increase in cell growth. Thus, long term 
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regulation of EGFR expression may be another mechanism by which CSPG regulates 
neurosphere formation.  
 
CSPG was able to induce a robust stimulation of STAT3 phosphorylation, which was 
greater than the effect of EGF alone, and a combination of CSPG and EGF produced 
further stimulation of STAT3. This suggests that CSPG may be activating STAT3 via 
additional pathways besides EGFR. Cytokines such as LIF, IL-6 and CNTF activate 
the JAK/STAT pathway via the glycoprotein receptor gp130 (CD130) (Yanagisawa 
and Yu, 2007). This pathway plays an important role in astrocyte differentiation 
(Bonni et al., 1997; Nakashima et al., 1999), and can interact with proneural genes 
such as neurogenin to regulate neurogenesis (Sun et al., 2001). CNTF activation of 
gp130 has also been implicated in the maintenance of NSC self-renewal by inhibiting 
neural differentiation (Shimazaki et al., 2001). A possible mechanism for this is via 
regulation of notch1 expression and activation (Chojnacki et al., 2003). Indeed, direct 
binding between Hes and STAT3 has been demonstrated (Kamakura et al., 2004). 
Thus the gp130 receptor may be a potential route through which CSPG can stimulate 
JAK/STAT to promote NSC survival. 
 
CSPG did not directly stimulate Akt phosphorlyation. A slight increase in phospho-
Akt and pan-Akt level was only observed after culturing with CSPG for six days, 
which could be a result of increased cell growth in the presence of CSPG. The p38 
MAPK inhibitor SB203580 was also found to increase pan-Akt level but not phospho-
Akt level. In long-term cultures, the level of phosphoproteins may fluctuate 
depending on the presence of stimulatory signals at the time of cell collection. Thus 
the pan-protein level can be another indicator of pathway activity. These results 
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indicate that the increase in Akt expression may be a result of cell growth. Thus Akt is 
unlikely to be a direct target for CSPG. However, the chemical inhibitor studies 
indicate that PI3K is critical for the stimulatory effect of CSPG. Thus alternative 
pathways must exist to transduce the signal of PI3K if Akt is not involved. A potential 
pathway involves PI3K activation of PKC (Duronio et al., 1998). A number of reports 
have demonstrated the ability of CSPG to activate PKC. CSPG inhibition of neurite 
outgrowth involves the activation of PKC (Sivasankaran et al., 2004). On the other 
hand, neuroglycan C can promote neurite outgrowth, which also involves the 
activation of PKC (Nakanishi et al., 2006). Thus PKC appears to be the common 
target whereby different CSPGs can regulate neurite outgrowth. In addition, CS-B 
also uses the PKC pathway to stimulate B-cell proliferation (Aoyama et al., 2005). 
Thus it would be interesting to explore further whether CSPG stimulation of 
neurosphere formation involves PI3K/PKC signalling. 
 
Previously, the effect of EGFR inhibition on neurosphere formation was demonstrated 
by Campos et al. (2004) using another EGFR inhibitor AG1478. CSPGs such as 
versican and decorin, as well as a CSPG extracted from the chicken brain have been 
shown to bind and activate EGFR (Kaneko et al., 2007; Koprivica et al., 2005; 
Moscatello et al., 1998; Wu et al., 2004a). EGFR ligands have also been shown to 
stimulate secretion of CSPGs including phosphacan and neurocan in astrocytes (Smith 
and Strunz, 2005). For PI3K, LY294002 has previously been shown to decrease 
neurosphere formation (Torroglosa et al., 2007). In addition, null mutation in PTEN 
(Phosphatase and tensin homolog), a negative regulator of PI3K signalling, resulted in 
increased NSC proliferation and enlarged brains (Groszer et al., 2001). Over 
expression of Akt can stimulate hippocampal progenitor proliferation, whereas a 
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dominant negative Akt inhibits proliferation (Peltier et al., 2007). The PI3K/Akt 
pathway has also been linked to a number of CSPGs/CS-GAGs. For example, 
midkine signalling via RPTPζ results in the activation of PI3K (Hayashi et al., 2001; 
Qi et al., 2001), neuroglycan C signals via PI3K to promote neurite outgrowth 
(Nakanishi et al., 2006), and CS-B can activate PI3K/Akt to stimulate B cell 
proliferation (Aoyama et al., 2005). So although both EGFR and PI3K have been 
independently linked with NSC biology and CSPG signalling, the work presented 
here is the first to demonstrate a requirement for both proteins in CSPG signalling in 
the context of NSCs.  
 
The JAK/STAT pathway is an important pathway mediating cytokine and growth 
factor signalling (Aaronson and Horvath, 2002; Levy and Darnell, 2002). It is 
involved in maintaining stem cells in a number of systems including Drosophila 
germline stem cells (Kiger et al., 2001; Tulina and Matunis, 2001), and mammalian 
ESCs where it transduces LIF signalling (Burdon et al., 2002; Matsuda et al., 1999). 
In adult NSCs, cytokines such as LIF and CNTF have also been shown to regulate 
self-renewal, and the major signalling pathway for these cytokines is the JAK/STAT 
pathway (Bauer, 2009). JAK/STAT is expressed in the embryonic neocortex and 
mediates FGF2 maintenance of NSCs. Conditional deletion of STAT3 inhibits 
neurosphere formation and promotes neuronal differentiation, whereas over 
expression of this protein stimulates neurosphere formation (Yoshimatsu et al., 2006). 
The inhibitory effect of AG490 on neurosphere formation has also been noted by 
Yoshimatsu et al. (2006). However, in terms of proteoglycan signalling, CSPG has 
not been associated with this pathway, although heparin-binding growth factors such 
as HB-EGF and midkine are known to activate STAT3 (Lee et al., 2007; Ratovitski et 
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al., 1998). Thus, the current data demonstrates JAK/STAT as a novel signalling 
pathway for CSPG in NSCs. 
 
In summary, the work presented here demonstrates that CSPG stimulation of 
neurosphere formation is likely to involve activation of EGFR and two of its 
downstream pathways, JAK/STAT3 and PI3K, while the third pathway, ERK, is 
unlikely to be involved (Figure 4.3). Additional signalling molecules such as PKC and 




Figure 4.3. Potential signalling pathways for CSPG 
Inhibition of EGFR, PI3K and JAK/STAT all resulted in inhibition of CSPG 
stimulation of neurosphere formation. A potential signalling pathway for CSPG may 
involve direct activation of EGFR, leading to the activation of PI3K and STAT3. 
Alternatively, CSPG may activate other receptors such as gp130 to active STAT3 
signalling. CSPG did not stimulate Akt, the main effector of PI3K, thus alternative 
signalling molecules may be involved. A potential candidate is PKC which can be 
activated by PI3K. CSPG may also stimulate PKC directly. ERK is an important 
downstream signalling molecule for EGFR, but it is unlikely to be involved in CSPG 
stimulation of neurosphere formation.  
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4.7.2. Non-EGFR-related pathways 
Evaluation of the notch and the Shh pathways showed that inhibition of both 
pathways inhibits neurosphere formation and proliferation, confirming the importance 
of notch and Shh signalling in regulating neural precursor survival and proliferation. 
When the notch and Shh pathways were evaluated with respect to CSPG signalling, 
inhibition with the γ-secretase inhibitor L685,458 and cyclopamine respectively 
produced similar IC50NF values in CSPG and control cultures, while the IC50NP value 
is greater for CSPG treated cells. As discussed above, it is unclear based on these data 
alone how these two pathways may be interacting with CSPG. An interesting point to 
note is that L685,458 treatment did not affect neurosphere size significantly, 
suggesting that the notch signalling pathway may be primarily involved in 
neurosphere formation rather than proliferation. 
 
Evaluation of the p38 MAPK pathway with the kinase inhibitor SB203580 showed 
that SB203580 stimulates neurosphere formation and proliferation, similar to the 
effect of CSPG. Shortly after this observation was made, an article was published 
demonstrating the same effect (Sato et al., 2008). Thus p38 MAPK negatively 
regulates neurosphere formation and proliferation. In support of this, activation of this 
pathway inhibits neurosphere formation and promotes differentiation of NSCs (Yang 
et al., 2006), and reactive oxygen species decrease NSC proliferation via activation of 
p38 (Kim and Wong, 2009). In long-term cultures SB203580 was found to increase 
cyclinD1 and D3 expression, and reduce p15 expression. This suggests that p38 
regulates cell cycle regulators to control neural precursor proliferation. A similar 
effect has been demonstrated in cardiomyocytes where SB203580 was found to 
stimulate proliferation, and increase expression of p21, cyclin D, cyclin B and Cdc2 
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(Engel et al., 2005). When CSPG was evaluated with respect to p38 MAPK 
signalling, it did not affect the phosphorylation state of this protein. An additive effect 
was also observed on both neurosphere formation and proliferation when cells were 
treated with CSPG and SB203580. Finally, SB203580 was able to rescue the 
neurosphere inhibitory effect of chABC. The latter two results suggest that CSPG and 
SB203580 may be signalling via independent pathways to regulate neurosphere 
formation and proliferation. 
 
Evaluation of the Wnt pathway produced some rather unexpected results. Inhibition of 
this pathway with Dkk-1 did not affect neurosphere formation, but addition of 
recombinant Wnt3a inhibited neurosphere formation and induced cells to proliferate 
as an adherent layer. Wnt3a purified from mouse L-cell CM can induce hESC-derived 
neurosphere formation and proliferation (Davidson et al., 2007). Kalani et al. (2008) 
also showed that CM purified Wnt3a can stimulate neurosphere formation, whereas 
Dkk inhibits this process. On the other hand, Hirsch et al. (2007) demonstrated that 
the same recombinant Wnt3a that I had used can stimulate NSC proliferation in 
adherent cultures. Thus, the inhibition of neurosphere formation and induction of 
adherent proliferation may be due to the Wnt protein I had used. However, I was also 
unable to detect Wnt1 and Wnt3a expression in my neurosphere cultures, suggesting 
that Wnt3a may not be a functional pathway in these cells. With regards to CSPG 
signalling, neither Dkk-1 nor Wnt3a affected the neurosphere stimulatory effect of 
CSPG. However, before any relationship can be deduced between the Wnt signalling 
pathway and CSPG, additional experiments will be required to validate the presence 
of the Wnt signalling pathway in the cells used, and determine the appropriate 
inhibitors/activators to use for signalling studies. 
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Two additional pathways related to CSPG signalling were investigated, phosphatases 
and Rho/ROCK. The phosphatase pathway is of interest because RPTPβ/ζ and its 
splice variant phosphacan are CSPGs (Maurel et al., 1994; Shitara et al., 1994). One 
of the primary roles of phosphatases is to regulate intracellular signalling molecules in 
conjunction with tyrosine kinases, where the kinases are responsible for protein 
phosphorylation and phosphatases for dephosphorylation. Two common classes of 
phosphatases are the tyrosine phosphatases such as RPTPβ/ζ and Shp (Paul and 
Lombroso, 2003), and serine/threonine phosphatases such as PP1 and PP2A (Cohen et 
al., 1990). Due to their ubiquitous role in the regulation of intracellular signalling, it 
was not surprising to find that both types of phosphatases are required for neurosphere 
formation. However, it was interesting to note that while inhibition of tyrosine 
phosphatases with SOV also inhibited neurosphere proliferation, inhibition of 
serine/threonine phosphatases with OA treatment only inhibits neurosphere formation 
with no effect on neurosphere proliferation. This suggests that the serine/threonine 
phosphatase pathway is involved in the survival of NSCs, but is not required for these 
cells to proliferate. Thus, inhibiting this pathway results in a loss of NSCs, but those 
that survive continue to proliferate and give rise to normal size neurospheres. 
Experiments that will help to validate this include serial passaging and single 
neurosphere differentiation of OA treated cells. With regards to CSPG signalling, the 
chemical inhibitors data alone does not allow interpretation of a relationship between 
CSPG and phosphatase signalling. Additional studies such as protein analysis and 
phosphatase activity assays will be required to elucidate this relationship. 
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A number of publications have demonstrated a role for Rho/ROCK in neural 
differentiation and cell fate decisions (Cappello et al., 2006; Chen et al., 2006; Pacary 
et al., 2007). Inhibition of the Rho/ROCK pathway reduced apoptosis of neural 
progenitor cells during dissociation and transplantation (Koyanagi et al., 2008). 
Conditional deletion of the Rho GTPase Rac1 resulted in reduction of the neural 
progenitor pool in vivo (Chen et al., 2009). The Rho/ROCK pathway has also been 
implicated in the proliferation of a number of cell types including gastrointestinal 
cells, kidney cells, corneal epithelial cells and glioblastomas (Chen et al., 2008; He et 
al., 2005; Meyer et al., 2006; Zohrabian et al., 2009). However, the data presented 
here is the first to demonstrate a direct effect of Rho/ROCK inhibition on neurosphere 
formation, thus implying a role for Rho/ROCK in NSC self-renewal. An interesting 
point to note is that in the presence of Y27632, cells were able to proliferate to a 
certain extent as an adherent layer. This suggests that ROCK is involved in formation 
of the neurosphere structure. Treatment with C3 on the other hand inhibited 
neurosphere formation without inducing cells to grow as an adherent layer, suggesting 
that Rho may be regulating neurosphere formation via other pathways in addition to 
ROCK. The effect of C3 and Y27632 on cell proliferation needs to be evaluated to 
determine the function of Rho/ROCK in this regard.  
 
The Rho/ROCK pathway is traditionally associated with regulation of cell shape and 
migration. So why are these molecules also involved in neurosphere formation? Ultra-
structural study of neurospheres has showed that some cells within the neurosphere 
have a single cilium (Lobo et al., 2003), similar to adult NSCs (Doetsch et al., 1999). 
In addition, healthy cells within the neurosphere also extend processes to phagocytose 
dying cells (Lobo et al., 2003). Thus the Rho/ROCK pathway may be involved in 
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maintenance of these cilia structures and regulation of phagocytosis to support the 
neurosphere structure. In addition, the Rho/ROCK pathway also plays an important 
role in cytokinesis (Piekny et al., 2005), and may have a similar function in NSCs. 
With regards to CSPG signalling, full inhibitor dose-dependent curves need to be 
generated before any relationship between CSPG and Rho/ROCK can be deduced. 
 
In summary, all of the above pathways are involved in neurosphere formation and 
proliferation. Additional experiments are required to determine how these pathways 
may be involved in CSPG signalling in the regulation of neurosphere formation and 
proliferation. 
 
4.8. Implications of current work 
A direct implication of this work for NSC research is that demonstration of clonality 
and multipotency in the same neurospheres allows an accurate estimation of NSC 
frequency. This allows meaningful interpretation of whether a compound of interest 
directly affects NSC survival. Based on these criteria, CSPG is demonstrated to be a 
survival factor for NSCs. In addition, CSPG regulates neural precursor proliferation 
and maintains the neurosphere structure. Together, this indicates that CSPG is 
essential for maintaining the NSC niche. Factors within the NSC niche are important 
in maintaining the stem cell state. Thus understanding the function of CSPG will 
improve our understanding of how NSCs self-renew, and maintain multipotency. 
 
CSPGs are known to play a role in CNS injury and inhibition of regeneration 
(Properzi et al., 2003). The findings reported here of CSPG stimulation of NSC 
survival and proliferation suggest that CSPG could aid in brain repair. How can these 
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distinct functions of CSPG be rationalised? One possible explanation is that the 
barrier property of CSPGs is involved in both inhibition of regeneration and 
maintenance of NSCs. It is well established that CSPG is an inhibitory component of 
the glial scar and prevents axon regeneration by directly repelling extending axons as 
well as collapsing the axon growth cone (Borisoff et al., 2003; Snow et al., 2001). 
CSPG may achieve this by regulating the availability of growth factors to the growing 
axons as well as through direct signalling pathways (Carulli et al., 2005). CSPGs may 
also form barriers around NSCs and regulate proliferation, differentiation and 
apoptosis signals to maintain the NSC state. Such a model has been proposed for 
CSPG maintenance of the articular cartilage stem cell niche (Hayes et al., 2008). The 
authors proposed that stem cells are surrounded by hyaluronic acid and CS-GAGs that 
prevent growth factors from binding to their receptors (Figure 4.4). This niche 
environment protects stem cells from differentiation signals and maintains the stem 
cell state. During asymmetrical division the daughter cell destined for differentiation 
leaves this CS-GAG zone, and becomes accessible to growth factors that will regulate 
their proliferation and differentiation. The other daughter cell will remain in the niche 
to maintain the stem cell pool. It is possible that this model also applies to NSCs and 
CSPGs in and around the NSCs microenvironment help to maintain the NSC state.  
 
The close relationship between CSPGs and NSCs presents a number of utilities for 
these molecules including (1) using them as surface markers for NSCs, for example 
the 473HD epitope and NG2 have already been used. Expressions of aggrecan and 
versican have been correlated with a subpopulation of FACS-sorted cells that display 
high side and forward scatter. These cells show increased neurosphere forming ability 
in vitro (Anuradha Poonepalli, unpublished data). 
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Figure 4.4 CSPG and the stem cell niche 
A hypothetical model showing the proposed role of differential CS sulfation of matrix and 
cell-associated PGs in forming a stem cell niche and thereby regulating the proliferation 
/differentiation state of stem/progenitor cells. (A) Stem cells are protected from the influence 
of growth factors by a shield of hyaluronic acid and proteoglycans containing non-sulphated 
or minimally sulphated CS glycosaminoglycans that prevent their binding with cell surface 
receptors. (B) During stem/progenitor cell division, one of the daughter cells is translocated 
outside the pericellular shield of non- and minimally sulphated CS proteoglycans, where it 
becomes susceptible to binding of growth factors. (C) This daughter cell is now completely 
removed from the stem cell niche, and growth factor–receptor binding leads to cell 
differentiation/proliferation (green cell). The parent/daughter cell, meanwhile, remains within 
the low sulphated CS-PG–shielded niche [modified from Hayes et al. (2008)].
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Different sulfation motifs on CS-GAGs may also be used to identify different 
populations of cells within the stem cell niche (Hayes et al. 2008). (2) The ability of 
CSPG to stimulate NSC survival can be used to help generate clonal neurospheres for 
the identification and characterisation of bona fide NSCs. If a homogeneous 
population of NSCs can be isolated, it will help to advance our understanding of 
fundamental concepts such as the regulation of self-renewal and lineage commitment. 
(3) CSPG has also been found to play a role in the expansion of ESC-derived 
neurospheres (Hui Theng Gan, unpublished data). ESCs cultured in NSC medium 
without LIF can spontaneously form neurospheres at a very low rate (0.05%). 
Previously, NSC-CM was found to stimulate generation of NSCs from ESC (Zhang et 
al., 2006). Addition of CSPG can result in a more than 10-fold increase in 
neurosphere formation from ESCs. The neurospheres generated can be serially 
passaged and are multipotent, capable of giving rise to neurons, astrocytes and 
oligodendrocytes. Given the low rate at which ESCs normally convert to 
neurospheres, addition of CSPG represents a very useful tool to generate ESC-derived 
NSCs, and will assist in delineating the developmental processes involved in the 
transition from ESC to NSC.  
 
4.9. Conclusion and future directions 
I have shown here that CSPG is an essential component of the NSC niche. It is 
involved in regulating NSC survival and proliferation, in neurosphere formation and 
maintenance. CSPG is secreted by neural precursors and exogenous addition of this 
compound can stimulate neurosphere formation and proliferation. CSPG is likely to 
act on NSCs as evident by the self-renewal capacity and increased multipotency of 
CSPG generated cells. Based on the percentage of clonal and multipotent 
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neurospheres observed, I provided an estimation of the NSC frequency, and showed 
that CSPG increases the NSC frequency by more than four-folds. Potential signalling 
pathways for CSPG were also identified. These include EGFR, JAK/STAT3 and 
PI3K. Further experiments will be required to delineate the full signalling pathways of 
CSPG. In addition, it is also important to address whether CSPG regulates 
symmetrical or asymmetrical cell division as this will distinguish between the role of 
CSPG in NSC self-renewal and NSC survival. 
 
Understanding factors that regulate NSC survival and growth is fundamental to the 
utilisation of these cells for therapy, either as cell transplants or by activation of 
endogenous NSCs. Given the importance of CSPG in regulating NSC biology, it may 
assist in brain repair. In this regard several important issues need to be addressed. 
Does CSPG have the same stimulatory effect on adult NSCs? Does CSPG promote 
recruitment of endogenous NSCs post-injury? Can CSPG enhance the survival of 
transplanted NSCs? How can the neurite inhibitory effect and NSC growth promoting 
effect of CSPG be balanced to achieve repair? Currently, research on the function of 
CSPG concentrates either on its growth promoting effect or its regeneration inhibitory 
effect. Uniting these apparently divergent functions may shed light on the true 
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